kiralik-arabalar

Ellen de brabander, phd, named head of global r&d, merial ltd

2011-06-08T20:09:00.000-07:00

Ellen de Brabander, PhD, Named Head of Global R&D, Merial Ltd.

Ellen de Brabander, PhD., has been appointed Global Head of Merial Research and Development for Merial Limited, a world leader in research, manufacturing and marketing of animal health pharmaceuticals and vaccines. Dr. de Brabander reports to José Barella, Merial’s Executive Chairman, and is a member of Merial’s executive leadership team.

Duluth, GA (Vocus) June 5, 2008

Dr. de Brabander joins Merial with a broad background of executive R&D positions at DSM, the Netherlands-based global life sciences and material sciences company, and Intervet, the global animal health company. Her most recent position was Head of R&D for Intervet.

As Global Head of Merial R&D, Dr. de Brabander will lead the company’s global research and new product development activities in nine R&D centers around the world. Merial’s R&D division employs more than 700 people.

“The Animal Health industry is a very attractive environment for research and development,” said Dr. de Brabander. “There is a constant and strong demand for new and better products, but this is also a business with complexity and dynamics that are very different from other industries. It is exciting to be able to meet this market demand by applying new technologies that allow us to develop products that make a real difference for our customers. Merial’s capabilities in these new technological areas are impressive. I am fully committed to further strengthen the innovative power at Merial. I am very pleased to have joined Merial because it is an innovation-driven, world-leading animal health company with a strong existing foundation in all major species,” she said.

During the first part of Dr. de Brabander’s career with DSM, she held successive global senior executive-level positions in the Coating Resins and Chemicals divisions. She was appointed CEO of DSM’s Pharma Chemicals in 2004. The following year, she was named Vice President Corporate Technology for all of DSM.

As Head of R&D and Board Member for Intervet beginning in 2006, Dr. de Brabander was responsible for that company’s global R&D organization, managing the R&D activities in both vaccines and pharmaceuticals at 14 sites.

Dr. de Brabander has a PhD in bio-organic chemistry from Leiden University, and completed a post-doctoral program at the Massachusetts Institute of Technology. She will be relocating to Duluth from the Netherlands later this year.

Dr. de Brabander succeeds Dr. Kevin Schultz, who leaves after performing the role of Head of Merial R&D for ten years. Dr. Schultz will remain with Merial as a consultant on special projects and external collaborations.

About Merial
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs more than 5,400 people and operates in more than 150 countries worldwide. Its 2007 sales were nearly $2.5 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please see www. merial. com.

Contacts:
Steve Dickinson
Merial
678-638-3683

Philip Connolly
Merial
+44 1279 77 5846

###

Point of care dispensing improves doctor-patient relationships

2011-06-08T17:07:00.000-07:00

Point of Care Dispensing Improves Doctor-Patient Relationships

Physicians are providing improved patient services by offering Point of Care Dispensing of pharmaceutical medicines to their patients. By doing so, a physician can be unique in the marketplace by helping their patients in several key areas. Though costs to patients are about the same as local pharmacies, Point of Care Dispensing is still profitable for physicians giving them an extra incentive to try this relatively unknown practice.

Sugar Land, TX (PRWEB) May 24, 2006

A small but growing number of physicians around the country are utilizing Point of Care Dispensing (http://www. PointOfCareDispensing. net) purely for the patient benefits the practice can provide. Point of Care Dispensing is a process where physicians provide complete prescriptions rather than hand out samples, saving their patient a trip to the pharmacy. Physician offices that incorporate this into their routine can provide significant benefits to their patients at a price that provides profitability to the physician's practice while not costing the patient any more than they would have paid at their local pharmacy.

"In today's business climate, even doctors compete for clientele in areas outside price" says Jeff Dodson, an independent dispensing consultant at MedX Sales (http://www. PointOfCareDispensing. net), a provider of dispensing services via repackagers of pharmaceutical drugs. "A doctor that provides improved patient services like Point of Care Dispensing stands out above physicians that don't. This can be a significant marketing advantage over nearby competing physician offices."

The list of patient benefits would seem to resonate with most physician's patients. They include:

Save The Patient Money: Many patients do not have drug or medication benefits and the cost to obtain drugs in a pharmacy can be very expensive. Many of the generic drugs a physician would carry in a Point of Care Dispensing (http://www. PointOfCareDispensing. net) program have very reasonable wholesale pricing making the retail price to the patient very affordable.

Save The Patient Time: The convenience of getting your prescription filled at the doctor's office and going home to bed is very appealing to every patient.

Improved Patient Therapy Compliance: It is a known fact that many patients leave the physician's office and never fill their prescription. Pharmacies report this statistic could be as high as 30%. Doctors can now be certain that the patient has the necessary medication and has taken their first dose right in their office.

Reduction In The Error Rate: The potential for fatal errors at pharmacies for the wrong drug, wrong dosage and wrong strength is approaching 5% in some areas. Cross-contamination is virtually 100%. Pharmacies often use the same trays to count different types of drugs. A pharmaceutical re-packager is under a more stringent set of rules and guidelines set by the DEA and FDA that prevent such occurrences.

Confidentiality: Many patients who would rather not discuss their medical situation outside their physician's office appreciate not having to go to their local pharmacist to get a prescription.

"Point of Care Dispensing just makes sense, on many levels," says Jeff Dodson. "Patients can be confident they are getting the right medicines at a cost that is about the same as their neighborhood pharmacy and physicians have an opportunity to increase patient care. For most physicians, it is a matter of when they will dispense medicines, not if they will."

Jeff Dodson is an independent dispensing consultant for MedX Sales. You can read more about Point of Care Dispensing (http://www. PointOfCareDispensing. net) and the company he represents at his web site, www. PointOfCareDispensing. net where you can also watch 2 short videos explaining this practice.

###

The sweetest little shop in winston salem has just celebrated its first birthday

2011-06-08T08:31:00.000-07:00

The Sweetest Little Shop in Winston Salem Has Just Celebrated its First Birthday

Winston Salem, NC (PRWEB) September 14, 2006

The sweetest little Shoppe in Winston-Salem has just celebrated its first year in business at 1228 Reynolda Road.

The aroma of freshly brewed coffee and gourmet chocolates tickles the senses as you make your entrance into SWEETIE’S, a quaint little dwelling that is now home to an array of unique candies and gift items.

Owners Russ & Jackie Williams stated that they wanted to bring a friendly, relaxed shopping experience to the local consumer who is searching for that little gift or candy item that might be out of the ordinary. As well as to provide corporate clients with exceptional items to satisfy their gift giving needs.

The 1928 bungalow that sits opposite the Children’s Home of North Carolina was painstakingly restored to reflect it’s elegant beginnings. With the help of friends and family members every surface was repainted, the hardwood floors restored to their original splendor.

In what was once the living room of Mac and Treva Teague, now serves as the inviting front room of SWEETIE’S. There is an antique fudge case well over 100 years old that houses mouth-watering truffles from Birnn in Burlington, Vermont and a selection of fudge from the Outer Banks. Light fixtures from the local Habitat Re Store and a lovely old sideboard from the downtown Rescue Mission outfitted the store and a large selection of handmade cabinetry much of it made by Russ.

A walk through the store reveals another room dedicated to uniquely packaged gift items by Jackie who claims that if “I can put candy on it around it or near it I will”. Evident by her ability to turn the likes of glass blown candleholders or crystal martini glasses into delightful explosions of chocolate and colors.

Travel a few more steps into the kitchen where there are always plenty of tasty samples and you’ll also find aromatic coffees and teas as well as gourmet cookies, chocolate covered pretzel rods and a very decadent caramel popcorn drizzled with white chocolate and nestled in with pecans, cashews, peanuts and bits of Belgian and white chocolate.

Jackie tells us that part of the charm and appeal of this little sweet Shoppe is that we have taken the time our first year in business to really listen to our consumer to provide them with not only the different and unusual but to also support the local artist and vendors right here in Winston Salem. It is all part of the charm of our store and gives our local artisans a place to showcase their wares.

To that end you will find an entire room dedicated to wonderful stationery, invitations and gift cards by local Winston artist and designer Devora Transou of Devora Designs’ whose latest designs now grace ladies silk PJ’s by Calvin Klein being sold at Neiman Marcus in New York City.

Beautiful tile trivets and hand painted ceramics, award winning photographic greeting cards by Winston’s very own Maria Braucht who for many years had her own very popular coffee and gift shop on Stratford Road. “Maria was and remains an icon in Winston” According to Russ we also carry several flavors of Maria’s locally roasted coffee beans. Here at Sweetie’s you cannot only sample her coffees but it is available for sale freshly brewed by the cup or whole bean by the pound.

There are fragrant gel candles, hand crafted by local husband and wife team, Andy and Debbie Winfrey, and lighting up the corners here and there are the charming seasonal glass blocks by Sandy.

New to Sweetie’s are the decidedly delicious Homemade Goodies by Karen and Nancy; two sisters who moved their respective families from hundreds of miles apart to Winston to be able to start a business venture together. Karen and Nancy provide scrumptious handmade caramels and white chocolate macadamia nut biscotti.

You’ll find two “life size” bunnies waving at you from the front porch every day they have become the store mascots and were hand crafted by local artisan Dee Keegly, whose fabulous stick ponies and unique wooden purses also call Sweetie’s home.

Jackie can be found on many a day helping to make the dreams of local brides come true or catering to the needs of special occasions in the way of hand crafted and customized favors for weddings, birthday’s, anniversaries, Bar or Bat Mitzvah’s. Corporate gift baskets and many ideas for pharmaceutical reps to realtors are her specialty.

She enjoys working with fine candies from around the world and her colorful candy arrangements can be found throughout the store and her work has been commissioned by the likes of Harley Davidson, Regal Marine boats, Outback Steak house and Westgate Resorts in Orlando, Florida. A former merchandising manager for Michael’s Art & Crafts in Florida she made an easy transition to Candy Bouquet Franchise owner and with the help and backing of her husband Russ they moved their business from New Smyrna Beach to Winston.

Russ a North Carolina native was born and raised in Siler City and is a graduate of Davidson College. Jackie, the product of a military home has lived “most everywhere” including a year in Alaska and several years abroad.

We chose Winston because we have a blended family, Russ has two daughters who live here with their families a son and his family in Jacksonville NC. Jackie has two sons in the Marine Corps, stationed at Camp LeJuene in Jacksonville, NC who currently serve with Operation Iraqi Freedom.

Russ, Jackie and the staff at Sweetie’s extend a warm invitation for you to come on by, sample our sweet treats grab a cup of freshly brewed coffee and sit for a spell on our front porch bench. Check out what’s on tap for Halloween and the upcoming Christmas holiday. Whatever the season, whatever the reason Sweetie’s has something special for everyone.

Store hours are Monday – Saturday from 10:00 AM to 6:00 PM.

For additional information contact Jackie or Russ at 336-723-4264.

# # #

Uv-visible-nir microscope for broadband inspection

2011-06-08T01:31:00.000-07:00

UV-Visible-NIR Microscope for Broadband Inspection

CRAIC Technologies introduces the UVM-2 broadband microscope for UV, visible and NIR range microscopy in both transmission and reflectance.

San Dimas, CA (PRWEB) March 26, 2007

CRAIC Technologies, the leader in UV-visible-NIR microscopy and microspectroscopy, today released the new UVM-2™ Broadband Microscope. This new instrument represents a major step forward in the field of microscopy as it is able to image from 250 to 2000 nm over narrow bands or large spectral regions. The UVM-2™ can acquire transmission and reflectance microscopic images with sub-micron resolutions.

"The UVM-2™ was developed in response to customer requests for UV and NIR imaging. This system allows for our customers to acquire high resolution micrographs quickly, easily and non-destructively. The UVM-2™ is designed to meet those requirements with a robust and durable instrument," says Dr. Jumi Lee, Senior Vice President. "With such features as broadband optics, broadband light sources and digital UV and NIR imaging, this microscope can be used for scientific research and industrial quality control in many different fields."

The UVM-2™ uses range from purely scientific research to industrial applications to quality control. For example, the UVM-2™ is equally at home being used for inspection the interior structures of bonded silicon devices as it is directly imaging protein crystals used in pharmaceutical research. Absorbance, transmission, and reflectance illumination in the UV, visible and near infrared regions can all be done with the same microscope.

CRAIC is dedicated to working with its customers to enable them to obtain and maintain the latest microscopy technology. The UVM-2™ is an example of this dedication. For more information on this and other products, please contact CRAIC Technologies.

About CRAIC Technologies, Inc.

CRAIC is a leader in the design, manufacture and marketing of high-performance UV-visible-NIR range microscopes and microspectrometer systems. CRAIC instruments are used in a diverse range of fields including forensics, semiconductor metrology, flat panel display metrology, chemistry, biology and physics. Located near Los Angeles, at the foot of the San Gabriel Mountains, CRAIC's website is www. microspectra. com.

###

Apriori beauty launches celloxylin md

2011-06-07T12:49:00.000-07:00

Apriori Beauty Launches Celloxylin MD

No needles or knives, just advanced, innovative skincare products that replace expensive and risky medical procedures

Laguna Hills, CA (PRWEB) June 22, 2010

Apriori Beauty, LLC announced the launch of its anti-aging treatment brand, Celloxylin® MD -- pharmaceutical grade skincare treatment products that are undeniably effective without a prescription.

The Celloxylin MD brand launches with 20EX Acid Peel. Using the highest ingredient levels possible without a prescription, this non-abrasive peel provides intensive, 20% EXfoliation with a potent complex of glycolic acid, lactic acid, N-Acetyl glucosamine and encapsulated salicylic acid. Each ingredient in this proprietary complex is clinically proven to improve skin's appearance and texture and reduce the visible signs of aging, including: lines, wrinkles, hyperpigmentation and scarring. Soothing and calming ingredients, aloe vera and cucumber, help make this peel safe and effective, without long-term irritation. A natural alternative to professional treatments, this fast-acting peel provides immediate, visible results in the comfort of your own home!

"As a surgeon, I know firsthand the risks associated with elective surgical procedures. With Apriori Beauty's Celloxylin MD, women have the opportunity to look and feel beautiful at an affordable price and without any risk," said Lisa Karamardian, MD, Newport Beach, CA.

"Apriori Beauty continues its promise to offer pure product innovation with Celloxylin MD," said Candace Keefe, CEO of Apriori Beauty. "With this proprietary and potent formula, you can immediately feel and see results. Our Clients and Consultants are ecstatic about this product, especially since you can go out in public the same day after using it. There's no unsightly flaking, like professional treatments, and the results speak for themselves."

Apriori Beauty's products are sold exclusively through independent Consultants at aprioribeauty. com. Available for $55 (1.6 fl oz | 50 mL), 20EX Acid Peel is packaged in an easy-to-use airless pump tube.

Celloxylin MD is just what the doctor ordered.

###

The ugly truth about commercial cosmetics

2011-06-06T20:53:00.000-07:00

The Ugly Truth About Commercial Cosmetics

Afterglow Cosmetics explains the dangers behind many commerical cosmetics.

Boston, MA (PRWEB) May 4, 2006

Over 90% of all ingredients in commercially available cosmetics are of synthetic origin and directly linked to serious health risks like cancer, infertility, kidney and liver disease and severe skin issues.

Skin Deep's Report which recomends Natural Cosmetics (http://www. afterglowcosmetics. com) has identified over 900 chemicals commonly available for use in cosmetics that have toxic substances and are dangerous to your health. Environmental Working Group report called, “Skin Deep” found that almost 90 percent of the more than 10,000 ingredients used in personal care products have not been evaluated by government regulators. At the same time of the 20,000 different off-the-shelf cosmetic products that are for sales in the US, over 80% of the products surveyed contained one or more ingredients that have caused documented adverse reactions in humans and animals in the past.

Most of the large cosmetic and personal-care companies will tell you not to worry. They agree that there are many chemicals in their products, but say that the quantities are small and will not affect you. At first glance this seems reasonable. Unfortunately, this is a sugar coated public relations response and does not identify the true issue at hand. Medical science has proven that humans exposed over time to very small quantities of harmful chemicals do indeed suffer the consequences.

Medical science has proven that even the thin patches we stick to our arms or stomach with very small amounts of pharmaceutical chemicals can very effectively deliver chemicals into the bloodstream, totally changing the body's chemistry. Trans-dermal patches containing small traces of nicotine can effectively deliver chemicals directly into the bloodstream to alter tobacco cravings. The new contraceptive alternative to the “Pill” is a patch which contains very low levels of hormones and still has the ability to stop a woman from getting pregnant.

Little is known about the long term effects of the petroleum chemicals and synthetic products that we rub into our skin on a daily basis in the form of cosmetics, lotions, shampoos, etc. At this point scientists and researchers know that these chemicals pose a threat to human health and fertility and have been found in our bodies and breast milk. Chemicals found in cosmetics and personal-care products are linked to birth defects, hormone disruption and reduced fertility not to mention more pervasive cosmetic damage such as rashes, mild to severe acne and eczema. Many people use cosmetics and lotions to cure skin issues. Ironically, the products they are using and hoping for a cure are the very same products that are causing the problem.

Press Release by Gomvents Corp., a Boston Search Engine Placement (http://www. gomvents. com) and Marketing Firm.

###

Buy soma and carisoprodol online in the privacy of your own home at us-meds. Com

2011-06-06T08:39:00.000-07:00

Buy Soma and Carisoprodol Online in the Privacy of Your Own Home at US-Meds. com

Buy Cheap Soma and Carisoprodol online at US-Meds. com, an online pharmacy service specializing in the muscle relaxer Soma and it's generic counterpart Carisoprodol.

(PRWEB) September 10, 2004

Soma, or its generic counterpart called Carisoprodol, is a muscle relaxer that works to help the pain associated with muscle spasms, strained or torn muscles, and is one of the best selling muscle relaxant pills in the USA. US-Meds. com offers this amazing muscle relaxant online through their web site at http://www. us-meds. com/_buy_soma. htm (http://www. us-meds. com/_buy_soma. htm)

Soma, the frequently prescribed muscle relaxer pill has come under increased pressure from state governments this year because government officials have deemed it necessary to protect its citizens from this muscle relaxer, even though no evidence has been submitted to prove that Soma is dangerous at all if used as prescribed.

Some states have recently decided to enact laws to ban online pharmacies from shipping Soma and Carisoprodol to their state because the patient has not physically met with a doctor before ordering Soma or Carisoprodol. The only problem is that an increasing amount of doctors are unlikely to prescribe this medication due to political pressure even though their patients would benefit tremendously from taking Carisoprodol or its name brand counterpart - Soma. A large percentage of patients looking to purchase Soma or Carisoprodal online already use these medications and have a valid prescription for these medications but government officials still deem it necessary to protect these patients from these muscle relaxants even though the majority of these people are in greater risk of further muscle injury.

Soma or Carisoprodol can help these people and US-Meds. com can help them purchase these medications online discreetly, and without having to take time off of work or wait in a busy waiting room for hours at a time. Many people buy Soma or Carisoprodol online because it is a convenience for those who can not afford to take the time off of work or for those of us who do not have medical insurance. And in terms of cost, Soma and Carisoprodol pills are very cheap. Soma, in its generic form called Carisoprodol can be purchased for under $100 for a 90 pill supply - very cheap Soma indeed.

Because of the unwillingness of doctors to prescribe the medications, patients now have to go to an online pharmacy to get Soma or Carisoprodol prescribed to them, which is now harder to do than ever because there are so many online pharmacy scams out there. That is where US-Meds. com comes in. They have been in business for almost two years with tens of thousands of happy customers. You can still buy Soma or Carisoprodol online at US-Meds. com and if you qualify, their doctors will write a prescription for you - meaning you do not have to already have a prior prescription! After a doctor writes your prescription, your prescription will be forwarded to one of the many pharmacies that fill for US-Meds. com. The pharmacy will fill your order and ship it out to you via FedEx Overnight Express straight to your door.

Soma and Carisoprodol are available in 350mg round tablets and are available in quantities or 30 or 90 pills. Soma or Carisoprodol can be taken up to 4 times a day as prescribed by the doctor. No more waiting rooms, no more taking time off of work, no more appointments, no more embarrassing doctor visits. Buy Soma or Carisoprodal online today at US-Meds. com to stop the muscle pain and live your life to the fullest!

To order Soma (Carisoprodol) 350mg tablets online, please use the following url: http://www. us-meds. com/_buy_soma. htm (http://www. us-meds. com/_buy_soma. htm)

# # #

Mediregs, inc. Acquires the compliance products of ihs health group, expands library of resources for the medical compliance and reimbursement industriesmediregs, inc. Acquires the compliance products of ihs health group, inc

2011-06-06T00:29:00.000-07:00

MediRegs, Inc. Acquires the Compliance Products of IHS Health Group, Expands Library of Resources for the Medical Compliance and Reimbursement IndustriesMediRegs, Inc. Acquires the Compliance Products of IHS Health Group, Inc.

(PRWEB) October 11, 2002

Somerville, Mass., October 7, 2002ÂMediRegs, Inc., the leading provider

Innovative electronic compliance and reimbursement products, announced

Today

It has entered into a definitive agreement to acquire the assets of the

IHS

Health Group, a worldwide supplier of healthcare industry information.

This

Acquisition extends a long-standing relationship between the companies

And

Consolidates MediRegs leadership position in healthcare and life

Science

Regulatory compliance. The terms of the agreement were not disclosed.

ÂThe clients of both IHS Health and MediRegs will benefit financially

And in

Operational efficiency from having the most comprehensive, up-to-date,

And

Easy-to-use compliance and reimbursement products at their fingertips,Â

Said

Sandy Friedman, president of MediRegs. ÂWe believe that this is an

Ideal

Arrangement for the hospitals, law firms, pharmaceutical companies,

Medical

Device manufacturers, insurance companies, physicians groups, billing

Companies and other clients who rely on the products and services of

IHS

Health and MediRegs.Â

ÂWe have been working with MediRegs for a number of years,Â said Randy

Weil,

President and COO of IHS Engineering. ÂWe believe that MediRegs has

The

Technical know-how to take compliance and reimbursement solutions to

The

Next level of performance and utility. We have every confidence that

MediRegs will play a pivotal role in bringing greater productivity and

Efficiency to organizations of all types involved in the

Life-sciences.Â

ÂAdvances in medicine are driving new legislation and regulation,Â

Continued

Mr. Friedman. ÂThis coupled with the complexity of being in compliance

With

The Health Insurance Portability and Accountability Act (HIPAA),

Emergency

Medical Treatment and Active Labor Act (EMTALA), and Ambulatory Payment

Codes (APCS) and other recent legislation inspired MediRegs to create a

New

Generation of more user friendly compliance solutions.Â

MediRegs is able to offer clients customizable compliance solutions

From an

Inventory of approximately 1,000 electronic databases. Internet clients

Are

Able to use the MediRegsÂ software to customize compliance solutions

From

The individual desktop to the overall organization. The MediRegs

Software

Manages the myriad external databases and also serves as a publishing

Platform for internal policies, procedures and other related regulatory

Information. The result is a one-stop clearinghouse configured to the

Unique

Requirements of each organization.

IHS Health Internet products have been operating on the MediRegs

Technology

For two years and are used daily by all IHS Health Internet

Subscribers.

Clients of the IHS CD-ROM products will continue to receive their

Subscription products with no interruption in service.

MediRegs will offer Internet based orientation and training on all

Products

Beginning in October 2002. IHS clients seeking technical support,

Education, training or administrative assistance should contact

MediRegs at

(800) 808-6800 or support@mediregs. com.

About MediRegs

MediRegs has developed a unique software capability that enables

Companies

And individuals to tailor the compliance solutions they want

Interactively.

The goal of the MediRegs design is to make it possible to meet the

Compliance needs of any job function in health care. This approach

Offers

The most efficient and affordable way to keep people at all levels

Current

With compliance and reimbursement information.

About IHS Group

With over $400 million in annual sales, Denver-based IHS is the

Worldwide

Leader in developing and implementing engineering, technical and

Regulatory

Information solutions for customers in over 90 countries. IHS produces

Comprehensive collections of technical standards, design guidelines,

Vendor

And logistics information, energy exploration, health and regulatory

Data,

Production knowledge and information, and software tools. IHS

Solutions

Include CD-ROM and Internet subscriptions, customized solutions such as

Data

Conversion, information portals and systems integration, and hardcopy

Documents via Global Engineering Documents. The company employs more

Than

2,700 people worldwide and serves the vital information needs of

Customers

Across the world's technical, business and professional sectors. IHS

Ranked seventh in the Denver Business JournalÂs (DBJ) list of Top 100

Largest Colorado Private Companies. If you require additional

Information

On IHS and its products and services, visit www. ihs. com.

Protection for the modular data center

2011-06-05T16:11:00.000-07:00

Protection for the Modular Data Center

The modular data center concept has burst onto the scene with the biggest names in the IT industry touting the speed of deployment of their pre-configured servers in a portable shipping container. For scenarios where time is of the essence and cost is a secondary concern, a "data center in a box" is a viable solution. For more conventional data center applications, modular fireproof server vaults provide protection for mission critical data and infrastructure, while allowing expansion as needs grow.

Kutztown, PA (PRWEB) August 26, 2008

Heavy hitters like IBM, Sun, and Google are all offering "data center in a box" products as a way to quickly deploy computing power. The pre-configured IT equipment is delivered to the data center site in a standard shipping container, where it is typically parked outside the building and connected to the required power, communications and cooling systems. For several years FIRELOCK® has been building fireproof modular server vaults, but with the emphasis on protecting the mission critical equipment and data housed within the server room, rather than speed of deployment.

The high costs for building-in the future cooling and UPS capacity for future expansion equipment is often the driver for examining this modular approach. But an examination of this modular expansion concept reveals that clients forego this common sense approach due to the inflexibility of the design module and the high incremental cost of each cubic foot of expansion. The use of these add-on modules are almost exclusively used for disaster recovery situations, where the business continuity requirements outweigh the high incremental costs.

It makes sense to protect the mission critical server room with a data-rated fireproof server vault (http://www. servervaulting. com) chamber. Fortunately, the advantages of phased expansion can be applied to fire protection by installing a FIRELOCK® modular server vault. The modular panel design allows data center operators to protect the server racks they have now, and expand the fireproof vault area as their server room footprint grows.

It is inconceivable to build a data center without a fire suppression system to protect the equipment. No IT professional would even consider it. IT systems are too important to most organizations' survival to count on sprinkler systems alone to protect them from external fires (http://www. servervaulting. com/threats. asp). The server room must be able to survive a building fire, the fire fighting efforts of the building's sprinkler system and the high pressure hoses of the firefighters themselves. This mandates that a secure server room must be in fact, a server vault chamber.

The heat-sensitive nature of IT equipment--and perhaps even more important--the information stored upon that equipment, requires a Class 125 Fire-Rated vault to protect it. This vault can withstand heavy hose streams, the smoke and steam of a building fire as well as explosive fire development of the structure. The vault must be able to do this and still maintain a vapor tight chamber to protect the servers. FIRELOCK® server vaults are rated at least Class 125-2 Hour, which means the temperature must be held below the 125-degrees F. threshold for at least a two hour period with temperatures up to 2,000-degrees F. outside the vault. FIRELOCK® achieves this level of performance with a comprehensive vault system (http://www. servervaulting. com/components. asp). The modular vault panels that comprise the walls and roof structure utilize ceramic fiber, a high temperature industrial insulating material, to provide unsurpassed fireproofing and heat protection. Because there is no single fire door on the market that can provide Class 125 protection, a double door assembly is installed. These doors are equipped with automatic closers that are activated by heat, smoke, flammable gas or power failure. Specially insulated penetrations for power and network cables, coolant lines, and air ducting are installed to ensure there are no weak links in the chain. The cost difference between installing a data-rated vault versus conventional gypsum board structures is negligible, especially when compared to the value of the IT infrastructure and information that must be safeguarded.

A common misconception among architects and facilities designers is that fire rated gypsum board will adequately protect heat-sensitive IT infrastructure. Unfortunately, standard fire ratings (http://www. servervaulting. com/faq. asp) focus on how long it takes flame to penetrate a layer of gypsum board, not how much heat is being transferred through the barrier. Because gypsum board is a high-density material, it conducts heat very quickly. Heat-sensitive servers and data are destroyed long before flames penetrate traditional fire rated structures. Class 125 door systems, cable penetrations, coolant line penetrations and dampers are also overlooked in conventional facilities.

The "Modular Expansion" that the shipping container modules hope to target can be more easily achieved with an internally located server vault chamber. This chamber can be expanded as required with panels that offer phased expansion with simple interlocking panel add-ons. The new add-on occurs while the data center or server room operates and then at the final phase of construction, a removable panel opens the new addition to the existing data center. All the wire management, fire suppression systems and HVAC are in place for a smooth transition.

The "data center in a box" concept is well suited to applications such as disaster relief efforts, military operations, data center migrations (for temporary use), or rooftop deployment for facilities that run out of room. Critics of this concept have raised questions about physical security for containers full of IT equipment parked outside the facility. A single connection point for the dense power and communications services required is also cause for concerns about reliability. Then there is the question of what to do if you need to open the container during a rainstorm, or other adverse conditions.

One other use for "data center in a box" containers is as a temporary (and costly) replacement for IT equipment that has been damaged or destroyed by fire. Failure to protect the data center may create just such a need. For conventional data center applications, a modular fireproof vault offers the design flexibility needed to optimize data center operations and protect mission critical information.

About FIRELOCK® (http://www. servervaulting. com/about. asp)
FIRELOCK® provides custom design expertise and manufactures and installs modular server vaults and media storage vaults in a variety of sizes, from small rooms up to 25,000 cu. ft. These vaults are designed to provide UL Class 125 fire protection, along with environmental controls for your critical or vital information assets. Lightweight, expandable panel systems are available to construct fire-safe and heat-safe vaults for the protection of IT infrastructure, magnetic media, micrographic media, and optical disks. The FIRELOCK® vault is the highest rated fire protection storage environment for heat-sensitive processing equipment and computer media available in the industry. Our client list includes service organizations of all types and sizes from diverse industries, ranging from hospitals and pharmaceutical companies, to major financial houses and State and Local Government offices. Information about FIRELOCK® is available at www. servervaulting. com.

###

New year's resolution: tackle ugly, yellow toenails and wear sandals this summer

2011-06-04T19:40:00.000-07:00

New Year's Resolution: Tackle Ugly, Yellow Toenails and Wear Sandals This Summer

Changing habits is a challenging process, whether we're trying to eliminate a bad habit or develop a good one. Experts in the field of lifestyle change suggest that it takes at least 21 days to replace an old habit with a new one. In the case of feet, developing good foot care habits can improve the appearance of unsightly toenails and dry, cracked heels and soles.

Princeton, NJ (PRWEB) December 29, 2007

Millions of men and women hide their yellow or discolored toenails and avoid wearing sandals or open-toed shoes in summer because they're embarrassed by the appearance of their feet. But, having attractive feet and toenails are within reach for those willing to make a commitment to using the right products and to developing good foot care habits.

Carol J. Buck is CEO of Xenna Corporation, which distributes natural foot care products (www. xenna. com) to chain drugstores and mass retailers. She says," Creating good habits is the key to looking younger and feeling healthier. The critical period is the first 21 days. During that time doing a new habit daily is, quite honestly, annoying, but after 3 weeks, the brain accepts the new habit as a normal and expected activity which you no longer mind doing. "

Feet Often Neglected in New Year's Resolutions

New Year's Day is a time for making new habits related to self-improvement from head to toe. We all remember to work on our faces and bodies, but feet are usually ignored until the warmer months when the sandals come out of the closet. This is unfortunate because January is the perfect time to start a new regimen geared to making ugly feet more attractive. This is because it can take months of personal attention (and new habits) to feel confident in sandals or bare feet.

Fortunately, Xenna's natural NonyX® Nail Gel and CalleX® Ointment for Dry, Cracked Feet with natural enzymes are money-back guaranteed to make nails and feet more attractive.

Xenna's patented NonyX® Nail Gel is for use by those with unattractive yellow, discolored or thick toenails, including diabetics. NonyX Gel breaks down and softens keratin debris buildup under toenails - the discolored, yellow or thick granular buildup under nails which is the actual source of nail discoloration.

Within 3 or 4 weeks, the keratin debris is loose enough to begin scraping out from under the nail. With continued use, overall nail appearance improves over time, resulting in nails that are clear and healthy-looking after 5 to 12 months. Once keratin debris is removed, NonyX Gel then keeps nails looking clear and attractive with periodic use. NonyX Nail Gel is found in the foot care aisle of drugstores and supercenters. (See store list.)

Patented CalleX® Ointment for Dry, Cracked Feet thins and softens thick, flaky skin on feet and rejuvenates and moisturizes dry, cracked heels. Its natural enzymes selectively exfoliate dry, cracked, thickened or scaly skin while its petrolatum base retains natural skin moisture. Acid-free and diabetic-friendly, CalleX Ointment has been shown in consumer studies to significantly reduce thickened skin areas within 15 to 30 days and is sold in most drugstores in the foot care section. CalleX Ointment is free of acids, mineral oil, colorants and lanolin. Lightly fragranced with refreshing peppermint oil, the 1.75 oz. jar is a one to two month supply.

Used by podiatrists, diabetic-friendly NonyX Nail Gel and CalleX Dry Heel Ointment are free of parabens, lanolin, and animal-derived ingredients and are not tested on animals. They are also made in the USA.

Good Foot Care Habits for 2008

In addition to consistently using the right products, developing good foot care habits are key to having attractive feet. Good foot care habits include:

· Thoroughly washing and drying feet daily
· Throwing out all old shoes or donating to charity those that do not fit properly
· Changing shoes and socks at least twice a day
· Taking your own nail implements when getting a pedicure; never share nail tools with others
· After purchasing new shoes, place shoes periodically in a sunny place where they can air out.

"January is a perfect time to start thinking about your feet," reiterates Ms. Buck, "especially if you have discolored toenails. Once you get into the habit of using a topical gel or ointment, a few seconds a day leads to fun shopping in the spring for the latest sandal styles with baby-soft heels and gorgeous, natural nails next summer. While it can take several months to almost a year to solve the problem of ugly toenails, attractive feet and toenails are within reach, and the resulting self-confidence is definitely worth the effort!"

All Xenna products are unconditionally money-back guaranteed. For photos of toenails and heels before and after using Xenna products, click on www. xenna. com.

NonyX Nail Gel can be purchased in the foot care section of Walgreens, Rite Aid, CVS, Wal-Mart, Longs, TARGET, Eckerd Pharmacy, Brooks Pharmacy, Duane Reade, Kerr Drug, Snyders, HEB, Bi-Lo and Giant Eagle grocery stores and most Medicine Shoppes.

CalleX Ointment is sold at Rite Aid, Walgreens, Duane Reade, Kerr Drug, HEB, Giant Eagle, Bi-Lo, Snyders and Longs. Online, both are also available at http://www. xenna. com (http://www. xenna. com)

Xenna Corporation is a privately-held, woman-owned company based in Princeton, NJ which develops and distributes natural personal care products for skin, hair and nails. To contact them call 800-368-6003 (business hours, Mon-Friday Eastern Time) or email.
View their press page at http://www. xenna. com/info_pressreleases. html (http://www. xenna. com/info_pressreleases. html)

###

American corporate identity honors mcmillian design

2011-06-02T01:05:00.000-07:00

American Corporate Identity Honors McMillian Design

McMillian Design has recently been honored with four corporate identity projects to be included in the American Corporate Identity 21 design annual.

Brooklyn, NY (PRWEB) March 21, 2005

McMillian Design has recently been honored with four corporate identity projects to be included in the American Corporate Identity 21 design annual. American Corporate Identity is the only annual national competition devoted specifically to the field of corporate identity. The 20 previous competitions have provided a highly respected showcase for the very best corporate identity in use today in the United States. This is the eighth consecutive year McMillian DesignÂs work has been included in the annual.

Awards for corporate identity excellence were received by Lansdowne Resort for MMG Worldwide, Protech Pharma, Downtown Conference Center for MMG Worldwide and Pharmaboard. com.

William McMillian has won over 250 awards from organizations across the country and around the world. His work is also regularly featured in design books and trade publications.

William McMillian

Art Director/Principal

McMillian Design

81 Clifton Place, #3G

Brooklyn, NY 11238

T 718.636.2097

C 917.734.2440

F 718.504.3699

Http://www. mcmilliandesign. com (http://www. mcmilliandesign. com)

###

Pharmavoxx selected by med ad news as one of three most innovative pharmaceutical marketing ventures for its superior competitor intelligence database

2011-06-01T13:42:00.000-07:00

PharmaVoxx Selected by Med Ad News as One of Three Most Innovative Pharmaceutical Marketing Ventures for its Superior Competitor Intelligence Database

Database of promotional material helps clients turn data into actionable competitive analysis, and is recognized for innovation by industry publication

Orange, CA (PRWEB) November 30, 2010

PharmaVoxx, a leading provider of competitor intelligence and business analytics for pharmaceutical marketing, today announced that it has been selected by Med Ad News as one of three "Pharmaceutical Marketing Ventures to Watch" in 2010.

"It is an honor to be recognized by a leading industry publication like Med Ad News," said Dao Vo, General Manager at PharmaVoxx. "Our sole focus is to help our customers stay ahead of the competition and anticipate changes in pharmaceutical marketing quickly. A glowing acknowledgment like this confirms that we are living up to our vision of being the innovative leader in competitive analysis."

This is the fourth year that Med Ad News has named the list of top Pharmaceutical Marketing Ventures to Watch. Only three companies, including PharmaVoxx, were chosen from dozens of nominations.

One of the reasons for the industry notice recently is that PharmaVoxx aggressively evolved new product offerings to meet the changing digital demands of customers. In 2009, PharmaVoxx expanded its competitor intelligence database of promotional materials to include digital media and e-promotions. In 2010, PharmaVoxx added pharmaceutical television advertising and online video monitoring in its database.

The full article, "Ad-ventures in Marketing VI" is featured in the November/December 2010 issue of Med Ad News, and is available to online subscribers at http://www. pharmalive. com/magazines/medad.

About PharmaVoxx
PharmaVoxx delivers highly specific, summarized intelligence of pharmaceutical messaging and promotional strategies. More than an online library of marketing materials, PharmaVoxx gives marketing and competitive intelligence managers a full suite of solutions to track-and-analyze competitor promotional activities. For more information, visit http://www. pharmavoxx. com.

###

It is becoming more cost effective to move pharmaceuticals production overseas. How is this going to affect your businessÂ viability now and in the future?

2011-06-01T10:16:00.000-07:00

It is Becoming More Cost Effective to Move Pharmaceuticals Production Overseas. How is this Going to Affect Your BusinessÂ Viability Now and in the Future?

Experts in the fields of Risk, Systems Thinking and Programme Management will provide insights into how these disciplines can be used to redress the balance and bring success back into pharmaceutical manufacturing.

(PRWEB) February 17, 2005

Pharmaceutical Manufacturing Survival in the 21st Century 6 April 2005 One Birdcage Walk, Lodnon, SW1H 9JJ. This seminar will stimulate new thinking on how to deal with the problems that are affecting the entire industry. Speakers will specifically focus on developing strategies for success within pharmaceutical manufacturing. Delegates will also benefit by obtaining an overview of what key challenges are facing the industry.

As well as will stimulating new thinking on how to deal with the problems that are affecting the entire industry, speakers will specifically focus on developing strategies for success within pharmaceutical manufacturing. Delegates will also benefit by obtaining an overview of the key challenges that are facing the industry.

For further information, please visit our webiste

Www. imeche. org. uk/conferencesandevents/pharma21c (http://www. imeche. org. uk/conferencesandevents/pharma21c )

About the Institution of Mechanical Engineers

The Institution has been the home of mechanical engineers for 150 years. Around 80,000 engineers world-wide are members. The Institution of Mechanical Engineers (IMechE) is the United Kingdom's qualifying body for mechanical engineers.

Members work in research, design, development, manufacturing, installation, commissioning, contracting, consulting and teaching in fields as diverse as lubrications, satellite launching, surgical implants and power stations. all find out about the latest developments in their own related fields through the Institution's hundreds of Conferences, Seminars and Events.

Contact Information

Victoria Gatt

Events Assistant

Institution of Mechanical Engineers

Tel +44 (0)20 7973 1316

###

Gridlogics launches chemical patent analysis edition of patent insight pro – chempat™ edition

2011-06-01T03:15:00.000-07:00

Gridlogics Launches Chemical Patent Analysis Edition of Patent iNSIGHT Pro – CHEMPAT™ Edition

Gridlogics, a patent analytics solutions specialist and the company behind Patent iNSIGHT Pro, announced that it has partnered with ChemAxon to enable a specialized edition of the product (CHEMPAT™ Edition) suited for Chemical and pharmaceutical companies. Patent iNSIGHT Pro CHEMPAT Edition is the first chemical patent analysis tool suited for the needs of patent information professionals. It allows users to extract chemical names intelligently from the text of patents and scientific records and then provides various tools to manage, filter, report and analyze the extracted chemicals.

(PRWEB) November 16, 2010

Gridlogics, a patent analytics solutions specialist and the company behind Patent iNSIGHT Pro, announced that it has partnered with ChemAxon to enable a specialized edition of the product (CHEMPAT™ Edition) suited for Chemical and pharmaceutical companies. The CHEMPAT Edition combines the Patent research, analysis and reporting capability of Patent iNSIGHT Pro with the Chemical extraction, storage, management and search capabilities of ChemAxon’s products JChem Base and Name to Structure.

Patent iNSIGHT Pro CHEMPAT Edition allows users to extract chemical names intelligently from the text of patents and scientific records and then provides various tools to manage, filter, report and analyze the extracted chemicals. In case of patents compounds coming from Bibliography, Claims and description are identified separately which makes it easier to investigate the record set from a patentability, infringement or freedom to operate perspective. The product uses JChem Base to store the extracted set of chemical names, conduct structure searching within them and display them as images or export them in various formats compatible with other cheminformatic tools.

The CHEMPAT Edition is available in Basic and Full versions. The Basic version is targeted towards day to day activities of patent professionals in chempharma companies whose needs are more of extraction, search, filter and in-context reporting of chemical entities present in patent and journal records. The full Edition allows analyst to further conduct different types of analysis suitable for medicinal chemistry projects such as drug discovery and new chemical entity research.

“Exporting structures from chemical databases can be quite expensive and new records are not always available quick enough. The rapid increase in rate of patent filings only makes this worse. Our users in chemical and pharmaceutical companies presently use Patent iNSIGHT Pro to integrate patents and journal information for a particular research area and further use the record set for analysis. They have been looking at cost effective ways to extract chemical names from the text of these records and use that further for patentability searches, reporting and patent analysis. We have launched CHEMPAT Edition to address this need.” said Manish Sinha, Chief Technology Officer, Gridlogics.

“We are pleased that Gridlogics has chosen ChemAxon's chemistry technology and has joined our partner community. This is a good example of the relevance of our technology and partnering approach, particularly where our name to structure and chemical search tools are being innovatively applied within the patent IP and text mining space” said Nora Lapusnyik, Partner Relationship Manager at ChemAxon.

“ChemAxon’s components outperformed alternatives in our testing and we were also quite satisfied with the support given during the trials. They turned out to be a natural fit for the CHEMPAT Edition” added Manish.

About Gridlogics Technologies Pvt Ltd
Gridlogics is a research driven software and services organization specializing in providing intellectual property analysis and visualization solutions to aid R&D and corporate strategy. Gridlogics products are used by leading legal services and research driven organization across US/Canada, Europe, South America and Asia/Pacific with more than 250 end users. Gridlogics is headquartered in Pune India and has a sales presence in India and US. For further information on Gridlogics and Patent iNSIGHT Pro please visit http://www. patentinsightpro. com or mail at sales@patentinsightpro. com.

About ChemAxon Ltd
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www. chemaxon. com.

###

Johnson & johnson wins economist intelligence unit awards programme

2011-05-31T20:55:00.000-07:00

Johnson & Johnson wins Economist Intelligence Unit awards programme

Pharmaceuticals giant Johnson & Johnson yesterday won first place in the Americas region in the Global Corporate Achievement Awards 2002, an awards programme organised by the Economist Intelligence Unit to recognise companies that have delivered outstanding performance in volatile economic conditions. Sponsored by Cap Gemini Ernst & Young, Oracle, SG Corporate & Investment Banking and Heidrick & Struggles, the awards sought out companies that have been able to thrive in bad times as well as good.

(PRWEB) October 25, 2002

Johnson & Johnson wins Economist Intelligence Unit awards programme

Southwest Airlines awarded special commendation for strategy

New York, October 23 2002 -- Pharmaceuticals giant Johnson & Johnson yesterday won first place in the Americas region in the Global Corporate Achievement Awards 2002, an awards programme organised by the Economist Intelligence Unit to recognise companies that have delivered outstanding performance in volatile economic conditions. Sponsored by Cap Gemini Ernst & Young, Oracle, SG Corporate & Investment Banking and Heidrick & Struggles, the awards sought out companies that have been able to thrive in bad times as well as good.

Johnson & Johnson won top honours in a highly competitive group of ten finalists, all with records of sustained profitability, innovation and leadership. Southwest Airlines, a thriving regional airline whose no-frills approach has been widely imitated, took second place, with a special commendation for strategy. Apollo Group, Harley-Davidson and Whole Foods Market were all awarded third-place honours; Apollo, a pioneer in adult education, won a special commendation for innovation. FedEx, Johnson Controls, MBNA, Starbucks and Wal-Mart were finalists.

Honourable mentions went to firms that, while not qualifying for an award under the programme criteria, were success stories: Caterpillar of the US; and Cemex and Grupo Bimbo, of Mexico.

An awards ceremony held yesterday in New York was the culmination of a rigorous selection process. First, an expert panel comprising leading business thinkers and corporate leadersÂamong them the chief executives of Tesco, Nissan and Schlumberger, and the former CEOs of NestlÃ© and SASÂset tough criteria for the awards. Outstanding financial performance over a period of years was a prerequisite, but each company was also required to have shown particular resilience in turbulent times. Next, the Economist Intelligence Unit selected 30 finalistsÂten per regionÂfrom among 175 firms nominated by executives and business writers around the world. Finally, the expert panel chose the winners, after vigorous debate, in September.

Johnson & Johnson exemplified the awards criteria on all counts:

Â· Performance: With revenues of $32bn in 2001, the company has recorded 17 straight years of double-digit profit growth, increased its dividend 40 years running and roughly doubled its share price over the past five years.

Â· Strategy: Strong research-and-development efforts are matched with an aggressive acquisitions strategy; the companyÂs decentralised structure, with nearly 200 autonomous businesses, helps make acquisitions a success.

Â· Leadership: Low-key rather than flashy, the companyÂs leaders encourage decentralised decision-making paired with an ironclad responsibility to deliver results. The recent succession, from Ralph Larsen to current CEO William C Weldon, took place in quiet harmony, without rancour or defections.

Â· Innovation: More than one-third of sales come from products launched in the past five years, or from existing products launched in new markets.

Â· Impact and image: Long a model of corporate responsibility, the company won a reserve of public credit in its handling of Tylenol product-tampering cases. Despite recent challenges, its reputation as a values-based business remains intact.

Johnson & Johnson had plenty of competition. Indeed, although scandals and faltering performance have tarnished corporate reputations, the awards programme showed that there is no shortage of companies that exemplify outstanding achievement. Even in industries where conditions have turned hostile, innovative firms are bucking the trend. The aviation industry is in a tailspin, but second-placed Southwest expects a 30th year of profits. The Internet is in disrepute, but third-placed Apollo Group is recording phenomenal growth in its online education business.

Such success stories are not confined to the US. Winners for the Asia-Pacific region, selected from an equally impressive roster of finalists, will be announced on November 6th; winners for Europe, the Middle East and Africa will be honoured in London on November 13th. Profiles of the finalists are available on the awards website, www. eiu. com/awards (http://www. eiu. com/awards), along with a list of nominated firms, interviews with the experts, the awards criteria and a description of the selection process. An Economist Intelligence Unit white paper, to be published in November, will present case studies of the winners and define the factors that enable firms to thrive in good times and bad.

_______________________________________________________________________________ _______

About the Economist Intelligence Unit

The Economist Intelligence Unit, the business information arm of The Economist Group, publisher of The Economist, is the worldÂs leading provider of country intelligence, with over 500,000 customers in corporations, universities and government institutions. Our mission is to help companies do better business by providing timely, reliable and impartial analysis on market trends and business strategies. Through its global network of 500 analysts, the Economist Intelligence Unit assesses and forecasts political, economic and business conditions in 195 countries.

About the sponsor companies

The Cap Gemini Ernst & Young Group is one of the largest management and IT consulting organisations in the world. The company offers management and IT consulting services, systems integration, and technology development, design and outsourcing capabilities on a global scale to help businesses implement growth strategies and leverage technology in the new economy. In early 2002 the organisation employed more than 56,500 people worldwide and reported 2001 global revenues of more than Â8.4bn. More information about individual service lines, offices and research is available at www. cgey. com.

Oracle is the world's largest enterprise software company. For more information about Oracle, visit the company's website at www. oracle. com.

SG Corporate & Investment Banking is the corporate and investment banking arm of the SociÃ©tÃ© GÃ©nÃ©rale Group. Present in over 50 countries and with expertise in capital markets, advisory and origination services, structured finance and commercial banking, SG builds innovative, integrated financial solutions for its corporate, institutional and public-sector clients. For more information, visit www. sgib. com.

Heidrick & Struggles International is the worldÂs premier provider of executive search and leadership services consulting, employing approximately 1,600 executive search professionals and employees around the world. The companyÂs core business, Heidrick & Struggles Executive Search, has been an industry leader for nearly 50 years, specialising in chief executive, board member and senior-level management assignments for a broad array of clients. The firms conduct more than 4,000 search engagements a year worldwide for clients representing every industry. For more information, visit www. heidrick. com

Marine biotech revenues projected to reach $3.78 billion by 2012, according to new report by global industry analysts, inc

2011-05-31T04:41:00.000-07:00

Marine Biotech Revenues Projected to Reach $3.78 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Driven by growing interest from the medical, pharmaceutical, aquaculture, nutraceutical and industrial sectors, the global market for marine biotechnology is projected to reach a value of US$3.78 billion by 2012.

San Jose, California (PRWEB) February 28, 2008

Comprising the largest part of the planet's biosphere, the marine environment contains the most diverse and ancient forms of life. The advent of advanced scientific disciplines such as molecular biology, genomics, bioinformatics and application of information technology to biotechnology, has tremendously enhanced human understanding of marine life. Widening applications in several end-use areas including marine transportation, environmental remediation, cosmetics, research, and food sectors also contributed to market growth. However, the industry is still in a nascent stage and accounts for a tiny percentage of the overall biotech market. Given the vast untapped potential, the marine biotech sector holds promising growth prospects for the future.

United States is the single largest market for marine biotechnology (http://www. strategyr. com/Marine_Biotechnology_Market_Report. asp) worldwide. The market is forecast to be over US$1 billion in 2008 as stated by Global Industry Analysts, Inc. Non-US markets are projected to record faster growth with a compounded annual rate exceeding 5% through 2012. Biomaterials represent the largest segment with a 50% share. Thickeners including agar, alginates, and carrageen, and flocculents comprising mainly of chitosan, account for a majority of the marine biomaterials market. Bioactive substances represent the second-largest segment generating sales of US$1.44 billion.

The marine biotech sector is characterized by the presence of numerous players ranging from pharmaceutical companies to research-oriented niche companies. Market participants include Aker BioMarine ASA, CP Kelco US Inc, Cyanotech Corp, Elan Corp, FMC Corp, FMC Biopolymers AS, GlycoMar Ltd, Integrin Advanced Biosystems, International Specialty Products Inc, Lonza Group Ltd, MariCal, Marinova, Martek Biosciences Corp, Mera Pharmaceuticals Inc, New England Biolabs Inc, PharmaMar S. A, PML Applications Ltd, Primex Ltd, Prolume Ltd, Sea Run Holdings Inc and Tequesta Marine Biosciences.

"Marine Biotechnology: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, product/technology profile, players, end-use analysis, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets including United States and rest of world. Analytics are provided in terms of product segments including Marine Biomaterials, Marine Bioactive Substances, and Others. The study also covers end-use analytics for Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure sectors.

For more details about this research report, please visit http://www. strategyr. com/Marine_Biotechnology_Market_Report. asp (http://www. strategyr. com/Marine_Biotechnology_Market_Report. asp).

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (http://www. strategyr. com) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR. com
Web Site www. StrategyR. com

###

Latin america gets first taste of what's hot: beverage products in aluminum bottles

2011-05-30T19:40:00.000-07:00

Latin America Gets First Taste of What's Hot: Beverage Products in Aluminum Bottles

CCL Container, North America’s leading producer of impact-extruded aluminum packaging, is giving Latin America its first look at re-sealable aluminum containers.

Hermitage, PA (PRWEB) November 13, 2005

CCL Container, North America’s leading producer of impact-extruded aluminum packaging, is giving Latin America its first look at re-sealable aluminum containers. They are being used for HOT Hangover Tea, an invigorating drink that wards off the unpleasant sensations of a hangover. According to CCL Vice President of Sales and Marketing, Ed Martin, the makers of HOT wanted to introduce the product in a container as new and different as the product category itself.

The HOT aluminum bottle features CCL’s CT-38 threaded plastic sleeve that is fitted to the top of the container to accommodate consumer-preferred, tamper-evident, re-sealable plastic caps. Graphics feature a fiery design of yellow and red, over brushed aluminum. Product information appears in black type in Spanish and English with an area for printing an expiration date.

Innovacion Comercial en Alimentos S. A. de C. V., the marketers of HOT, chose CCL because of its notable expertise and pioneering work with aluminum beverage bottles. To date, CCL’s bottle package has been successfully used for new product launches, limited-edition promotions, anti-counterfeiting measures, product line extensions, and as the catalyst for brand revitalization. Aluminum bottles are lightweight, durable, re-sealable, fast-chilling, recyclable, and deliver product distinction at point-of-sale and are.

Arturo Gonzalez de Aragon, spokesperson for Innovacion, commented, “We are delighted with the packaging and highly confident that it will greatly contribute to the product’s success in the marketplace. The CCL team met our needs efficiently and made important recommendations that resulted in an improved final package.” Initial distribution will be in Mexico, and later throughout Latin and North America.

About CCL

CCL is North America’s leading manufacturer of recyclable aluminum packaging for the beverage, food, personal care, pharmaceutical and household markets, with ISO 9002 Registered manufacturing facilities in Hermitage, PA, Penetang, ONT and Mexico City, Mexico.

For more information on CCL’s products and services, please contact:

Ed Martin, Vice President, Sales and Marketing

CCL Container

Tel: (203) 354-4523

Fax: (203) 354-4524

CCL Container U. S. Operations:

One Llodio Drive

Hermitage, PA 16148

For further press information, please contact:

Ed Delia

Delia Associates

Tel: (908) 534-9044

Fax: (908) 534-6856

For a downloadable version of this release and photo,

Please visit www. cclcontainermedia. com/pr/pr-HotHangoverTea. html (http://www. cclcontainermedia. com/pr/pr-HotHangoverTea. html )

For more information on CCL Container, go to www. cclcontainermedia. com.

###

Mitchell joins amohs™, inc. Board of directors

2011-05-29T16:09:00.000-07:00

Mitchell Joins AMoHS™, Inc. Board of Directors

AMoHS™, a global provider of mobile Operating Rooms, transportable field hospitals and mobile clinics today announced that Malinda Mitchell, former CEO of Stanford University Medical Center has been appointed to the Company's Board of Directors. Over the last 40 years, Malinda has held a series of leadership roles in nursing, hospital administration and hospital development for United States and international organizations.

Santa Barbara, CA (PRWEB) November 9, 2007

AMoHS™ (www. amohs. com), a global provider of mobile Operating Rooms, transportable field hospitals and mobile clinics today announced that Malinda Mitchell, former CEO of Stanford University Medical Center has been appointed to the Company's Board of Directors. Over the last 40 years, Malinda has held a series of leadership roles in nursing, hospital administration and hospital development for United States and international organizations.

From 1974 to 2001, Malinda held various positions at Stanford University Hospital and Clinics in Stanford, CA. Her career at Stanford began as a Clinical Nursing Coordinator on the Urologic Nursing unit and quickly evolved into a series of Assistant Director and Director of Nursing positions. In these roles, she was responsible for five inpatient surgical units, administration of 1200 nursing employees managing 663 beds, and culminated in managing all Nursing Units in addition to the Operating Rooms, Emergency Rooms, Pharmacy, Therapies, and Home Care. From the Director of Nursing position, Malinda advanced to Vice President and Chief Operating Officer spending 12 years in that role. During which time she was responsible for all hospital and clinic operations, new program development, human resources and information systems. This position involved executive management responsibilities for over 5,000 employees and a $500 million USD budget. As President and Chief Executive Officer of Stanford, Malinda was responsible for all hospital and clinic functions. Highlights of her tenure at Stanford include leading a $50 million USD cancer center project from inception through the beginning of construction, and Associate Directorship of the $120 million USD Stanford Hospital Modernization Project from planning and design through construction and occupancy.

Since 2001, Malinda has performed the role of consultant and Program Director for the Hospital Council of Northern and Central California. In this role she led a grant-funded project for the uninsured and homeless needing health care and social services at four Santa Clara County hospitals.

From 2005 to 2006, Malinda consulted on Clinical Program Planning for a 500+ bed hospital in Doha, Qatar. In this role, she facilitated clinical programming between Cornell University Medical School faculty and local physicians in Doha to provide for an academic hospital to accompany the Cornell Medical School in Doha.

Malinda's previous Board experience includes Stanford Hospitals and Clinics, Lytton Gardens Senior Housing (non-profit senior housing, assisted living, and skill nursing facility), and the Stanford University Business School Sloan Program (Alumni Advisory Board member). Currently, Malinda is a member of the Board of Directors and the Co-Chair of Fund Development Committee for the American University of Paris, Paris, France.

"It is a great honor that Malinda Mitchell has agreed to join our Board," said Jeffrey Merino, CEO of AMoHS. "Her expertise in hospital management, facility planning and the surgical environment, is perfectly suited for the growth of our business and is invaluable to achieving our long-term vision," Merino said.

"Since initially seeing the mobile operating room in 2004, I recognized the benefit that this product provides for hospitals. Even upgrading a surgical suite can cost as much as several million dollars and take as long as 18 months. During that time the OR is out of service, and the hospital is losing revenue, surgical cases, and in some instances, even surgeons to other competing hospitals," said Malinda Mitchell. "As soon as I walked into the mobile OR, its value in eliminating these issues and in increasing OR capacity at busy medical centers was obvious. Additionally, in mass disaster scenarios, many local healthcare facilities are either damaged or overwhelmed by the volume of services required by the victims of the disaster. While staff and physicians are readily responding from other areas, they need an adequate facility in which to perform their much-needed trauma and surgical services. The AMoHS product line provides the mobile facility for those services to be delivered," Mitchell said. "I have always held a passion for delivering healthcare to those in need and I am thrilled to be a part of AMoHS in their delivery of facilities to accomplish this goal," said Mitchell.

About AMoHS™, Inc.
AMoHS is a California corporation formed in 2004 and holds the only issued U. S. patents for a mobile operating room. The company specializes in the design, development, manufacture, and distribution of mobile operating rooms, mobile clinics and rapid deployment field hospitals. The mobile operating rooms are utilized by hospitals and ambulatory surgery centers experiencing over capacity (census) issues or undergoing Operating Room retrofits. The mobile clinics are utilized by hospitals providing outreach services, humanitarian and governmental organizations providing medical care and corporate interests. The rapid deployment field hospitals are utilized by humanitarian and military organizations providing medical care in remote areas of the world and emergency medical and disaster preparedness organizations.

To date, virtually every type of surgery with the exception of open heart and complex neurosurgery has been performed in the patented mobile operating room products. All AMoHS products meet United States DOT requirements for standard transportation over US roads and can also be transported via military aircraft such as the C-5A or C-17. Existing Field Hospitals built under this design have successfully been used at hospitals, correctional institutions, governmental facilities, ambulatory surgery centers, and in field situations.

Additional information is available at www. amohs. com or call 303-670-1177.

Media Contact:
Anita Chambers
Chief Strategic Officer
AMoHS, Inc.
650-823-3014 (direct)
Achambers @ amohs. com

###

Biodreaming: express through art what biotechnology means to you

2011-05-28T08:51:00.000-07:00

BioDreaming: Express Through Art What Biotechnology Means To You

Biotechnology Institute launches the first annual BioDreaming Poster Contest for all students in grades K-12.

Arlington, VA (PRWEB) April 13, 2004 -

Â The Biotechnology Institute, an independent, national nonprofit educational organization, launches the first annual BioDreaming Poster Contest for students in grades K-12. Partial funding for the competition is provided by Nektar Therapeutics, (NKTR) a pioneer and leader in advanced drug delivery technologies that enable highly differentiated products. The contest offers students the opportunity to showcase, and be recognized, for their artistic talents in expressing what biotechnology means to them. The winner will have their work published in Your World, a nationally distributed magazine. The top 12 winners will have their work displayed at the InstituteÂs booth at the Biotechnology Industry Organization (BIO) Convention, in San Francisco, June 6-9, 2004. Divisional winnersÂ work will be displayed on the InstituteÂs website.

Kathy Frame, Vice President for Educational Programs at the Biotechnology Institute, states: ÂThis is an exceptional opportunity for students to display their artistic talents to increase the understanding of what biotechnology is. Winners will receive national and international recognition through Your World magazine, the BIO convention in San Francisco, and the InstituteÂs website.Â

The BioDreaming Poster Contest is free to enter. Posters are grouped in four grade categories. All posters will be judged based upon; message clarity, adherence to theme, creativity, originality, artistic quality, and visual clarity.

To be eligible, BioDreaming Poster Contest entries must be received postmarked no later than April 30, 2004. Winners will be notified via email.

For more information and to apply to the BioDreaming Poster Contest, please visit the Biotechnology InstituteÂs website at www. biotechinstitute. org, or call 703.248.8681.

The Biotechnology Institute (www. biotechinstitute. org) was founded in 1998, as an independent, national nonprofit organization, dedicated to education about the present and future impact of biotechnology. Its mission is to engage, excite and educate as many people as possible, particularly young people, about biotechnology and its immense potential for solving human health, food and environmental problems.

Nektar Therapeutics (NKTR) (www. nektar. com) (formerly Inhale Therapeutic Systems, Shearwater, and Bradford Particle Design) is a pioneer and leader in advanced drug delivery technologies that enable highly differentiated products. Our goal is to help our pharmaceutical and biotechnology partners realize the full potential of their molecules by solving complex development challenges to create breakthrough therapeutics, extend product franchises, and fuel product pipelines.

CONTACT INFORMATION:

Kathy Frame

Biotechnology Institute

703.248.8681

703.248.8687

Pr@biotechinstitute. org

Carterbaldwin executive search places former schering plough exec joe ciaffoni at atlanta's sciele pharma

2011-05-27T19:54:00.000-07:00

CarterBaldwin Executive Search Places Former Schering Plough Exec Joe Ciaffoni at Atlanta's Sciele Pharma

Empowered to run sales and marketing at Sciele, Ciaffoni relocates from New Jersey to Atlanta, the third pharmaceutical executive placed by CarterBaldwin at Sciele.

Roswell, GA (PRWEB) August 26, 2008

CarterBaldwin Executive Search, a leading provider of retained executive search services in Atlanta (http://www. carterbaldwin. com/firmprofile. html), today announced that Joe Ciaffoni has accepted the position of Chief Commercial Officer for Atlanta-based Sciele Pharma. Ciaffoni comes to Sciele from Schering Plough's Kenilworth NJ headquarters where he served as National Vice President.

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on cardiovascular, diabetes, women's health and pediatrics. The company, which employs 900 in the Atlanta area, licenses and acquires late stage and commercialized products for sale in the United States. Chief among Ciaffoni's duties will be driving sales and marketing efforts for the company's large product pipeline.

The search for Sciele was led by CarterBaldwin founding partner Jennifer Poole Sobocinski, who successfully completed the critical search in less than 90 days. Ciaffoni is the third addition to Sciele's leadership team provided by CarterBaldwin executive search in Atlanta (http://www. carterbaldwin. com/firmprofile. html), which also placed the company's current Chief Financial Officer and Vice President of Business Development.

Sobocinski is one of the CarterBaldwin partners who specializes in Board of Director and C-level placements for the medical, bio-tech and pharmaceutical industries. She described the Sciele search profile as "a dynamic and entrepreneurial culture looking for a strong leader who not only possessed 'Big Pharma' leadership skills, but also could work in a highly nimble and growth-oriented company." Sobocinski emphasized that Ciaffoni's track record of driving the commercial operations across multiple organizations of varying sizes made him an excellent choice in terms of both skill set and culture fit.

Ciaffoni's move to Atlanta will be a homecoming of sorts. Before joining Schering Plough in 2004 he was headquartered in Atlanta while serving as Southeast Area Vice President for Sanofi-Synthelabo, Inc. Ciaffoni, who assumed his new duties with Sciele on August 4th, commented that he is "very excited about working with this leadership team. I already feel a part of the organization."

About CarterBaldwin:
CarterBaldwin is an Atlanta executive search (http://www. carterbaldwin. com/expertise. html) firm managed by a partnership team with more than 50 years of combined experience. The company was named for the second year running to the prestigious Inc. 500 list of America's fastest growing privately held companies. With extensive industry knowledge, a clear understanding of nuances in creating strong management teams, and a hands-on approach, CarterBaldwin stands as a leader in the executive search (http://www. carterbaldwin. com/clients_overview. html) industry. The company is headquartered just north of Atlanta. Additional information is available at www. carterbaldwin. com.

About Sciele Pharma:
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular, Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular and Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit/hyperactivity disorder (ADHD).

###

Growth hormones direct teams up with fight magazine

2011-05-26T06:43:00.000-07:00

Growth Hormones Direct Teams Up With Fight Magazine

Growth Hormones Direct teams up with FIGHT Magazine.

Mesa, AZ (Vocus) August 11, 2010

Growth Hormones Direct (http://www. growthhormonesdirect. com) teams up with FIGHT Magazine. FIGHT Magazine (http://www. growthhormonesdirect. com/growth-hormone-news/growth-hormone-news/partnerships/ghd-fight-magazine. php) is the world’s premiere Mixed Martial Arts (MMA) magazine. Their unbiased fighter ranking system has stirred up a reaction from their fans but has proven more accurate than popularity based rankings. FIGHT magazine is a resource for fighters and fans alike. Aside from the magazine, FIGHT’s on-line resource announces upcoming fighting events, photo shoots of the fighters, videos and more.

Growth Hormones Direct sells a medical grade homeopathic Growth Hormone formula that can increase speed, strength, endurance and recovery as well as general health. Growth Hormone products are getting a lot of attention from the MMA world as fighters look for new ways to improve their performance and get an edge over their competitors.

Growth Hormones Direct is launching a new “No Prescription Necessary” Growth Hormone product that is formulated to offer all the benefits of prescription HGH without needles or the high cost associated with prescription HGH. Growth Hormones Direct products helps athletes and every day sports enthusiasts alike. Using Growth Hormones Direct products may increase lean muscle mass, help burn calories and rejuvenate the body. The Growth Hormones Direct products can also help people get the most out of every workout.

Growth Hormones Direct urges consumers to watch “Science...Meet Nature” as they reap the benefits of optimizing their hormone levels through proper use of the homeopathic Growth Hormone formula (http://www. growthhormonesdirect. com/growth-hormone-about-gh. php). Optimal hormone levels allow individuals to enjoy increased general health. Growth Hormones Direct is an Arizona based distributor of quality health foods, supplements, pharmaceuticals and neutraceuticals.

To get further information on Growth Hormones Direct or the benefits of the homeopathic Growth Hormone formula contact:

Contact: Dr. J. Ronald Willis
Company: Growth Hormones Direct
Www. GrowthHormonesDirect. com
Phone: 480-281-7593

###

Applied clinical trials european summit launches networking forum for 2007

2011-05-25T18:27:00.000-07:00

Applied Clinical Trials European Summit Launches Networking Forum for 2007

Worldwide publisher and event organiser Advanstar Communications has announced the launch of an innovative Networking Forum to run alongside its Applied Clinical Trials European Summit from 29 - 31 October 2007 at the Dorint Sofitel Schweizerhof, Berlin, Germany.

(PRWEB) December 10, 2006

The newly introduced Networking Forum will become an integral part of the 2007 event and will provide vendors with a valuable platform to meet and do business with purchasers and influencers from leading pharmaceutical, biotech and contract research organisations. The Networking Forum will enable Hosts (vendors) to invite a select number of their top clients and/or prospects to the event as Hosted Delegates, providing a unique environment in which all participants in ACT can network and do business.

"The Networking Forum has been launched in direct response to research conducted amongst suppliers to this market into what they need and want from their industry event. It will enable vendors to do business away from the traditional exhibition format in a relaxed but professional environment, enabling them to offer the very best customer service and hospitality to their existing clients and potential customers," commented event director Jessica Blue.

The Networking Forum has been designed to make the process of doing business as easy as possible. "This new format enables vendors to take part in an event where all of the hassle of organising an exhibition stand is taken away. Once vendors make the decision to become a Networking Host, Advanstar Communications will manage every aspect of organizing the attendance of their Hosted Delegates, from booking hotel rooms to setting up meetings," added Blue.

The ACT European Summit & Networking Forum is the leading information and networking event for senior level European clinical trials professionals. The three-day event consists of a day of pre conference seminars followed by two days of plenary sessions and workshops. The content focuses on the latest issues and trends affecting: clinical research, clinical trials, clinical operations, regulatory affairs, data management/EDC, project management, quality assurance and drug safety.

The Applied Clinical Trials European Summit & Networking Forum: 29 - 31 October, Dorint Sofitel Schweizerhof, Berlin, Germany. For more information on becoming a Networking Host, contact Catherine Mealor on +44 (0) 1244 393422 or email.

For information on delegate places, visit www. actsummit. com

Advanstar Communications Inc. (www. advanstar. com) is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries. Advanstar serves business professionals and consumers in these industries with its portfolio of 85 events, 55 publications and directories, 75 electronic publications and Web sites, as well as educational and direct marketing products and services. Market leading brands and a commitment to delivering innovative, quality products and services enables Advanstar to "Connect Our Customers With Theirs." Advanstar has roughly 1,000 employees and currently operates from multiple offices in North America and Europe.

###

Less medicine, better compliance: a revolution in the treatment of illness?

2011-05-24T16:34:00.000-07:00

Less Medicine, Better Compliance: A Revolution in the Treatment of Illness?

Recent research indicates that antibiotic delay may be an option when treating earaches in children. This approach, known as "wait and see prescribing," advises parents to delay filling prescriptions for 48 hours unless the child fails to improve or gets worse. A method of this kind addresses the growing issue of antibiotic overuse, and thus the emergence of drug-resistant microbes. However, when medications are necessary, it is imperative that patients strictly adhere to drug directions and doctor instructions to guarantee the drug's full benefit.

Bethesda, MD (PRWEB) September 20, 2006

In a recent study published by the Journal of the American Medical Association, researchers questioned the necessity of prescribing antibiotics for children with earaches. This goes against the long-thought grain of using antibiotics for treatment and instead examines a process known as “wait-and-see prescribing” (WASP). Doctors, in the United Kingdom and many other European countries, that practice WASP write a prescription but advise parents not to fill it unless the child fails to improve, or gets worse 48 hours after the appointment. Of the utmost importance is that ultimately if a child needs medication, he/she remains compliant to drug regimens and doctor instructions; behavior which can be better achieved through patient health programs such as FLAVORx. Non-compliance can be a key contributor to treatment failures that may result in deterioration of patient health, need for additional consultations, use of extra drugs, additional hospital admissions, higher total costs of care and an increased potential for bacterial resistance.

The study followed 300 children who were taken to emergency rooms with an earache. Half of the children were instructed to fill their prescriptions, while the other half followed the WASP procedure. Reports showed that 2/3 of the children that did not have their prescriptions filled recovered just as quickly as the children that were given antibiotics immediately. These results are quite eye-opening, especially for a society that has recently begun to acknowledge the growing threat of antibiotic resistance as a pressing public health problem.

According to the Centers for Disease Control, over the last decade, almost every type of bacteria has become stronger and less responsive to antibiotic treatment. Improper and over-use of antibiotics are the primary contributors to increases in drug-resistant bacteria. Sensitive bacteria are killed by antibiotics, but in some cases resistant bacteria survive with an ability to neutralize or escape the effects of the antibiotic. That one surviving microbe then continues to multiply in the body and eventually spread to family members, friends and coworkers.

It is important to clarify that the issue here is not to negate the use of antibiotics, but instead to ensure that when antibiotics are needed, they are taken properly. Failure to adhere to a drug regimen or follow doctor instructions further aggravates the possibility of drug-resistant strains. If bacteria are given partial exposure or selective pressure from antibiotics, it enables them to become resistant to low-levels to a point at which they can survive and re-infect.

So how do young patients, like those plagued by earaches, ensure compliance? Studies show that palatability plays an important role when it comes taking medications, especially in children. Most children are not yet mature enough to understand the importance of taking medications, which is why forcing them to swallow a bitter, foul-smelling, and in general, bad-tasting medication can prove particularly stressful and traumatic.

Luckily there is a solution. FLAVORx, Inc is a pharmaceutical flavoring company that has addressed the problem of non-compliance through its scientifically-tested and medically-designed flavoring system for over-the-counter and prescription medications. The company has developed FDA-approved, non-allergenic, sugar-free, dye-free, alcohol-free, and phosphate-free flavors that are safe and effective for all children in combating the existing taste of a medication. In addition to the improvement of taste and smell, studies show that children are more invested in taking medications that have been flavored because they play an active role in making a ‘choice’ of flavor. In addition, flavoring helps overcome any issues of food/drug interaction that may occur when patients improperly mix medications with food in an effort to improve taste.

The conservative, responsible and proper allocation of antibiotics with methods like WASP, in combination with programs to increase compliance will ultimately aid in the suppression of drug resistant microbes.

FLAVORx is available in over 35,000 chain and independent pharmacies nationwide including Walgreens, CVS, Wal-Mart, Target and Rite-Aid. To date, over 40 million prescriptions have been flavored without any incidence of allergy, adverse reaction or changes in efficacy. For more information, please contact Teresa Chen at 800.884.5771 extension 234.

###

The lanier law firm opens new york office

2011-05-23T06:00:00.000-07:00

The Lanier Law Firm Opens New York Office

The Lanier Law Firm, the Houston-based litigation powerhouse that recently won the nation’s first VIOXX-related jury verdict, has opened an office in New York City.

New York (PRWEB) November 16, 2005

The Lanier Law Firm, the Houston-based litigation powerhouse that recently won the nation’s first VIOXX-related jury verdict, has opened an office in New York City. The New York Office will operate as The Lanier Law Firm, P. L.L. C.

Heading the office will be the firm’s founder W. Mark Lanier and Richard D. “Rick” Meadow.

Lanier said the decision to open a New York office was cemented by several pre-existing relationships.

"We have great clients in New York and great friends in the New York Bar who we look forward to working with further," said Lanier, who tried the VIOXX case and was featured in a 2004 profile in The American Lawyer magazine titled “Lone Star Rising: Is Mark Lanier America’s Next Great Trial Lawyer?”

Meadow, who has more than two decades of trial experience and several multi-million dollar verdicts and settlements, is joined by attorneys Evan Janush, David Kuttles, and Meredith Gursky.

The office will represent clients in a variety of practice areas, including pharmaceutical liability, commercial litigation, product liability, personal injury, maritime, and medical malpractice. The firm will also work as trial counsel to other plaintiff’s law firms.

In August, a Brazoria County, Texas, jury delivered a $253 million verdict against pharmaceutical giant Merck & Co. The case was one of many The Lanier Law Firm is preparing against pharmaceutical companies whose products have injured or killed those who have taken them. In addition to VIOXX, the Lanier Law Firm represents clients who have taken Neurontin, Zyprexa, Celebrex, Bextra, and Accutane, among others.

The aesthetic highlight of The Lanier Law Firm’s New York office is a 15-foot long mixed-media paint, pencil and charcoal drawing by U2 lead singer and human rights activist Bono and his daughters, Jordan and Eve. The work was created as part of a series designed to accompany a new interpretation of Prokofiev’s Peter & the Wolf by Irish musician and performance artist Gavin Friday. It was purchased at auction at Christie’s, New York in 2003. All funds raised were donated to the Dublin-based Irish Hospice Foundation and targeted to train hospice caregivers in AIDS-ravaged Africa, the USA and elsewhere around the world.

Moving the piece into the firm’s sixth-floor offices in Midtown East was a bit of performance art in itself, requiring more than a dozen workmen and the closure of an entire city block. In a harrowing delivery, a 10-story crane moved the crated artwork to the sixth floor (where workmen had removed a large pane of glass)—only to find the crate was too large to make it through the window.

In a heart-stopping, mid-air maneuver, the artwork was delicately removed from the crate and moved to its new home in The Lanier Law Firm’s offices at 126 E. 56th Street.

For more information on The Lanier Law Firm, visit www. lanierlawfirm. com.

###

Teleosis institute's "green pharmacy program" reduces pollution in the san francisco bay

2011-05-23T02:51:00.000-07:00

Teleosis Institute's "Green Pharmacy Program" Reduces Pollution in the San Francisco Bay

700 pounds of unused medicines collected in the first six months.

Berkeley, CA (PRWEB) January 9, 2008

Over 700 pounds of unused and expired medicines were diverted from San Francisco waterways in 2007, thanks to the efforts of Berkley-based Teleosis Institute and its partners EBMUD, Save The Bay, Kaiser Permanente, Elephant Pharmacy, Pharmaca, Whole Foods and City of Berkeley.

The Teleosis Institute, a non-profit dedicated to sustainable medicine and a healthy environment, launched the Green Pharmacy Program (www. teleosis. org/greenpharmacy (http://www. teleosis. org/greenpharmacy)) in May 2007 in an effort to reduce pharmaceutical pollution of San Francisco waterways and increase public awareness about the environmental impact of discarded medications. Recent studies find over 80% of waterways tested in the U. S. show traces of common medications such as acetaminophen, hormones, antidepressants, blood pressure medicine, codeine and antibiotics. Consumers often discard of unused and expired medicines in the sink or toilet, which can contaminate waterways and damage aquatic life.

The Green Pharmacy Program sponsors events advocating environmentally safe disposal of unwanted medications and established community-based take-back sites where consumers can return unused medications. Green Pharmacy is unique in that the site manager documents all returned medicines through the Unused & Expired Medicine Registry, a program developed by the Community Medical Foundation for Patient Safety in Texas, which compiles national statistics on medicines returned and reasons for disposal. Once a statistically significant sample is documented, the data will be presented to pharmaceutical researchers, manufacturers and governmental organizations to build support for take-back programs nationwide.

The Green Pharmacy Program uses a product stewardship approach to "green" the pharmaceutical life-cycle. The Program spans multiple sectors of the industry, educating and engaging manufacturers, distributors, pharmacists, physicians, consumers, and waste management to participate in a solution to the growing problem of pharmaceutical pollution in environment.

Currently 12 pilot take-back sites are operating in Bay Area pharmacies, doctor and dental offices, veterinarian hospitals, health care facilities and local recycling events. Staff at take-back sites document all returned medicines and screen for controlled substances, which are turned away because of current DEA restrictions. Medications are collected from take-back bins for incineration (the most environmentally safe disposal method) by Integrated Waste Control, Inc., a Hayward-based waste hauler.

According to Dr. Joel Kreisberg, executive director of the Institute, the purpose of collecting data on unused medicine is to identify which pharmaceuticals are most often unused or over-prescribed. "By deepening our understanding of the quantities of medicines discarded, we can better comprehend the effectiveness of our current pharmacological approaches to illness, presenting a case for sustainable health care," Kreisberg said.

You can participate in the solution to prevent pharmaceutical water pollution by safely disposing of unwanted medications at a Green Pharmacy take-back site near you:
Pharmaca Integrative Pharmacy, Berkeley, CA Teleosis Institute Office, Berkeley, CA Transcendentist, Berkeley, CA Foundation For The Healing Arts, San Rafael CA Chimes Pharmacy, Berkeley, CA Elephant Pharmacy, Los Altos, Walnut Creek, Berkeley Health First! Pharmacy, Windsor, CA VCA Albany Animal Hospital, Albany, CA United Pharmacy, Berkeley, CA Kaiser Permanente Pharmacy, Location to be determined

The Green Pharmacy Program is an integral part of the Teleosis Institute's Green Health Care model (www. greenhealthcare. org), a vision of medicine that provides leadership in environmental and sustainable healthcare by developing innovative approaches to reducing the environmental impact of medicine.

About The Teleosis Institute:
The Teleosis Institute is an educational non-profit organization devoted to reducing the environmental impact of health care. The Institute promotes sustainable medical practices and works in partnership with the health care community to build a movement for positive social and environmental change. Our programs and educational materials include: The Green Health Care Program, The Green Pharmacy Program, Symbiosis: The Journal of Ecologically Sustainable Medicine, and Environmental Health Brochures. Visit www. teleosis. org for more information.

###

&Amp;#20013;國生產的品質承&#35582

2011-05-23T02:13:00.000-07:00

中國生產的品質承諾

在中國產品質量備受質疑﹐大批由於質量問題而導致產品召回的中國企業中﹐ 一家美國上市公司卻因其在中國的高質量生產而名聲漸起。American Metal & Technology, Inc. (Stock Symbol: AMMY Quote) 總裁指出抓好質量控制是抓住客戶的關鍵.

Los Angeles, CA (PRWEB) October 14, 2007

- 近期 "中國製造"這個金字招牌因有毒牙膏﹐含鉛玩具﹐問題輪胎等持續受到輿論抨擊。面對國際市場對中國生產廠商的質疑﹐那些質優價廉的中國廠家應如何證明自己的實力?

"持之以恆的質量控制", American Metal & Technology, Inc. (Stock Symbol: AMMY Quote (http://finance. yahoo. com/q? s=ammy. ob)) 總裁高晨先生指出, "本公司主營精密鑄造和機加工. 所處理的產品通常是國際大型生產商使用的中間品. 抓好質量控制是抓住客戶的關鍵. 唯有自始至終貫徹執行嚴格的質量控制, 對每件產品每個客戶無偏見不鬆懈的執行質量監督, 才是最佳解決方案."

事實證明短期內幾分錢的節省可能會導致幾千萬以上的損失. 近期新澤西州的美國外國輪胎銷售聯盟有限公司不得不將有中國杭州中策橡膠有限公司生產的450,000套問題輪胎召回. 杭州中策為了節省40美分而未在輪胎鋼絲之間加入6毫米的橡膠層. 此次召回損失超過$9000萬美元.

"越淺顯的道理越是成功的金條玉律. 今年我們的股票(Stock Symbol: AMMY Quote (http://finance. yahoo. com/q? s=ammy. ob)) 在美國納斯達克市場(Nasdaq) 上市, 成功進入美國金融市場憑的就是 '持之以恆' 四個字. 中國人說 "路遙知馬力", 我們在中國的生產基地已持續多年的向歐洲, 美國客戶, 提供符合他們要求的高質量產品. 除了我們所有工廠已全部通過 ISO9001和 ISO14001 認證之外, 我們定期對員工進行培訓. 邀請歐美企業管理人員參觀並給予意見. "

輿論易以偏蓋全, 2006年中美貿易順差為1770億美元, 中國產品出口不可能達到零次品率, 並非代表中國出產均為次品. 9月21日, Mattel已經正式向中國政府致歉. China Architectual (RCH Quote (http://finance. yahoo. com/q? s=RCH)) 和 China Shenghuo Pharma 昆明聖火藥業 (KUN Quote (http://finance. yahoo. com/q? s=KUN)) 等中國概念股在這段時間均有亮麗的表現.

"與建築業, 生物科技行業相比, 客戶對於精密鑄件通常有更加嚴格的要求." 高先生補充道, "自2002年以來, 本公司的銷售業績以每年40%快速增長. 我們除了在技術上取得領先外, 更加重視的是保證產品質量. 無論外界輿論如何, 我們都會持之以恆,繼續努力提昇公司品牌形象, 增強客戶信心, 努力為投資人(Investor 爭取更加亮麗的成績."

如需了解更多關於American Metal & Technology, Inc. (Stock Symbol: AMMY Quote (http://finance. yahoo. com/q? s=ammy. ob) 的資料, 請參閱 http://www. ammyusa. com (http://www. ammyusa. com).)

Cme outfitters announces new rheumatology cme snack series

2011-05-22T23:39:00.000-07:00

CME Outfitters Announces New Rheumatology CME Snack Series

Five-part series titled "The Management of Rheumatoid Arthritis" features short-form webcasts designed to emphasize one key learning point for clinicians to apply to practice that day.

Rockville, MD (PRWEB) February 16, 2010

CME Outfitters, LLC, an award-winning accredited provider of multidisciplinary continuing education, is pleased to announce the immediate availability of a new CME Snack series at cmeoutfitters. com. The five-part series of CME Outfitters Snacks, titled "The Management of Rheumatoid Arthritis" was launched on December 21, 2009.

The first two parts of this series are also featured on ReachMD. com.

CME Outfitters Snacks are short webcasts designed to emphasize one key learning point for the clinician to apply to practice that day. This instructional format allows physicians to take advantage of educational information with a minimum time requirement.

The five-part series of CME Outfitters Snacks is on the topic of management of rheumatoid arthritis. Each of the five available Snacks is a standalone CME activity offering between 0.50 and 0.75 credit hours.

Series Topics:
Part 1: Improvement in Patient Care Through Patient Education and Measurement of Disease Activity
Part 2: Comorbidity and Complications of Treatment in Rheumatoid Arthritis—Cardiovascular Risk
Part 3: Comorbidity and Complications of Treatment in Rheumatoid Arthritis—Infection and Osteoporosis
Part 4: Referral Issues in Rheumatology—Early RA
Part 5: When Cancer Should Arise

There is no fee to participate or receive CME credit for this series; however, registration is required. For more information, or to participate in this series, please visit http://www. cmeoutfitters. com/PR428 (http://www. cmeoutfitters. com/PR428)

Moderator:
(All parts)
John J. Cush, MD
Director of Clinical Rheumatology
Baylor Research Institute
Professor of Medicine and Rheumatology
Baylor University Medical Center
Clinical Professor, Internal Medicine
The University of Texas Southwestern Medical School
Dallas, TX

Faculty:
(Part 2, Part 3)
Jeffrey Curtis, MD, MPH
Associate Professor of Medicine
Director, UAB Arthritis Clinical Intervention Program (ACIP)
Associate Director, UAB Center for Education and Research on Therapeutics (CERTs)
University of Alabama at Birmingham
Birmingham, AL

(Part 1, Part 4)
J. Timothy Harrington, MD
Professor of Medicine, Rheumatology Division
Department of Medicine
University of Wisconsin School of Medicine and Public Health
Madison, WI

(Part 1, Part 4)
Bernard R. Rubin, DO, MPH, FACP
Professor of Medicine
Department of Internal Medicine
University of North Texas Health Science Center at Fort Worth
Fort Worth, TX

(Part 5)
Maria E. Suarez-Almazor, MD, PhD
Barnts Family Distinguished Professor
Chief, Section of Rheumatology
Deputy Chair, Department of General Internal Medicine
University of Texas M. D. Anderson Cancer Center
Houston, TX

Statement of Need:
Regularly scheduled, standardized, quantitative measurement of disease status is widely recognized as essential to improving chronic disease management and outcomes. Optimal therapeutic decisions depend on and are driven by such measurement. The management of inflammatory arthritis is a complex matrix of managing symptoms with risk not only associated with disease progression, but also with complications that arise from drug therapy and various comorbidities. Patients can present with hypertension, diabetes, osteoporosis, cancer, and an increased susceptibility for infection. The epidemiology and natural history of rheumatoid arthritis (RA) support early, aggressive treatment to reduce joint damage and functional decline. However, early treatment of RA requires timely referrals and improved communication between rheumatology and primary care. Patient education has become an integral part of the therapeutic approach to helping patients with RA to self-manage their arthritis. A variety of evidence indicates that educational attainment is associated with better disease outcomes in RA. In this series of interviews and case vignettes, the faculty will address the issues facing rheumatologists and their patients in achieving improved outcomes in the management of RA.

Series Goal:
To increase awareness and recognition of gaps in knowledge related to the diagnosis of rheumatoid arthritis, the development of treatment strategies, and the integration of patient education to improve patient outcomes.

Learning Objectives:
Part 1: Compare and contrast evidence-based tools to measure disease status in patients with rheumatoid arthritis, and identify strategies for effective implementation in clinical practice; recognize the value of patient education to improve quality of care, increase patient satisfaction, and optimize disease outcome. Part 2: Recognize complications to treatment associated with comorbid cardiovascular risk factors, and describe strategies for effective management. Part 3: Recognize complications to treatment associated with comorbid osteoporosis and increased risk for infection, and describe strategies for effective management. Part 4: Examine referral issues in rheumatology, and identify methods for the diagnosis and treatment of early rheumatoid arthritis. Part 5: Explain what a concomitant diagnosis of cancer means for patients with rheumatoid arthritis and implications for treatment.

Target Audience:
Rheumatologists, primary care physicians, internists, family practice physicians, pain specialists, and any clinical healthcare professional interested in the management of rheumatoid arthritis.

Financial Support:
These activities are supported by an educational donation provided by Amgen and by an independent educational grant from Wyeth Pharmaceuticals.

Credit Information:
This series offers CME credit for:
Physicians (ACCME/AMA PRA Category 1)
All other clinicians will receive a CME Attendance Certificate.

Post-tests, credit request forms, and activity evaluations must be completed online at www. cmeoutfitters. com/test (http://www. cmeoutfitters. com/test) (requires free account activation), and participants can print their certificate immediately.

About CME Outfitters:
CME Outfitters, LLC, develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com) or call 877.CME. PROS (877.263.7767).

Clinical Compass, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all of our news and information. To subscribe, visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com) and click on the "Create User Profile" link.

Contact:
Jessica Primanzon
CME Outfitters, LLC
614.328.4508 direct
240.243.1033 fax

###

Physicians total care helps connecticut facility get started with physician medication dispensing

2011-05-22T13:59:00.000-07:00

Physicians Total Care Helps Connecticut Facility Get Started with Physician Medication Dispensing

When Phoenix Internal Medicine Associates wanted point-of-care dispensing in their practices, they looked to Physicians Total Care to help them get their idea off the ground.

Tulsa, OK (PRWEB) February 21, 2008

When Phoenix Internal Medicine Associates, a Connecticut-based health care facility with two separate locations, first looked into physician medication dispensing, they weren't sure where to start.

"We were quite intrigued by the concept of operating our own dispensary within the confines of our office," said Carole Torello, site manager of Phoenix Internal Medicine Associates. "Having the ability to offer our patients the convenience of receiving their medications while seeing their physicians was a great concept that we were interested in pursuing further."

That's where Physicians Total Care came in. Phoenix Internal Medicine Associates turned to them for their physician medication dispensing software, the PTC9000.

Both the Phoenix locations installed the physician dispensing software in December 2007. Between the two of them, they have seven prescription writers: six physicians and one nurse practitioner.

"The PTC9000 is ideally suited for health clinics of any size, whether you've got one prescribing physician or more than a dozen," said Warren Moseley, president of Physicians Total Care (http://www. physicianstotalcare. com (http://www. physicianstotalcare. com)), which is in its 23rd year of operation.

After Phoenix Internal Medicine Associates installed their software, they found insurance issues to be their biggest challenge.

"There are so many variables involved in the insurance process that this became our greatest challenge when trying to fill prescriptions," said Torello. "Many were rejected for one reason or another."

However, the solution was easy. For each insurance problem, Phoenix Internal Medicine Associates recorded the rejection code and card number, and then sent the information to Physicians Total Care to help them resolve the issues. To date, Torello says that the majority of the problems have been taken care of.

"You're not just providing software," Moseley said. "You've also got to provide the customer service. Every software has a learning curve, and it is vital that you're there to help walk your customer through it. You want the software to work for them as much as -- if not more than -- they do."

Torello also said that both Phoenix locations -- and their patients -- were embracing the new system.

"Patients have overwhelmingly embraced this concept and are very excited about using the dispensary," said Torello. "They love the convenience of it most of all, and we are very happy that we can supply them with this new service."

For more information about physician medication dispensing, or for a free analysis on how physician dispensing could work in your practice, visit Physicians Total Care online at http://www. physicianstotalcare. com (http://www. physicianstotalcare. com)

About PTC
PTC has repackaged and distributed pharmaceuticals since 1986. Based in Tulsa, Okla., PTC maintains DEA, FDA and state pharmaceutical licenses in 25 states (and growing). PTC developed the PTC9000 Medication Management System® dispensing software for use in all point-of-care environments - from a solo practice to the largest and most sophisticated multi-site clinic. The software is maintained at state-of-the-art levels for all PTC9000 users at no additional charge. Since 2000, regional and national media attention has resulted in PTC's rapid growth and many more satisfied patients and physicians.

Press release provided by Xeal Inc. (http://www. xeal. com (http://www. xeal. com))

###

A company overview of shire pharmaceuticals group plc including information about 46 deals made and 53 partnering companies

2011-05-21T07:37:00.000-07:00

A Company Overview of Shire Pharmaceuticals Group PLC including Information about 46 Deals Made and 53 Partnering Companies

Dublin (PRWEB) October 31, 2005

Research and Markets (http://www. researchandmarkets. com/reports/c26524 (http://www. researchandmarkets. com/reports/c26524)) has announced the addition of Shire Pharmaceuticals Group PLC Deals Briefing to their offering

Description

Shire Pharmaceuticals Group PLC Deals briefing provides an in-depth view of the 46 deals made by Shire Pharmaceuticals Group PLC and its subsidiaries with 53 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Scope

The report contains:

A brief company profile including subsidiary names

Financial information where disclosed

A deals overview

Specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage

A detailed listing of the company's deals and alliances.

Key questions answered

Shire Pharmaceuticals Group PLC Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

Identifying active partners

Tracking competitor activity

Benchmarking deals

Comparing the finances of different deal types.

Shire Pharmaceuticals Group PLC Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Shire Pharmaceuticals Group PLC.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

For more information visit http://www. researchandmarkets. com/reports/c26524 (http://www. researchandmarkets. com/reports/c26524)

Laura Wood

Senior Manager

Research and Markets

Press@researchandmarkets. com

Fax: +353 1 4100 980

# # #

Legalview recounts the results of a recent mesothelioma study that reported high survival rates among patients taking new treatment

2011-05-19T17:33:00.000-07:00

LegalView Recounts the Results of a Recent Mesothelioma Study That Reported High Survival Rates Among Patients Taking New Treatment

LegalView reported the results of an Italian study to its mesothelioma blog readers; the results detailed a positive outcome and increased survival rate for elderly pleural mesothelioma victims. The study, recently published in a British medical journal, used a combination of two medicinal treatments commonly prescribed separately.

Denver, CO (PRWEB) August 14, 2008

LegalView, the most comprehensive legal resource available on the Web, recounted the results of an Italian study to its mesothelioma information (http://mesothelioma. legalview. com/blog) blog readers. The study attempted to increase the survival rate of elderly pleural mesothelioma patients (http://mesothelioma. legalview. com/mesothelioma-treatment. aspx) by combining two medications: Alimta (pemtrexed) and Paraplatin (carboplatin). The results of the study were released in a June issue of the British Journal of Cancer and the conclusions detailed the highly-effective treatments, which increased the survival rate among pleural mesothelioma patients 65 years of age or older.

Mesothelioma is an incurable cancer that is often attributed to the inhalation of asbestos fibers and dust containing tremolite. Asbestos is a known carcinogen, according to the Environmental Protection Agency (EPA), which is responsible for regulating the cleanup of the hazardous material. Asbestos was often prized for its ability to remain fire-resistant, while being produced cheaply, and served as a key ingredient in many products including insulation that was implemented into homes, apartment complexes, universities, schools, business offices and hospitals around the country. Individuals who suffer from mesothelioma cancer are advised to speak with a knowledgeable mesothelioma attorney (http://mesothelioma. legalview. com/find-mesothelioma-lawer. aspx) in order to better educate themselves on the possibility for developing a mesothelioma lawsuit (http://mesothelioma. legalview. com/mesothelioma-lawsuit-results. aspx). Due to the extremely costly medical bills associated with increasing survival rate among mesothelioma cancer victims, developing litigation may result in monetary compensation to assist with those medical bills.

LegalView not only offers resources on the most recent mesothelioma news and clinical trials, but also offers information on a variety of other legal issues afflicting millions of Americans. Most recently, LegalView updated several of its pharmaceutical drug information portals with news on updates and recalls; some of the portals include Viapro, Ketek and the Zimmer Durom cup.

The development of the Viapro information portal occurred after the U. S. Food and Drug Administration (FDA) issued a press release on the recall of the drug because of contamination of a harmful chemical known as thiomethisosildenafil. The male sexual-enhancement prescription drug, manufactured by EG Labs, is used to treat erectile dysfunction (ED). The undeclared ingredient may be harmful to patients especially when interacting with nitrates found in other prescription drugs. The Viapro recall (http://viapro. legalview. com) occurred because the drug may cause dangerously low levels of blood pressure among patients also taking nitroglycerin for diabetes, high blood pressure, high cholesterol or heart disease.

Ketek, which is an antibiotic used to treat upper respiratory infections such as pneumonia, bronchitis and sinusitis, had its warning labels increased recently due to the threat of liver disease among patients consuming the drug. To learn more about the Ketek side effects (http://ketek. legalview. com), visit http://ketek. legalview. com/ (http://ketek. legalview. com/).

Also among the recently updated information portals is that of the Zimmer Durom cup. Zimmer Holdings has ceased production of its Durom cup because of complaints that the hip socket was failing among many patients. Although the company has ceased production of the hip socket, pending internal investigations into the potential failure, the hip socket has already been used in over 12,000 hip replacement procedures since its introduction to the market in 2006. Patients who may be at risk for the Durom cup failure (http://zimmer-durom-cup. legalview. com) should seek medical attention immediately to ensure no further damage occurs.

About LegalView:
LegalView. com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView. com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www. LegalView. com/ (http://www. LegalView. com/).

###

Colorado confirmed as top bioscience state by national rankings

2011-05-18T20:03:00.000-07:00

Colorado Confirmed as Top Bioscience State by National Rankings

It's been a banner year for Colorado in the highly competitive state rankings arena. Genome Technology's June publication ranks Colorado as one of the top 20 biotech locations in the world, and the Families USA Global Health Initiative Report ranked Colorado fourth among states that generated the most economic activity per dollar of funding from the NIH. Further, Colorado placed in the top five of all five categories in the Milken Institute's State Technology and Science Index, moving ahead of California in the new overall rankings. Milken ranked Colorado second in the concentration of scientists and engineers.

Denver, CO (PRWEB) July 2, 2008

"According to recently released national rankings, Colorado is a fertile state for bioscience and technology initiatives, and we're incredibly thrilled," says Chris Shapard, Deputy Director of the Colorado Bioscience Association (CBSA). "It's nice to see other non-biased sources confirm what we've always known. Denver/Boulder was included in Genome Technology's 20 Best Places For Biotech plus concurrently we were ranked fourth by the Families USA's Global Health Initiative among states that generated the most economic activity per dollar of funding for the National Institutes of Health (NIH) and to top it off, we placed third ahead of California in the Milken Institute's State Technology and Science Index."

Genome Technology's June article about the top 20 Biotech locations in the world includes Colorado's Denver/Boulder market: "With some 10,000 people employed in biotech, the Denver/ Boulder corridor in Colorado got a major boost recently with the reassignment of the Fitzsimons Army Medical Center as a bioscience park. Located in the Denver metro area, the park teams research facilities for the University of Colorado Health Sciences Center and Hospital Complex with the Children's Hospital as well as dedicated incubator and office space. By 2010, planners expect employment at the Fitzsimons site to reach 19,000 people. In 2006, Amgen said it would fund a $150 million expansion of its manufacturing plant in Boulder." The article is available by subscription at http://www. genome-technology. com/issues/ (http://www. genome-technology. com/issues/)

According to a Families USA's Global Health Initiative report, Colorado ranked fourth among states that generated the most economic activity per dollar of funding from the NIH. For every dollar of NIH funding, Colorado generated $2.34 in business activity, only Texas, California and Georgia ranked higher. In 2007 Colorado received approximately $336 million in NIH funding generating a total of $787 million, the report said.

The 10 states that generated the most economic activity per dollar of NIH funding were Texas ($2.49), Illinois ($2.43), California ($2.40), Georgia ($2.36), Colorado ($2.34), Pennsylvania ($2.32), Tennessee ($2.32), Utah ($2.30) Ohio ($2.29), and New Jersey ($2.26). The report is available at http://www. familiesusa. org/issues/global-health/publications/in-your-own-backyard. html (http://www. familiesusa. org/issues/global-health/publications/in-your-own-backyard. html)

Colorado placed in the top five of all five categories of the Milken Institute's State Technology and Science Index, moving ahead of California in the new overall rankings. Milken ranked Colorado second in the concentration of scientists and engineers.

Milken's 2008 State Technology and Science Index looks at 77 unique indicators that are categorized into five major components: Research and Development Inputs, Risk Capital and Entrepreneurial Infrastructure, Human Capital Investment, Technology and Science Work Force, and Technology Concentration and Dynamism. It is one of the most comprehensive examinations of state technology and science assets ever compiled. For the report, visit: http://www. milkeninstitute. org/pdf/StateTechScienceIndex. pdf (http://www. milkeninstitute. org/pdf/StateTechScienceIndex. pdf)

About Genome Technology:
The Genome Technology Online website and a monthly magazine with print and digital editions - reaches a global community of active scientists working in pharmaceutical and biotech companies, universities, and biomedical research institutions. Genome Technology Online is a free Web service supported by advertising. Genome Technology Magazine is a free journal for qualified subscribers and is supported by advertising. Visit http://www. genome-technology. com (http://www. genome-technology. com)

About Families USA:
Families USA is the national organization for health care consumers. It is nonprofit and nonpartisan and advocates for high-quality, affordable health care for all Americans. Visit http://www. familiesusa. org (http://www. familiesusa. org)

About the Milken Institute:
The Milken Institute is a nonprofit, independent economic think tank whose mission is to improve the lives and economic conditions of diverse populations around the world by helping business and public policy leaders identify and implement innovative ideas for creating broad-based prosperity. It is based in Santa Monica, CA. Visit www. milkeninstitute. org

About Colorado BioScience Association:
CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. Visit http://www. cobioscience. com (http://www. cobioscience. com)

Contacts:
Christine Shapard, Colorado BioScience Association, 303-592-4089

Maggie Chamberlin Holben, APR, Absolutely PR - http://www. absolutelypr. com (http://www. absolutelypr. com) - 303-984-9801

###

Piribo: new publication announcement, medicines, ethics and practice a guide for pharmacists

2011-05-18T11:57:00.000-07:00

Piribo: New Publication Announcement, Medicines, Ethics and Practice A Guide for Pharmacists

Piribo, (piribo. com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Medicines, Ethics and Practice A guide for pharmacists - Edition number 30”.

(PRWEB) August 18, 2006

This book provides practical pharmaceutical information to help the user to answer common and less frequent queries quickly and competently. It brings together disparate information not easily found in other reference sources. This book is not a comprehensive drug reference, but aims to complement existing resources such as the BNF and to provide the user with a range of tools, suggestions and advice to assist in the provision of effective pharmaceutical care.

This book can be used as an aide-memoire to resolve routine queries arising from therapeutic drug monitoring, electrolyte disturbances, management of disease states and perioperative drug administration as well as more obscure problems.

Who should buy this book:

Hospital pharmacists, particularly junior pharmacists; pre-registration pharmacists; undergraduate pharmacy students; pharmacists returning to/crossing into hospital pharmacy; primary care pharmacists and other healthcare professionals.

Contents

Asthma Management

Carbamazepine

Diabetes Mellitus

Grapefruit Juice Interactions

Haemofiltration Solutions

Intravascular Devices

Liver Function Tests

Nitrate Administration

Thyroid Function

Rheumatoid Arthritis

“Clinical Pharmacy Pocket Companion” is available from Piribo. For more information go to: http://www. piribo. com/publications/pharmacy/clinical_pharmacy_pocket_companion. html (http://www. piribo. com/publications/pharmacy/clinical_pharmacy_pocket_companion. html)

Piribo Product ID: PHP052

About Piribo.

Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Index ventures closes €350m fund and appoints three new partners

2011-05-18T01:12:00.000-07:00

Index Ventures Closes €350M Fund and Appoints Three New Partners

Index Ventures, a Europe-based venture capital firm, today announced the closing of Index Ventures IV, bringing the firm's total capital under management to more than €1 billion.

London, Geneva and Jersey, UK (PRWEB) February 14, 2007

Index Ventures, a Europe-based venture capital firm, today announced the closing of Index Ventures IV, bringing the firm's total capital under management to more than €1 billion. A small group of new investors joined existing investors the new fund which was capped at €350M. Index Ventures IV will pursue the firm's strategy of partnering with highly talented entrepreneurs to build global companies in the information technology, life science and green tech sectors.

The firm also announced today the addition of former Skype global marketing vice president and Video Island founder Saul Klein as a venture partner. The firm also announced additions to its life science team with the appointment of PanGenetics founder Mark De Boer to venture partner and the promotion of experienced pharmaceutical executive, Michèle Ollier, to partner.

"We are grateful for the support of our investors and the dedication and vision of the entrepreneurs who have worked with us to put European venture capital on the map," said David Rimer, a general partner with Index. "We are excited as ever to be tapping into the growing talent pool we see in Europe."

Since its inception in 1996, Index Ventures has backed visionary entrepreneurs who have taken on incumbents and built seminal companies in a number of growth sectors including: open source software companies such as MySQL, Trolltech, Zend and Pentaho; broadband and VOIP companies such as Virata, Skype, FON and Rebtel; Internet service companies such as Betfair, Oanda, Last. fm, SpotRunner, Lovefilm, Stardoll and Netvibes; and life science companies such as Genmab, ParAllele Biosciences, BioXell, 7TM Pharma, Addex Pharmaceutical and PanGenetics.

"Everything we do is about helping entrepreneurs move quickly to become global market leaders," said Index Ventures general partner, Bernard Dallé. "Success for European companies has depended on their ability to extend their geographical reach quickly and cost-effectively. We invest in entrepreneurial teams going after global opportunities, whether they are in Tallinn, Toronto, Los Angeles, London or Madrid."

About Index Ventures

Index Ventures has been active in technology venture investing since 1996. The firm is dedicated to helping great entrepreneurial teams in the life science and information technology sectors build their companies into market-defining global leaders. The firm has offices in Geneva, London and Jersey, UK. Landmark investments include Genmab, one of the largest antibody companies in the world, Betfair, the world's largest betting exchange and Skype, recently sold to eBay. For more information visit http://www. indexventures. com (http://www. indexventures. com).

# # #

Launch of cancertreatmentmedicine. Com: characteristics of the main drugs used for the treatment of cancer

2011-05-17T18:10:00.000-07:00

Launch of CancerTreatmentMedicine. com: Characteristics of the Main Drugs Used for the Treatment of Cancer

There is a lack of basic information available detailing the various options for treating cancer. CancerTreatmentMedicine. com details the different areas relating to cancer treatment.

New York, NY (PRWEB) August 30, 2005

CancerTreatmentMedicine. com (http://www. CancerTreatmentMedicine. com (http://www. CancerTreatmentMedicine. com)) is a new website which details the different drug treatments available for treating Cancer.

Chemotherapeutic antineoplastic agents can be classified according to their structure and mechanism of action into the following SIX MAJOR CLASSES: Alkylating agents, Platinum co-ordination complex, Antimetabolites, Plant alkaloids, Anti-tumour antibiotics and Miscellaneous.

CancerTreatmentMedicine takes a look at each of these categories in more detail and explains the elements of each category.

CancerTreatmentMedicine is meant to be simple and straightforward to use, so that the average visitor seeking information about cancer drugs, can find the required information quickly and easily.

CancerTreatmentMedicine is written by a pharmacist who qualified in 1973, and whom for the last 5 years has worked in an oncology clinic preparing and administering chemotherapy treatments. The pharmicist was looking on the Internet for an overview of Cancer Treatment medicine options, and when they couldn't find the required information, they decided to do something about it.

# # #

Pharmaceutical/biotech stability storage facility opens

2011-05-17T12:12:00.000-07:00

Pharmaceutical/BioTech Stability Storage Facility Opens

Precision Stability Storage opened a new facility for the pharmaceutical/biotech industry, providing state-of-the-art offsite stability storage rooms and chambers.

Wilson, NC (PRWEB) September 16, 2007

Precision Stability Storage has opened a stability storage facility in Wilson, NC. PSS provides environmentally-controlled storage to the biotech and pharmaceutical industries. They have also launched a new web site, at: www. precisionstabilitystorage. com

The facility is designed to meet the needs of companies that require off-site storage, redundant storage, short term growth needs, back-up storage, or long term stability storage conditioning.

Multiple stability rooms at custom and ICH conditions are available that are fully validated to meet strict temperature and humidity specifications.

ICH, or International Conference on Harmonization, refers to the combined efforts of regulatory authorizes in Europe, Japan and the U. S. as well as experts from the pharmaceutical industry to maintain the consistency of scientific and technical aspects of product registration.

Each of the 900 cubic-foot rooms is continuously monitored and remote paging is provided for alarm conditions. An automatic emergency generator provides redundant facility power to ensure the integrity of stored material.

Ken Edwards, PSS director of business development and partner, expects the 13 proposed units will be at capacity within the first year.

"Wilson is strategically located to pharmaceutical companies in need of our services. We see more of these companies outsourcing this storage service because it makes sense economically," Edwards said.

Other primary partners are Phil Clark, Ross Hile, engineering manager and Clay Hile, managing partner.

PSS will hire four to five full-time employees to manage this facility.

Precision Stability Storage opened this new facility early this year, providing state-of-the-art offsite stability storage rooms and chambers. The storage facility is compliant with current Good Manufacturing Practices.

PSS provides multiple pharmaceutical stability chambers for the storage of products that require environmental conditions that must adhere to ICH guidelines. Their cGMP facility contains various chambers and rooms that have been mapped and validated for pharmaceutical stability storage and biotech stability storage.

PSS has also launched a new web site: www. precisionstabilitystorage. com

# # #

Vapor4life explains what is in the "juice" known as propylene glycol

2011-05-14T19:06:00.000-07:00

Vapor4Life Explains What is in the "Juice" Known as Propylene Glycol

An up close and personal look at what's behind the sensation that is hitting the smoking world by storm - The e-Cigarette, with a spot light on it’s side kick known as “The Juice.”

Wilmette, IL (PRWEB) November 24, 2010

The number one question faced at Vapor4life, an electronic cigarette distributor worldwide, is "What's in the juice known as propylene glycol?" Maybe the question posed by the consumers should be "What's NOT in the juice?"

Numerous studies have shown that conventional tobacco cigarettes can contain upwards of 4000 toxic chemicals. Decades of research has shown that these chemicals cause cancerous cell growth, chronic obstructive pulmonary disease, and numerous other life-shortening illnesses. Around the globe, smokers struggle to get away from these dangerous “death sticks” but often find that their dependency on nicotine makes cessation nearly impossible.

Now there is an alternative. In 2003 electronic cigarettes (e-Cigarettes) emerged from China. This new technology, created as an alternative to traditional smoking, involves no combustion whatsoever and offers a simple way for users to satisfy their nicotine cravings through inhalation of nicotine transported via an agent which is commonly used in numerous pharmaceutical and household items, propylene glycol.

The electronic cigarette user, or “vaper”, uses a battery operated vaporizer. Liquid (also referred to as “nobacco juice” and “e-juice”) is heated to produce a visible vapor that resembles cigarette smoke. The “vaper” inhales the vapor and receives a similar sensation to inhaling smoke while receiving their nicotine that they crave. Electronic cigarettes produce no smoke, no distinct odor, and nor do they burn or create any combustion. It has heads turning and has people questioning the age old adage “Where there is smoke, there is fire.” This couldn’t be further from the truth.

Vapor4Life touts it’s 2 piece models, known as The Original Vapor King comprised of a battery, a cartomizer (atomizer/cartridge one piece unit) , which offers a smoker the sensation of inhaling “smoke” via water vapor that is produced by propylene glycol while acting as an agent of transport for flavoring and the nicotine that the user craves while satisfying the hand-to-mouth habit that is developed through smoking. That is a mouthful for what consumers have begun to call “vaping” or “vape” - and just like that, a verb is born.

Comprised of propylene glycol, food grade flavorings and nicotine; the “juice” delivering the nicotine takes advantage of a commonly known as the element in fog machines that creates the artificial fog. Propylene glycol is also the component in asthma inhalers that creates the mist that delivers the crucial medication to the asthmatic patient. It is also the main element in gel capsules containing over-the-counter and prescription medications. Oral, inject-able and topical pharmaceutical formulations often use propylene glycol as the carrier of medications.

Propylene glycol is a colorless, nearly odorless, organic compound. Studies conducted in 1942 by Dr. Oswald Hope Robertson of University of Chicago's Billings Hospital showed vaporized propylene glycol inhalation in laboratory mice may prevent pneumonia, influenza, and other respiratory diseases. Additional studies in monkeys and other animals were undertaken to determine longterm effects, especially the potential for accumulation in the lungs. After a few months of treatment, no ill effects were discovered. (1)

Members of the electronic cigarette industry are, more often than not, users of electronic cigarettes themselves who are seeking an alternative to the conventional tobacco cigarette. ”We don’t claim that this is smoking cessation product line. We are looking to provide an alternative to smoking that allows the user to get their nicotine” says Dave Stepen, Executive Vice President of Operations and Marketing for Vapor4Life. “Vapor4Life’s goal is to provide it’s customers with the most flavorful and effective use of this new technology. ” The primary ingredient in Vapor4Life’s tasty “nobacco juice” is none other than propylene glycol. “We only use the highest quality propylene glycol in our juice and our manufacturers take incredible steps to ensure that we deliver the best flavors without having to take shortcuts in quality assurance.” states Mr. Stepen.

With starter kits as low as $45.00, e-cigarettes are drastically cheaper than traditional tobacco cigarettes, as well as being more public friendly due to the lack of odor. The renowned model of e-cigarette sold by Vapor4Life is the Original Vapor King KR808D-1, being one of the most popular models available due to the extensive flavor variety and ease of use of the prefilled cartomizer and battery unit.

Vapor4Life, founded in Northbrook, IL in 2009 by Steve “Smilin”, is one of the largest providers of electronic cigarettes in the United States. Offering the revolutionary Original Vapor King, Vapor4Life offers more than 130 flavors of “nobacco juice” for their customers to choose from. “We want to be the best. In order to be the best, we listen to our customers and treat them as we’d like to be treated.” says Smilin, CEO of Vapor4Life.

Vapor4Life’s flagship Original Vapor King, outstanding customer service, no hassle warranty, and wide variety of Nobacco juice flavors; has brought them more than 40,000 customers worldwide, proving them to be a force to be reckoned with in the e-Cigarette industry. “We just want to do it right.” Smilin says humbly.

Since 2003 electronic cigarettes have taken the world by storm. With over a million of smokers now using the smoke-free electronic cigarette alternative to get their nicotine fix, it has become clear that electronic cigarettes have carved their place in the world and are here to stay.

1. Source - http://tinyurl. com/mvwnr4

###

Selling warehouse direct indonesian furniture online

2011-05-13T22:22:00.000-07:00

Selling Warehouse Direct Indonesian Furniture Online

Have you ever considered moving to another country? This often means that you have to rebuild your career or business from scratch. Doing this doesnÂt have to be as daunting as it seems. E-commerce offers great opportunities to establish a viable business independent of your country of residence.

(PRWEB) September 25, 2004

In 2002, Glenn Madden decided to move from the United States to Indonesia in order to be with his wife and child. He set up an Internet business offering Web design services and also started selling collectibles and warehouse direct, hand-carved teak and mahogany furniture online.

Quality Furniture from Master Craftsmen

Since Glenn can source furniture directly from local producers in Indonesia, the hand-carved furniture he offers on his site http://tradur. com (http://tradur. com) is significantly cheaper than retail prices in the U. S., Europe and Australia. He also offers the ability to custom build furniture by Indonesian master craftsmen according to customer specifications.

In addition, his collectibles site http://t456.com/collectibles (http://t456.com/collectibles) and his Web design business http://web-design-companies. com (http://web-design-companies. com) enable Glenn to diversify his income stream.

About American TradUR Company

Glenn Madden owner of American TradUR Company is from Laurens, South Carolina. He was working for a large corporation in Greenwood SC up until two years ago installing process control systems. At first he started the American TradUR Company offering process control system services and web design http://web-design-companies. com (http://web-design-companies. com). Later he added our gifts site at http://t456.com/collectibles (http://t456.com/collectibles), which he operates through a contract service out of California.

In 1998 he married Teti Rohmah Mutia in Indonesia whom he met while upgrading the computerized process control systems at a pharmaceutical factory located just outside of Jakarta. Teti moved back to the US with Glenn. In March 2000 they had a daughter, Tiara Mutia Madden. Due to continuous travels they never filed for immigrant status to the US.

In January 2001 Teti had problems to return to the US because of papers that were filed incorrectly with immigration. Glenn spent a year + trying to get Teti and Tiara back stateside. No luck, all the way up to the president. So in September 2002 he was making enough money from American TradUR Company to resign from the company he was working for and moved to Indonesia.

Our factory is owned TetiÂs brother, AA Saca whom has been supplying resellerÂs that you find on the Internet for more than 15 years. We have recently brought in several new resellers whom have bought a considerable amount of furniture from us in the past 4 months. We are presently expanding our operation to include more direct wholesalers and individuals via the Internet wanting to save a lot of money for the best quality furniture.

Note From Glenn Madden...Our factory here is what I would call traditional. You will not see any flashy assembly lines. Everything is done the old fashioned way by hand as it has been done for hundreds of years. People in Indonesia are still willing to work for 25 thousand rupia a day, about $2.50 US. We do pay more than that to our workers. We have a large factory located near to Bandung and another one in Sumedang for our furniture production. We also have more than 50 homes that manufacture smaller items throughout the surrounding area. Our staff fluctuates from 25 to 500 people based on orders. We turn out orders in sizes of single item purchases to as much as a 40 ft container.

If you would like to visit our factory just give me a call and I will meet you at the airport personally. (62) 81 320618550. You are welcome to stay here in our humble home for the duration of your stay. But do not expect a big corporate red carpet rollout. We sell the furniture at a small margin of profit and live modestly. You will be treated as family while in our home. I want be entertaining you with a big party dinner are anything like that either. You will have to eat some of Tetis traditional Indonesian style food, some of the best. I would be more than willing to take you site seeing. Bandung has some wonderful places to visit that are not listed in any advertising brochures I have ever seen.

CONTACT INFORMATION:

Glenn Madden

American TradUR Company

Http://www. tradur. com (http://www. tradur. com)
Phone # 62 81 320618550

TRS p. s.m.

Suka Bakti V11 no.64

Kiara - Condong

Bandung, Indonesia

US Office

Mildred Madden

678 Deer Valley Rd

Laurens SC, 29360

# # #

No walls needed! Freestanding rotocube rotating bulletin towers put information on the shop floor in the work cell

2011-05-12T14:56:00.000-07:00

No Walls Needed! Freestanding RotoCube Rotating Bulletin Towers Put Information on the Shop Floor in the Work Cell

Production managers nationwide are using patented freestanding RotoCube rotating whiteboard bulletin towers..."We need production metrics and instructions out on the shop floor where our associates use them..." says a Michigan Pharmaceutical company "We don't have enough wall space for a traditional whiteboard. Because RotoCubes are freestanding, we can put them right at the point of use in a work cell."

Macedon, NY (Vocus) September 15, 2009

Production managers nationwide are using patented freestanding RotoCube (http://www. magnatag. com/RotoCube) rotating whiteboard bulletin towers..."We need production metrics and instructions out on the shop floor where our associates use them..." says a Michigan Pharmaceutical company "We don't have enough wall space for a traditional whiteboard. Because RotoCubes are freestanding, we can put them right at the point of use in a work cell." An Arizona medical equipment manufacturer adds "The four sides make it easy to organize information. We put a production metric on each side for safety, quality, inventory and productivity. They enable communication between shifts and encourage collaboration among employees."

"Because of it's compact space saving design, one RotoCube holds the same amount of information as a 4' x 6' whiteboard but has just a 19 inch footprint. You can put them in high traffic areas where they are seen and used. RotoCubes can be viewed from all four sides without crowding or blocking the view and rotate silently in either direction with the touch of a finger" says RotoCube spokesman Christian Krapf "Our customers tell us having production metrics and instructions at the point of use is critical to the success of their lean programs. We offer a choice of 24 different side panels from classic calendars to kanban, safety, quality and hourly productivity tracking systems. Each side has a changeable marquee title area. We've even added a larger 33" Island RotoCube which displays over 42 square feet of information"

RotoCubes (http://www. magnatag. com/RotoCube) arrive assembled, ready to use, with magnets and write on accessories for each side panel. You build your own custom RotoCubes online and order them factory-direct only from Magnatag Visible Systems. For more information and to see the RotoCube video, go to www. magnatag. com/RotoCube (http://www. magnatag. com/RotoCube).

Summary:
Freestanding RotoCubes put whiteboard and bulletin board information on the shop floor Visual communications are important for successful lean manufacturing Inventory, safety, quality, productivity are key metrics in lean manufacturing ABOUT Magnatag® (http://www. magnatag. com/RotoCube): Magnatag® Visible Systems, a division of W. A. Krapf, Inc., designs, manufactures and direct-markets over 2,300 magnetic steel whiteboard kits, calendar boards, maps, and other information display systems for manufacturers, hospitals, schools, business, organizations and government. www. magnatag. com or call 800-624-4154.

###

Age productions lends a hand to jane pauley

2011-05-10T20:17:00.000-07:00

AGE Productions Lends a Hand to Jane Pauley

AGE Productions' President, Amy Goldwert Eskridge, comes to the rescue of television shows in need. When there is too much work for the staff to handle, Eskridge is hired to help. Running her own corporate video business and freelancing in TV is the best of both worlds for Eskridge.

New York, NY (PRWEB) September 30, 2004

When the Jane Pauley Show was gearing up for its debut this fall, things couldn’t have been busier. Show guests were lined up, but video packages needed to be shot and edited before the shows could be taped at their Rockefeller Center studio. That’s when AGE Productions’ President, Amy Goldwert Eskridge, got a phone call from a senior staff member.

“She said they had a lot of work to do before the show could get on the air. I was pleased to receive the phone call because I have great respect for Jane Pauley,” says Eskridge.

Eskridge gets frequent calls from television shows in need of experienced producers. A television producer for twelve years, she left broadcasting in 1999 after working on the Donahue show, Entertainment Tonight and other national programs. Armed with her vast television experience and a desire to learn more about public relations, Eskridge secured a coveted position as Senior Producer for Edelman’s video and multimedia division. A glowing reference from her former boss, Phil Donahue, clinched the deal.

“I asked if he would mind giving me a reference for a job I was applying for, hoping he’d write a nice note. Instead, he called my prospective employer himself and gave me a rave review. His generosity never ceases to amaze me,” says Eskridge.

While at Edelman, Eskridge produced video for clients in every sector of business, including Kraft, Johnson & Johnson, Eli Lilly, Pharmacia, IBM, Microsoft and countless other major corporations. Last year, Eskridge formed AGE Productions, a full service video production company based in the New York metro area. Though most of her time is now spent on video news releases and corporate communications video, she still gets requests from television shows in need of help.

“I’m ecstatic having my own company and business is booming, so I continually turn down full time television positions. But an occasional freelance television gig enables me to stay in the broadcast world while focusing my full attention on my corporate clients,” say Eskridge.

AGE Productions produces and distributes all forms of video to support business growth, including video news releases, audio news releases and b-roll packages for broadcast, as well as live event coverage, presentations for meetings, sales and training, trade shows and other events. AGE Productions will be featured at the Public Relations Society of America’s International Conference located in New York City in October. Please visit the company's web site at www. ageproductions. com.

# # #

Thinspring will be exhibiting at the dia global electronic labeling seminar on sept. 26-27, 2006

2011-05-05T11:37:00.000-07:00

ThinSpring Will Be Exhibiting At The DIA Global Electronic Labeling Seminar on Sept. 26-27, 2006

Baltimore, MD (PRWEB) September 14, 2006

ThinSpring, a leading provider of XML-based solutions such as SPL Server™ and the FDA’s Electronic Labeling Information Processing System (ELIPS), will be exhibiting at the 2006 DIA Global Electronic Labeling Seminar at the Sheraton Philadelphia City Center in Philadelphia, PA, on September 26-27, 2006. Stop by the ThinSpring table for the latest developments in SPL electronic submission and the new Physician Labeling Rule (PLR) requirements.

New and upcoming products and services will be demonstrated in the ThinSpring booth. Representatives will be on hand to discuss SPL Server™, SPL conversion including PLR, and PIM Server™ as ideal solutions to your immediate and long-term structured content management and regulatory compliance needs.

The FDA currently uses ELIPS as a part of the process to internally validate SPL submissions from pharmaceutical manufacturers. From the experience of developing ELIPS, ThinSpring is able to provide effective SPL software solutions, high accuracy XML-based data conversion, and 100% assured compliance. When ThinSpring takes responsibility for the conversion of a label, you are assured that the label will pass the FDA’s validation process and business rules review.

For more information go to the ThinSpring website, contact Earl Pendleton at (919) 654-4535, or stop by our ThinSpring table at the 2006 DIA Global Electronic Labeling Seminar at the Sheraton Philadelphia City Center in Philadelphia, PA, on September 26-27, 2006. We hope to see you there.

About ThinSpring:

ThinSpring, founded by former pharmaceutical and medical device professionals, specializes in XML-based Web service solutions, integration and data conversion. ThinSpring has used its industry expertise to develop a dynamic XML engine, MatriXML™. This patented XML technology is the basis for SPL Server™. ThinSpring’s solutions have gained acceptance as an essential, collaborative application-development platform for FDA regulated companies. ThinSpring’s core team manages technology and regulatory consulting divisions that support its clients’ operations throughout the United States, Europe, Asia and South America. ThinSpring headquarters is in Bridgewater, New Jersey, with offices in California and North Carolina. More information about ThinSpring and ThinSpring SPL Server™ can be found on their website at: http://www. ThinSpring. com (http://www. ThinSpring. com).

###

Tippingsprung fields second brand-naming survey -- survey, in collaboration with brandweek magazine, identifies best and worst brand names in 10 popular categories

2011-05-05T10:29:00.000-07:00

TippingSprung Fields Second Brand-Naming Survey -- Survey, in Collaboration with Brandweek Magazine, Identifies Best and Worst Brand Names in 10 Popular Categories

Results from brand consultancy, TippingSprung's Second Annual Brand-Naming Survey of the best and worst brand names reveals key trends in corporate and product naming. The survey was conducted in collaboration with marketing news weekly, Brandweek magazine.

New York, NY (PRWEB) June 28, 2007

Results from TippingSprung's second survey of brand names, produced in collaboration with marketing newsweekly Brandweek, revealed the top brand names in 10 key categories. Major trends in brand naming were also uncovered. The survey focused on names and products released within the prior 18 months.

"Selecting a strong name is one of the first steps marketers take when building a brand," says Martyn Tipping, president of branding consultancy TippingSprung, LLC. "And it's also one of the most challenging, given the difficulty of finding a name that is legally available as a trademark."

THE TOP BRAND NAMES
A total of 1,331 senior marketing and branding professionals responded to the survey. They chose the following as the top brand names:
Best new name for a low-cost airline. Over half the respondents (51.9%) liked go!, a discount Hawaiian airline. Its brevity, simplicity, and direct call to action seem to be the most likely reasons for the name's popularity in the survey. Clickair was a distant second with 18%.

Best new spirits or cocktail-mix name. Spykes came in first with 33% of survey respondents, followed by vanilla liquor, Kajmir (24.9%). (The Spykes name may in fact have been too clever for its own good in the marketplace, the survey sponsors observe: Anheuser-Busch withdrew the product from the market shortly after its announcement, after critics complained that it was too appealing to under-age drinkers.)

Best name for a spin-off or startup. Nike's Tailwind was the clear favorite with 71% of the vote. Tesco's Fresh & Easy Neighborhood Market came in a distant second with 12%.

Which evolutionary name change is most overdue? Almost 30% of respondents felt that the name change from 1800Mattress to 1800Mattress. com was most overdue. Masterfoods' rebranding of itself as Mars came in second with 23.4%.

Most consumer-friendly new drug name. The menopause drug Enjuvia took first place (25% of votes), with Reconcile, an anti-anxiety treatment for dogs a close second (21.9%). Exubera, a brand of inhaled insulin, came in third (18%).

Best cell phone/PDA name that fits product form. In this category, focusing on the trend of cell phones to be named after the product's shape or other design features, BlackBerry Pearl was the clear winner with 37% of the vote, followed by Motorola's PEBL with 16.3%.

Cleverest ice-cream flavor. In a category dominated by puns and others plays on words, this year's winner was Ben & Jerry's Bohemian Raspberry (28%), trailed by another flavor from the same firm, Karamel Sutra (26%).

Which new reality show would you check out based solely on its title? Nearly 38% of respondents gave their vote to "Are You Smarter Than a Fifth Grader." Second place was won by "So You Think You Can Dance" with 14% of the vote.

Best new hotel brand. Aloft, a new hotel brand from Starwood, was the clear favorite with 49% of the vote. Element, another Starwood brand, came in second with 27%.

Best new fragrance name. CK IN2U from Calvin Klein was selected as the best new fragrance name by 34% of respondents, perhaps reflecting its text-message-like allure. The category included a number of other strong finalists, including Jilt, Zestini, Flowerbomb, and Fleur du Mâle.

Worst new fragrance name. Ultraviolet Man Summer Pop from Paco Rabanne had the dubious distinction of coming in first in this category (35% of votes) followed by Intimately Beckham for Him (31.4%) and Perfect Man Alternative (16.6%).

What would you have called Apple's iPhone?
Given the popularity of evocative names such as Blackberry Pearl, Motorola PEBL, and Nokia L'Amour, TippingSprung wondered whether respondents would have liked to see a more fanciful name for Apple's iPhone. About one-fifth of respondents felt the iPhone name was the ideal choice, but others among the marketing professionals responding were happy to suggest alternative names, including: MacBerry, AppleSeed, Cameo, CorePhone, Eve, iCall, iMo, VoicePod, Tell, Simpo, and Pi.

What name would you give to the world's first truly green car?
The survey sponsors also asked what name they might devise for the world's first truly green car, given the initial forays into the market of Toyota (with the hybrid Prius), Citroen (with the C-Matisse concept car), and Saab's BioPower. Suggestions included: G-Machine, Viro, Hybra, Muir, Footprint, Algae, Rezume, Bluewind, Cumulus, Seabreeze, EarthShip, Econix, Jade, Leaf, Lightfoot, Orb, Verde, and Tournesol.

TRENDS IN BRAND NAMING
TippingSprung sees the following as important trends in naming, based on the types of names appearing in the survey as well as the votes of the responding marketing professionals.

1) Marketers play it safe.
With real-word names like go!, Fresh & Easy, and Spykes earning top grades in the survey, marketers gave their votes predominantly to the names that communicated most simply and directly with consumers. This result is somewhat counterintuitive, since many branding professionals, and even more corporate IP departments, generally advise against the more simple and straightforward names, as they are generally more difficult to protect as trademarks. At the same time, the respondents' votes may reflect their longing to use such straightforward names, in the midst of a more constraining trademark-protection environment.

2) Spelling rules are made to be broken.
One trick that marketers use with increased frequency is slightly misspelling a name to make it more distinctive and ownable. Spykes, PEBL, Amp'd Mobile, and Joost TV are all examples of this naming trend. And as text messaging gains popularity, it seems that spelling rules will become even more flexible, as illustrated by the high votes garnered by Calvin Klein's CK IN2U fragrance.

3) Transparency rules.
Mars, Crayola, and Macy's are examples of a growing trend for companies to adopt their leading brand as their corporate name (rebranded from Masterfoods, Binney & Smith, and Federated respectively). This makes sense to employees, consumers, and investors, and is likely to lead to greater marketing efficiencies over time.

4) Regulatory rules make it easier to name a drug for dogs than for humans.
In the realm of pharmaceuticals, soft-sounding names with feminine endings (typically "a") continue to appeal to consumers. Names like Enjuvia, Exubera, and Acomplia all have positive, easily recognizable roots - rejuvenation, exuberance, accomplishment. Of the pharmaceutical names included in the survey, it is interesting to note that the most simple, easy to remember name is Reconcile, an anti-anxiety drug for dogs from the makers of Prozac. (This may reflect somewhat more lenient regulatory requirements in the non-human drug space, note the survey sponsors.)

Background and Methodology of the Report
The naming survey was conducted by TippingSprung, an international brand consultancy based in Manhattan. "We noticed that few regular surveys focus on trends in brand naming," said Robert Sprung, TippingSprung's CEO. "Given the challenges that marketers face in coming up with names that are both memorable and protectible, we wanted to see which brand names attracted the attention of marketing decision-makers and which trends we might spot."

Consulting with a panel of branding experts, TippingSprung designed a brand-naming survey to help answer the key questions: Which names are most popular? Which are most effective? What are some of the major trends in brand naming today?

The 2007 survey, carried out in collaboration with Brandweek magazine, was sent to branding and marketing professionals. The 1,331 respondents came from a cross-section of companies including CitiGroup, Disney, Toyota, Unilever, General Mills, Clorox, Accenture, Kraft, and PepsiCo.

The survey was sent electronically the last week of May 2007, and results were collected through June 12, 2007. A full survey report is available from TippingSprung by calling Robert Sprung at 212.268.4800, ext. 201.

TippingSprung (www. tippingsprung. com) is a New York-based branding company with key practices in brand strategy, naming, design, licensing, and nonprofit consulting.

###

Impact unlimited adds bill smith as senior creative director and launches new west coast office moves bolster top-tier creative capabilities, strengthen west coast presence

2011-05-04T21:40:00.000-07:00

Impact Unlimited Adds Bill Smith as Senior Creative Director and Launches New West Coast Office Moves Bolster Top-Tier Creative Capabilities, Strengthen West Coast Presence

Impact Unlimited, a leading provider of brand communications for events, meetings, and exhibits worldwide, is pleased to announce the addition of Bill Smith as Senior Creative Director. An accomplished and respected creative professional with diverse experience in a variety of disciplines and industries, Smith will take the lead in establishing Impact's West Coast office and building a team of creative, business development and account service professionals for the company's newly established office in San Francisco.

Dayton, NJ (PRWEB) June 26, 2008

His responsibilities include leading the West Coast creative team, collaborating with the East Coast, European and South American offices, recruiting new talent and further building upon Impact's West Coast presence and client service capabilities. He brings a wealth of experience in a variety of design fields including exhibitions, architecture, retail and museum.

Prior to joining Impact, Smith was Creative Director for Sparks Exhibits Environments and was a Senior Exhibit Designer for Contempo Design. He has designed for an impressive list of clients including some of the leading technology, retail and pharmaceutical companies in both the U. S. and Europe.

"The timing was right for Impact to further enhance our West Coast presence and the new office will allow us to continue to provide our clients with exceptional service on both a national and global level," said Ken Payne, president of Impact Unlimited. "Hiring Smith and opening the San Francisco office exemplifies Impact's organic approach to growth," continued Payne. "Our company has had tremendous success by building businesses and offices through talented individuals. This strengthens our culture of creative passion, integrity and accountability that our clients experience every day."
To learn more about Impact Unlimited's national and global services, visit www. ImpactUnlimited. com.

About Impact Unlimited
Headquartered in Dayton, N. J., with offices in San Francisco, Zurich, and São Paulo, Impact Unlimited is a creative and strategic company that provides a breadth of products and services that help its clients optimize investments in events, exhibits, and meetings. The company's award-winning creative services, along with its in-house production capabilities and worldwide logistics network, provide clients with design-driven solutions for building their brands and their businesses at the most critical point in the marketing continuum -- face-to-face at events, exhibits and meetings worldwide.
With 35 years of experience and success, Impact Unlimited serves a Blue Chip portfolio of clients spanning North and South America, Europe, Asia, Africa and the Middle East.

###

6995diabetes. Com targets the uninsured with discount diabetes testing kit

2011-05-04T21:30:00.000-07:00

6995Diabetes. com Targets the Uninsured with Discount Diabetes Testing Kit

Online medical supplies company assists the growing community of uninsured and underinsured diabetics by offering affordable diabetic testing supplies online.

Carrollton, TX (PRWEB) March 13, 2006

6995Diabetes. com (http://www.6995diabetes. com (http://www.6995diabetes. com)) was recently launched to address the monthly testing needs of uninsured and underinsured diabetics. Studies estimate that 45 million Americans are now uninsured and 10s of millions fall under the category of underinsured. 6995Diabetes. com has responded to these escalating numbers by offering monthly diabetes testing supply kits for $69.95 each, a reduced rate now available to customers regardless of insurance status. 6995Diabetes. com expects to play a significant role in assisting diabetes patients nationwide.

The online company leveraged its relationship with sister website FIFTY50Pharmacy. com to create the monthly testing supply kit. Those who have no insurance or whose testing supplies are not fully covered by their insurance will benefit from the online deal. “We wanted to take advantage of not only our ability to offer lower prices on our name brand products but also to harness the power of the internet which allows people easy online access to ordering 24 hours a day,” said Rick Lynch, President of the FIFTY 50 Pharmacy division.

The kit, which includes a free testing meter with the initial purchase, consists of a month’s worth of test strips, alcohol swabs, lancets, glucose tabs and syringes. The $69.95 price tag includes shipping. Lynch added, “By combining these aspects along with the quality of the products in the kit, we feel our offer provides a legitimate price sensitive alternative to the other choices Diabetics with limited or no insurance have available to them.”

6995Diabetes has made individual supplies available online to supplement people’s needs. In addition to affordable diabetes testing products, the company endeavors to educate website visitors about diabetes testing and related topics through the 6995Diabetes. com newsletter, news feeds, and posted articles which are regularly updated on their website.

For more information or a list of discount products, visit the store online at http://www.6995Diabetes. com (http://www.6995Diabetes. com).

# # #

First four teams of world renowned scientists answer starting gun for competition to win the muthuselah mouse prize

2011-05-04T00:51:00.000-07:00

First Four Teams of world renowned scientists answer starting gun for competition to win the Muthuselah Mouse Prize

Serious race to Postpone and Reverse Human Aging begins. The "Methuselah Mouse" Prize (MMP) is designed to stimulate serious anti-aging research and intervention leading eventually to aging so slow that it is not measurable.

(PRWEB) September 27, 2003

Methuselah Foundation

Company Information:

Methuselah Foundation

9131 Stone Garden Drive

Lorton, VA 22079

Fairfax

Ph. 202-306-0989

Fx. 202-429-2015

David. gobel@dhs. gov

FOR IMMEDIATE RELEASE

First Four Teams of world renowned scientists answer starting gun for competition to win the Methuselah Mouse Prize

Serious race to Postpone and Reverse Human Aging begins

WASHINGTON, DC/EWORLDWIRE/September NN, 2003 --- The first four teams of world renowned scientists have announced their entry into the competition for the Methuselah Mouse Prize by registering with the Methuselah Foundation, which takes its name from the man reputed in Biblical records to have lived the longest in human history (969 years).

The "Methuselah Mouse" Prize (MMP) is designed to stimulate serious anti-aging research and intervention leading eventually to aging so slow that it is not measurable.

To compete for the Methuselah Mouse Prize, each team must secure their own financing from government, commercial or private sources. The prize is structured as a series where many winners are expected, each leap frogging the other as the ages of the mice grow longer and longerÂall along the way, serious, repeatable research of significant value to reversing human aging will be discovered and applied.

The first winner of the Methuselah Mouse Prize, Dr. Andrzej Bartke was announced in Baltimore on June 3rd for the mouse that lived nearly 5 years Â around 180 Â 200 years in human terms His team discovered the surprising effect of gene modifications on the mouseÂs lifespan. Future awards will acknowledge living mice that surpass the previous "age goal post" established by the first pioneering prize recipientÂ said Aubrey de Grey, architect of the Methuselah Mouse Prize, and Senior Science Advisor to the Methuselah Foundation.

The Methuselah Mouse competition, the first-ever life extension competition, follows in the footsteps of historical prizes which prove that the impossible can be done thru the right incentives, human genius and the support of visionary financiers. From the Longitude Prize of 1714 to find longitude at sea, to the Orteig Prize that moved Lindbergh to fly the Atlantic Â to the X Prize to incent private space transportation, performance prizes have a near 100% track record of solving near impossible problems in unexpectedly short timeframes.

Said Dr. Peter Diamandis, Chairman of the world famous X Prize Â ÂIn 1995 the X Prize started as an idea with no competitors and $5,000 seed money. Today, after only 7 years, we are offering a $10 million purse and have 25 teams from seven nations actively competing to be the first to jump-start the private space renaissance. I fully expect a similar outcome awaits the Methuselah Foundation and its prize to extend the healthy adult lifespan. That is why I have decided to personally support the Methuselah FoundationÂs vision. ItÂs in everyoneÂs enlightened self-interest to help our lifespan achieve Âescape velocityÂ!

Team Profiles:

Rich Miller has worked extensively in recent years on mice derived recently from the wild. These mice tend to live considerably longer than normal laboratory-bred mice, indicating that one effect of

The Miller Laboratory

Breeding mice for hundreds of generations in captivity has been to make them shorter-lived (at least in the normal lab environment). His work on these mice focuses on discovering how wild mice differ

From normal lab mice genetically, so as to determine which genetic pathways are most important in determining mammalian lifespan.

Rick Weindruch has focused throughout his career on the phenomenon of life extension by caloric restriction (CR). Since his doctoral work in the laboratory of CR pioneer Roy Walford, he has explored

the role of oxidative damage in driving the aging process and the ways in which this damage is resisted by the metabolic changes that CR brings about. He has mainly focused on the role of mitochondrial electron transport (oxidative phosphorylation) as the source and mediator of such damage.

Christian Sell and his group at the Lankenau Institute for Medical Research

Have created a set of 30 mice, called "midi" mice, which carry two copies of a mutation that reduces the amount of an important protein named IGF-1. IGF-1 is a "growth factor", a protein that promotes cell division and enlargement of tissues and of the whole body. Several other genetic modifications of related genes in mice have caused large increases in lifespan -- indeed, the mouse that won the inaugural prize had such a mutation, though in a different gene. Shortly, Dr. Sell's group will produce mice with even lower levels of IGF-1 production, by replacing one of the mutant copies with a version that makes no protein at all. (It is not possible to replace both copies with this non-producing mutation -- such mice die before birth because they cannot grow.)

Dr. Richard Cutler and his colleagues are applying the idea that simple genetic changes could have a large impact on lifespan, by investigating how to up-regulate many of the genes involved in controlling "oxidative stress" status -- the extent to which cells and tissues are constantly bombarded with free radicals, toxic molecules produced as a side-effect of using oxygen. These genes include the thioredoxin redox regulating system and the antioxidant response element (ARE) controlling an array of "phase II" proteins (proteins that are produced by cells when they sense elevated oxidative stress). Dr. Cutler is developing transgenic and pharmaceutical means to enhance expression of such systems to achieve a dramatic decrease in cellular oxidative stress. If this works they will then test the mice for lifespan enhancement.

A cash prize will be awarded in two categories. A Postponement Prize will go to the producer of the world's oldest ever mouse, restricted to the species used in laboratory work, Mus musculus, in recognition of extending healthy lifespan. Starting a year from now, a Reversal Prize will also be awarded to the producer of the world's oldest mouse whose life was extended due to effective late-onset life-extension interventions. Each prize will be awarded from a fund to which everyone who might be aging is encouraged to contribute, initially $5,000 for each prize; the amount won depends on the margin by which the previous record has been broken.

David Gobel, President of the Methuselah Foundation, explains, "The Methuselah Mouse Prize is meant to inspire and encourage serious scientific progress and innovation in extending the healthy human lifespan. We believe the Methuselah Mouse Prize can effectively raise public optimism and enthusiasm about potential human application of successful life-extending interventions used on laboratory mice that have already reached an advanced age."

The Methuselah Foundation also intends to promote public interest and involvement in mammalian life extension research by accepting public donations for future prizes along with corporate sponsorships.

Current prize donors/sponsors are the Methuselah Foundation, HMX Inc., The Maximum Life Foundation, The American Academy of Anti-Aging Medicine, The Longevity Meme, Diana Stackhouse of the Animal Health Institute and many others. The prize fund has more than quadrupled in just three months!

For more information about The Methuselah Mouse Prize, the competing teams and how to contribute to the prize fund see www. methuselahmouse. org or contact David Gobel at The Methuselah Foundation via e-mail at david. gobel@methuselahmouse. org

CONTACT: David Gobel

202 306 0989

David. gobel@methuselahmouse. org

Artcraft health education has been recognized in the healthcare marketing report for interactive patient education solutions

2011-05-03T23:54:00.000-07:00

Artcraft Health Education has Been Recognized in the Healthcare Marketing Report for Interactive Patient Education Solutions

Artcraft Health Education (AHE) is pleased to announce that they are the recipients of 3 Awards, chosen among 4,000 entries, for its work in integrated health education materials in diabetes, prostate cancer, and allergies.

Flemington, NJ (PRWEB) December 27, 2010

Celebrating its 28th year, Healthcare Marketing (part of HMR Publications Group, Inc) is the oldest, largest and most widely respected healthcare advertising awards. A national panel of judges grants awards to those entries that exemplify exceptional quality, creativity, and message effectiveness.

Since its inception, Artcraft Health Education has built a strong reputation as a full-service health education agency. Artcraft Health Education is committed to uncover, develop, and deliver interactive, engaging and accurate patient education and teaching materials that support pharmaceutical brand strategies.

Marc Sirockman, General Manager, explains: "Our primary focus is to create effective patient education materials. We strive to empower and motivate patients to take an active role in managing their own health and wellness through tactile and visually compelling education. We partner strategically with our clients to identify and address the needs of specific patient populations."

For additional information about Artcraft Health Education, please contact Marc Sirockman, msirockman(at)artcrafthealthed(dot)com, 70 Church St., Flemington, NJ 08822, 908-782-4921, http://www. artcrafthealthed. com/.

###

Beware of fake cures & other medical frauds on the web

2011-05-03T17:14:00.000-07:00

Beware Of Fake Cures & Other Medical Frauds On The Web

When the president of SiCap Industries discovered an unscrupulous internet company was stealing his customer's testimonials, his company began a fast and furious campaign to shut down every illegitimate snake oil salesman on the web. Their first case turned out to be a company peddling fake cures for the Flu, Migraine headaches and even Cancer. Now SiCap Industries is turning their attention to other internet medical scams in hopes of cleaning up the entire natural health industry.

Albany, NY (PRWEB) November 28, 2005

It all started when Wayne Perry, president of SiCap Industries, received a phone call from David Bonello of the Minnesota Wellness Directory. Bonello’s non-profit group runs a website (www. mnwell. org), covering important stories in the multibillion dollar health & wellness industry.

Bonello was investigating a Florida company accused of peddling fake medical cures over the internet. He explained how this fraudulent company was stealing customer testimonials from SiCap Industries to market a fake Migraine medicine over the internet.

“I was shocked when Dave called me. I pulled up the website and sure enough, there were our testimonials. Some of the names and cities were changed, but everything else was word for word. They stole testimonials compiled from our actual customers. We’ve built our reputation based on a product that really works. It’s a real shame that someone would steal our legitimate testimonials to support their illegitimate scheme,” says Perry.

Wayne's referring to SiCap’s flagship product, “Sinus Buster” the world’s first hot pepper nasal spray. This product has an impeccable reputation for relieving chronic headaches. Though Perry doesn’t profess his Sinus Buster formula to be a “cure,” there are hundreds of doctors and thousands of customers who will tell you it comes very close.

“It took a couple years to build the reputation we have today, and now we’ve got lots of doctors who swear by Sinus Buster. In the beginning, everyone thought we were a joke. Lets face it. Hot pepper up your nose? But it really works and that’s the truth. We’re in nearly a thousand stores now. Sinus Buster is a fantastic natural product that really helps people, and I’ll be damned if I’m going to sit back and let some bogus company steal our testimonials. That’s why we’ve launched a campaign to destroy all internet medical frauds. We plan on using our contacts at the FDA (www. fda. gov) and FTC (www. ftc. gov) to shut these scammers down for good,” boasts Perry.

After looking into this elusive internet company, Perry found they were peddling three fraudulent cures on four different websites -- each complete with fake photos and testimonials from doctors and patients who never existed. Perry was shocked to see bogus cures for Migraines, Influenza and most disturbingly, Cancer.

In their advertising, this Florida based company actually discourages sick people from seeking proven medical treatments in favor of their ($150 per bottle) sugar pill. Moreover, experts believe the pills are most likely private labeled multi-vitamins or possibly sugar pills.

“I was pissed when I saw what they were claiming about curing cancer. They were telling cancer patients to stop chemo treatments and take their pill instead. They were guaranteeing 100% cures for almost every kind of cancer you can think of. They actually say their pill is Camptosar, a Pfizer drug used for treatming colon cancer, but it’s clearly not Camptosar. According to Pfizer, Camptosar is only used to treat colon cancer, and it’s not intended to be a cure for any cancer. It’s a good drug, but it’s not for sale by anyone except Pfizer and it's prescription. The real Camptosar is also an injection not a pill. Pfizer oughta sue these bastards. I know SiCap will,” proclaims Perry.

Although SiCap Industries is correct about this fraudulent company’s activities, they cannot name the perpetrators directly in this article because it may compromise the present legal investigation headed by federal authorities.

“My attorneys say I can’t mention the company's name, or the names of their products until the investigation is finished, but I can say I know this company is selling fraudulent medical cures and using trademarked drug names from Pfizer and other large pharmaceutical companies to advertise those fake cures. We’ve opened one hell of a can of worms here and it feels good,” says Perry.

Once Perry’s initial information was presented to the board of directors, SiCap Industries immediately contacted the FDA. The company is presently working with special investigators to close down this internet scammer as fast as possible, but company officials do admit bureaucracy does take time. Until then, SiCap officials say the best advice is to be wary of health products making claims that seem too good to be true.

“We’ve started looking at other products on the web and there’s lots of false claims being made out there. There are bogus products all over the web and people need to be extremely careful. If there’s a product you’re interested in, talk to your doctor to see if it’s any good. There’s also lots of free research info on the web, but there’s a lot of bogus stuff too. You’ve got to turn to trusted sources for correct information. For general medical info, go to WebMD at(www. webmd. com). To check out clinical studies, go to the National Library Of Medicine at (www. pubmed. gov). Just play it safe and research every claim. And remember you can't dismiss the entire natural medicine industry based on a few rotten apples. When we find rotten apples, we’ll get rid of them for the good of our industry,” adds Perry.

To back up their words, SiCap Industries has officially launched a campaign to expose medical frauds on the internet. The company is presently recruiting volunteers to email anonymous tips and monitor possible frauds. To get involved, email webmaster@sinusbuster. com. All tips will be investigated thoroughly and held as confidential. Legitimate tips will be forwarded to the FDA, or other relevant government agencies. SiCap Industries also intends to follow up on every tip making certain fraudulent websites are effectively shut down.

###

Citybook. Com launches a unique, family-safe online yellow pages directory

2011-05-03T14:40:00.000-07:00

CityBook. com Launches a Unique, Family-safe Online Yellow Pages Directory

The founder of a new online Yellow Pages featuring over 16 million listings has set the lofty goal of creating and maintaining an online business directory that is completely safe for children and value-oriented families. It will not be an easy task, but Matthew Paolini is committed to presenting a directory that establishes the industry's highest possible standards. CityBook. com is free for all business to become listed.

Los Angeles, CA (PRWEB) June 7, 2007

Matthew Paolini, Founder and CEO of CityBook. com (http://www. citybook. com/), today announced the launch of his clean, family-safe online directory -- one that he hopes will set the standard for the Yellow Book genre.

"My goal is to provide a safe place where children and adults alike can search for businesses nationwide, without the fear of being subject to 'objectionable' content," he declared.

To achieve this objective, Paolini and his staff are extraordinarily careful to screen all CityBook. com business listings to ensure that the high standards of the directory continue to be upheld. The leading online Yellow Pages, however, do not subject their content to such rigorous inspections but list all types of information -- some of which could be deemed as inappropriate for children or family valued-oriented adults.

The directory's Submission Guidelines (http://www. citybook. com/guidelines. aspx) page provides detailed instructions for any business seeking a free listing on CityBook. com. According to Paolini, the following categories were recently removed:

1. Abortion Clinics - but not abortion alternatives
2. Pornography - in all of its forms.
3. Online casinos and pharmacies
4. Adult Entertainment - Dating and Escort Services, Strip Joints, etc....

While many may not view some of the noted categories as objectionable, CityBook. com is taking no chances. "People might say that it's wrong because we're letting our own political and personal views influence the content on our site," Paolini asserted. "However, there are still a lot of children surfing the Web unsupervised and we owe it to them and their families to provide safe and friendly content. … We remove anything that we feel is unsuitable for children."

Creating and maintaining this kind of directory is not an easy task. With over 16 million business listings, it is extremely difficult for[CityBook. com to locate and remove all offensive content. However, the CEO has promised that his company will do its best to eliminate such material, while stressing that doing so will be an ongoing process.

When perusing the CityBook. com directory, one can immediately locate vital information about the most popular cities in America. Detailed information about a given locale, such as business listings online (http://www. citybook. com/), employment agencies and shopping outlets are just a click away for any visitor to the site.

Case in point, one of the major Yellow Page directories features prominently placed sponsored "paid-for" listings, while another displays an incomplete list of categories when a visitor arrives at the landing page for a given city.

For persons contemplating relocation to another locale, CityBook. com is an indispensable tool for garnering as much information about the target city as possible. While the current listings are quite extensive, Paolini has set a goal to double the number of businesses listed within the next two years.

"We want CityBook. com to be the standard-bearer for the Online Yellow Pages (http://www. citybook. com/) industry," he said. "The leading directories of today are filled with useless information that is not helpful to their visitors. We will be successful in maintaining a site that is not only free from offensive material, but is also the most extensive of its kind."

About CityBook. com:

An online directory that takes pride in providing our visitors with a selective family-safe approach to finding Yellow Page listings online (http://www. citybook. com/).

For more information, please contact:
David Elliott
Director of Public Relations
Http://www. CityBook. com (http://www. CityBook. com)
Phone: (800) 514-6648 Ext. 702

###

Center for terrorism law announces legal conference on state open government law and practice in a post-9/11 world at national press club, nov. 15-16

2011-05-01T18:45:00.000-07:00

Center for Terrorism Law Announces Legal Conference on State Open Government Law and Practice in a Post-9/11 World at National Press Club, Nov. 15-16

The Center for Terrorism Law, at St. Mary's University School of Law in San Antonio, announces a major national legal and policy conference slated for November 15-16, 2007, at the National Press Club in Washington, D. C. The conference will feature approximately 30 legal and policy subject matter experts, who will comment on the non-release provisions to open government laws enacted by various states since the September 11, 2001 terrorist attacks.

San Antonio, TX (PRWEB) July 11, 2007

The Center for Terrorism Law, at St. Mary's University School of Law in San Antonio, announces a major national legal and policy conference slated for November 15-16, 2007, at the National Press Club in Washington, D. C. (529 14th Street N. W.), titled "State Open Government Law and Practice in a Post-9/11 World: Legal and Policy Analysis."

The conference will feature approximately 30 legal and policy subject matter experts, who will comment on the non-release provisions to open government laws enacted by various states since the September 11, 2001 terrorist attacks. The conference will also provide a first of its kind book detailing changes in State public information laws since the initiation of the War on Terror. In addition, as a point of comparison, the book will also contain similar legislation from four foreign nations plagued by international terrorism -- Israel, Colombia, France and the United Kingdom.

The conference is supported by a 2006 Congressionally-directed Homeland Defense and Civil Support Threat Information Collection grant, administered by the Air Force Research Laboratory. The Center for Terrorism Law is a non-profit, non-partisan academic research center dedicated to examining legal issues associated with terrorism and the War on Terror. A vital partner in this endeavor is the Reporters Committee for the Freedom of the Press (RCFP). RCFP accepts no money from the federal grant or the Center for Terrorism Law for its participation.

The review of State laws will be developed in the following categories of concern:
Critical Infrastructure -- Includes building/architectural plans; vulnerability assessments; energy/public utilities information; mass transit; telecommunications systems. Public Health -- Includes bioterrorism; medical/pharmaceutical/health/lab info; hazardous materials. First Response -- Includes emergency employee deployments; evacuation plans; emergency equipment holdings; tactical response/mitigation plans. Cyber Security -- Includes Geographic Information Systems (GIS) maps; personally identifiable information/identity theft; security investigations; security procedures/codes/surveillance/cyberterrorism. Political Structure -- Includes expanded executive powers; legislation proposed but not enacted; confidentiality based on federal regulations or federal programs; Homeland Security Commissions; closure of otherwise public meetings for security reasons. Terror Investigations -- Includes law enforcement investigations; expanded wiretapping powers; general criminal intelligence information.

"This conference will explore one of the most critical concerns raised in this post-9/11 age -- how to strike a balance between the public's long standing right to access public information and meetings vis a vis the need to keep the public safe from terrorist threats," Center for Terrorism Law Director Dr. Jeffrey Addicott said.

Addicott will also be releasing copies the 4th edition of his Terrorism Law: Materials, Cases, Comments (Tucson: Lawyers & Judges, 2007) at the conference. The book highlights some of the legal and policy challenges that confront the United States, and emphasizes the importance of developing capable military forces while promoting democracy as the long-term solution to terrorism.

It includes chapters on the Iraq war, Supreme Court decisions on detainees, interrogation techniques of the United States military, civil liberties and human rights, civil litigation, cyberterrorism, and bioterrorism. This new edition is designed to be used as a reference and text in this emerging area of the law. It includes many appendices containing important American and international documents pertaining to the War on Terror as well as discussion questions, citations of legal cases pertaining to terrorism, and bibliographic information for further reference.

###

San francisco pharmacy earns industry’s top quality & safety endorsement

2011-05-01T16:17:00.000-07:00

San Francisco Pharmacy Earns Industry’s Top Quality & Safety Endorsement

Koshland Pharm: Custom Compounding Pharmacy has become the first compounding pharmacy in San Francisco, and only the ninth in the state of California, to earn accreditation status with the Pharmacy Compounding Accreditation Board. This accreditation demonstrates that Koshland Pharm meets the highest quality and safety standards in its profession.

San Francisco, California (PRWEB) July 26, 2010

One local pharmacy is making it easier for doctors and patients in the Bay Area to choose a compounding pharmacy that meets the highest quality and safety standards in its profession. On July 15, 2010, Koshland Pharm: Custom Compounding Pharmacy became the first compounding pharmacy in San Francisco, and only the ninth in the state of California, to earn the Pharmacy Compounding Accreditation Board’s Seal of Accreditation – a new system of standards created by some of the leading organizations in the pharmacy profession. The accreditation demonstrates that Koshland Pharm meets the highest quality and safety standards in its profession.

Compounded, or custom-made, medications are an integral part of the practice of pharmacy, yet many people may not be aware of this option for their medical needs. Some conditions are best treated with medications that are not available in standard commercial formulations. Compounded medications fill this need by being tailored to a patient’s specific needs. These customized prescriptions are written by physicians and other legally authorized prescribers and prepared for an individual patient by a specially trained pharmacist. Examples of when compounded prescriptions are useful include:
To fill a patient’s need if there is a manufacturing shortage of the medication, such as the recent shortage of Armour Thyroid To treat menopausal symptoms by providing hormone replacement therapy tailored to a patient’s unique hormone profile To create a customized medication for a person who cannot tolerate the inactive ingredients (such as gluten or sugar) in manufactured medicines

Many pharmacies practice a small degree of compounding, while others, such as Koshland Pharm, specialize in this centuries-old practice.

“Our new PCAB Accreditation status and our designation as a PCAB Accredited™ compounding pharmacy lets the public know that Koshland Pharm ranks among the best for quality and safety,” said Peter Koshland, chief pharmacist and founder of Koshland Pharm. “The PCAB Seal of Accreditation shows our dedication to serving our patients by practicing safe, high-quality compounding.”

With the high volume of prescriptions that are compounded each year, there has been a need for an enhanced, profession-wide system of standards by which each compounding pharmacy can test its quality processes. While compounding pharmacy is regulated by the state, PCAB Accreditation is an even more comprehensive way to ensure a compounding pharmacy is meeting the highest quality and safety standards.

To earn PCAB Accreditation, Koshland Pharm had to complete an extensive application, document its written policies and provide an analysis of its quality procedures that was reviewed by the Pharmacy Compounding Accreditation Board and some of the leading figures in the field of compounding. Next, the pharmacy opened its doors for an extensive on-site inspection led by compounding experts. Only when these stringent evaluations were completed did the Pharmacy Compounding Accreditation Board officially grant Koshland Pharm the PCAB Seal of Accreditation and the right to use the designation “PCAB Accredited™ compounding pharmacy.”

“We are honored by this new accreditation. It confirms our commitment to providing safe, customized solutions that meet the medical needs of our patients – and the needs of the healthcare providers in our community who rely on us for these specialized medicines,” said Peter Koshland. “We are proud to become the first PCAB Accredited™ compounding pharmacy in San Francisco, and we believe this accreditation will further strengthen the bond of trust between our pharmacy and the Bay Area community.”

About Koshland Pharm: Custom Compounding Pharmacy
Koshland Pharm is a custom compounding pharmacy that specializes in hormone replacement therapy. They provide compounded medications of the highest quality with unsurpassed expertise, top-of-the-line equipment, and numerous quality control measures. They are dedicated to taking the time to engage in an on-going dialogue with patients and their doctors to support people as they to take charge of their health, improve their quality of life and prevent disease.

About the Pharmacy Compounding Accreditation Board
The Pharmacy Compounding Accreditation Board is a not-for-profit corporation formed by eight national pharmacy organizations that recognized the need for a national standards organization for compounding pharmacy. Together, these leading organizations developed the policies and standards for the practice of compounding pharmacy, as well as the PCAB Accreditation criteria and processes.

For more information on PCAB Accreditation, visit the PCAB Web site at http://www. pcab. info/about-pcab. shtml (http://www. pcab. info/about-pcab. shtml).

For more information about Koshland Pharm, and to learn more about their upcoming free seminar about managing menopause, visit their website at www. koshlandpharm. com.

# # #

Blair underwood's "man up" ad campaign promotes ahf's free hiv testing services

2011-04-28T18:27:00.000-07:00

Blair Underwood's "Man Up" Ad Campaign Promotes AHF's Free HIV Testing Services

Now Appearing on LA Billboards and Online, Campaign Directs Public to www. FreeHIVTest. net for Info on Free, Fast and Convenient HIV Testing Locations; Encourages Personal Responsibility and Need for Individuals to Know HIV Status to Protect Partners. Campaign is Part of AHF's Year-Long Initiative to Test 40,000 People for HIV in Los Angeles.

Los Angeles, CA (Vocus) April 10, 2009

AIDS Healthcare Foundation (AHF) (http://www. aidshealth. org/), which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched the second phase of its Los Angeles-area HIV prevention and testing initiative with its newest innovative and eye-catching campaign featuring actor Blair Underwood. Underwood's image can be seen on billboards throughout Los Angeles--as well as on one of AHF's mobile testing vans--with the words "Man Up" in bold printing next to his image. The ads direct the public to visit www. freeHIVtest. net to find out where to get tested quickly, conveniently and at no cost.

The campaign continues AHF's "Stay Negative" HIV prevention and testing campaign which began earlier this year with advertising materials that featured an eye-catching image of a semi-nude male with the words "Stay Negative" tattooed on his back. Like the previous "tattooed man" ad, the Underwood "Man Up" campaign includes billboards, an online presence which, in addition to its own website, includes banner advertisements on KIIS, HOT, MYFM radio station websites. The attention-grabbing image of Underwood and his direct message to viewers is already having an impact. The billboards and an increase in traffic to the www. freeHIVtest. net website have coincided with a dramatic increase in capacity and testing through the AHF Public Health Division.

"Personal responsibility is a key message of AHF's Blair Underwood 'Man Up' campaign. With Underwood's broad appeal, we hope to inspire people to see HIV testing as a necessary and routine part of their sexual health a way to protect themselves their partners," said Whitney Engeran III, Director of Public Health Division for AIDS Healthcare Foundation. "There are many uncertainties when addressing people's sexual behaviors but the one thing we know for sure is that HIV testing, detection and linkage to medical care works. The best way to break the chain of infection--in Los Angeles or anywhere--is for people to get tested and know their status."

A key component of the initiative is its website which contains crucial information about HIV transmission, prevention and treatment, including facts about condom use. The site also contains an extensive "myth vs. reality" section that frankly addresses false beliefs surrounding HIV that may prevent some individuals from accessing testing. Most importantly, the site lists AHF's free, community-based HIV testing locations including its Men's Wellness Center in Hollywood, select Out of the Closet Thrift Store locations and through its innovative mobile testing van (http://64.38.31.130/~aidsheal/calendar/month. php) that appears at public locations throughout the city including sites such as Target, Big Lots, local area churches, Food4Less, and Ross in areas of town that include Long Beach, Atwater, East Los Angeles, Venice, Inglewood and West Hollywood.

"The 'Man Up' campaign is a continuation of AHF's year-long effort to test 40,000 people in Los Angeles for HIV by working with community-based partnerships such as the City of Los Angeles, Bienestar Human Services, the Wall De Las Memorias, Homeless Healthcare, Reach L. A., Charles Drew University and other agencies," said Joseph Terrill, AHF's Domestic Testing Program Manager. "The goal of AHF's 'Man Up' campaign is in line with the initiative's overall goal: to increase awareness of the need to incorporate HIV testing as a part of everyone's routine efforts to maintain personal health and well-being, as well as to protect their partners. We hope that the billboards drive people to the www. freeHIVtest. net website where they will be able to find an HIV testing location that's convenient and accessible and completely free."

As an AHF spokesperson, Underwood recently appeared in a television public service announcement that aired throughout Los Angeles, urging everyone--whether HIV positive or not--to get their prescriptions filled at the non-profit AHF Pharmacy (http://www. ahfpharmacy. org/). The AHF Pharmacy, in addition to offering expertise in HIV/AIDS medications, is also a full-service pharmacy open to everyone, giving the community a unique opportunity to give back. Ninety-six cents of every dollar earned is re-invested into providing care and treatment for people living with HIV/AIDS in the U. S. and around the world. More information can be found at www. ahfpharmacy. org]. Underwood was also a special guest at this year's Florida AIDS Walk (http://ahf. convio. net/site/PageNavigator/FAW_Homepage), presented by AIDS Healthcare Foundation, AHF Pharmacy, Out of the Closet Thrift Stores, in Ft. Lauderdale which raised $351,500 for HIV/AIDS services in Florida. More information can be found at www. floridaaidswalk. org.

AHF's Public Health Division offers mobile HIV testing and counseling services, as well as non-traditional-venue HIV testing: at AHF's Out of the Closet® Thrift Stores, at the Men's Wellness Center, in the Bay Area through outreach programs targeting high-risk populations and in Los Angeles County Jails. Tests are performed by trained and certified testers.

About AHF: AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS organization. AHF currently provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at www. aidshealth. org.

Media Contact: Lori Yeghiayan
Telephone: (323) 860-5227 Mobile: (323) 377-4312
E-Mail: lori. yeghiayan(at)aidshealth. org

Media Contact: Ged Kenslea
Telephone: (323) 860-5225 Mobile: (323) 791-5526
E-Mail: gedk(at)aidshealth. org

# # #

Bidclerk reports construction projects up for bid in the chicago, il area

2011-04-28T09:02:00.000-07:00

BidClerk Reports Construction Projects Up For Bid in the Chicago, IL Area

BidClerk's weekly report on new construction projects coming up for bids in the Chicago, IL region.

Chicago, IL (PRWEB) February 24, 2009

BidClerk, the Construction Industry Search Engine, reported today that the following building projects are planning to go out for bids (http://www. bidclerk. com) or start construction (http://www. bidclerk. com) in the next 90 days in the Chicago, IL Metro Area. Businesses interested in providing services relative to these projects should visit BidClerk. com (http://www. bidclerk. com) and reference the Project ID listed below to obtain direct contact information for each job:

Hodgkins, IL - Wal-Mart #1892 Supercenter, 9450 W. Joliet Road, 80,000-square-foot retail expansion, April 2009, $7 million. Project ID : 857447

Aurora, IL - Chase Bank, Eola Road and Indian Trail, 4,000-square-foot bank, March 2009, $500,000. Project ID : 924146

Chicago, IL - CVS Pharmacy, W. Washington Street and N. Clinton Street, 13,567-square-foot retail build-out, April 2009, $750,000. Project ID : 919503

Fox Lake, IL - Menards - Garden Center Addition, 1400 S. US Highway 12, 23,000-square-foot garden center addition, April 2009, $2 million. Project ID : 924082

Shorewood, IL - Trinity Christian School Addition, 901 Shorewood Dr., 2-story private school addition, May 2009, $1 million. Project ID : 839842

About BidClerk. com
BidClerk. com is the only Search Engine dedicated to providing businesses with in depth information on thousands of construction projects coming up for bid all throughout the United States. Our daily updates of commercial and residential construction projects are available to contractors (http://www. bidclerk. com) and businesses in related industries that are seeking bid opportunities. For more information on bidding construction projects in your area, visit BidClerk online or call 877-737-6482.

###

College of microscopy changes its name to hooke college of applied sciences

2011-04-27T19:03:00.000-07:00

College Of Microscopy Changes Its Name To Hooke College Of Applied Sciences

The McCrone Group, Inc. announced today that its education and training division, formerly the “College of Microscopy,” has been renamed the “Hooke College of Applied Sciences.”

Westmont, IL (PRWEB) July 1, 2010

The McCrone Group, Inc. announced today that its education and training division, formerly the “College of Microscopy,” has been renamed the “Hooke College of Applied Sciences (http://www. hookecollege. com/).”

The College will expand its courses and programs beyond the realm of microscopy, and offer a wide range of hands-on, science-based, educational programs to adult professionals, college students, and advanced placement high school students. The new programs will include courses relevant to current and future technical occupations in chemistry, biology and microscopy with an emphasis on materials analysis, course tracks leading to professional certificates, as well as undergraduate and graduate degrees in collaboration with Chicagoland area colleges and universities.

The new college name honors Robert Hooke, a science pioneer who helped to shape scientific thinking in the 17th century with his contributions to microscopy, chemistry, biology, physics, engineering and astronomy. Hooke’s 1665 book entitled Micrographia was one of his most significant works published as it established microscopy as the foundation for advancing biological science.

Since its founding in 2004, the College of Microscopy has focused on the applications of microscopy and microanalytical techniques across a wide spectrum of industries, ranging from forensic and pharmaceutical sciences to nanotechnology and conservation. The new name, Hooke College of Applied Sciences, more accurately reflects plans for comprehensive offerings in science and a curriculum that recognizes the needs of today’s job market and prepares those entering or attending colleges and universities for tomorrow’s job market.

”Our goal is to broaden our offerings beyond teaching only microscopy-centric courses. The name change to Hooke College of Applied Sciences reflects those plans and is the first of many changes we will make to achieve that goal,” said Charles Zona, Dean of Hooke College of Applied Sciences.

The courses at Hooke College of Applied Sciences emphasize the importance of a well-rounded learning environment in several ways. Courses are led by world-class subject matter experts with an average of more than 20 years of experience in the private or government sector. Students engage with each other and the instructors, and participate in hands-on use of state-of-the-art instrumentation to solve real-world problems. Additionally, many courses offer a Web-Classroom-Web experience that enables students to preview material via the Web prior to a course. Then, after receiving on-campus training, students are provided unknowns to analyze in their own laboratories using their own equipment via instructor-led web-based sessions.

Students who attend Hooke College of Applied Sciences courses are eligible to receive International Association for Continuing Education and Training (IACET) continuing education units (CEUs), giving them the opportunity to obtain professional certificates and the ability to transfer class credits to other accredited schools and/or institutions. An advantage of being an IACET-certified institution is that it provides students with full disclosure of course specifics such as instructor education and experience, course syllabus, course expectations, instructional methods and student learning resources prior to registration.

About Hooke College of Applied Sciences
The Hooke College of Applied Sciences provides education and training to government and industry scientists and technicians worldwide. In addition to an undergraduate program offered in collaboration with Concordia University Chicago, Hooke College of Applied Sciences has more than 40 specialized short-courses in materials analysis. Topics covered include light and electron microscopy, spectroscopy, sample preparation, chemistry and laboratory safety, and image analysis. The new 40,000 square foot learning center at Hooke College of Applied Sciences contains classrooms and laboratories with state-of-the-art analytical instrumentation, as well as a 140-seat auditorium. Hooke College of Applied Sciences is a member of The McCrone Group, which is internationally known as the premier microscopy resource, based in Westmont, Illinois.

For more information or to register for a course, please visit hookecollege. com (http://www. hookecollege. com/)

###

Webhelps announces launch of new wiki package

2011-04-25T02:13:00.000-07:00

WebHelps Announces Launch of New Wiki Package

WhatHelps?, Inc., a global provider of hosted social networking and online community web services, announces the launch of their new 'Wiki Package,' which was formerly the Work Group Package. New features have been added to provide users with the latest in web-based collaboration. The Wiki Package will be one of five packages of hosted interactive tools offered by WhatHelps?, Inc. through their web site at WebHelps. com.

(PRWEB) July 24, 2005

Bellevue, IA - WhatHelps?, Inc., a global provider of hosted social networking and online community web services, announces the launch of their new Wiki Package.

The package lets users create a private business community for their project group or team members to communicate, collaborate, interact, share information and files, all within a private, hosted environment.

Setup is fast and easy; no training, downloading or special skills required. For those who need help building their Wiki, WebHelps Extreme SupportÂ with its small-team approach will deliver a level of service beyond most expectations. They place the most experienced, most highly paid people on each Support Team. Each Team is comprised of a team leader, support liaison, programmer, web designer and billing specialist.

Matthew Highland, WhatHelps? CTO, had this to say about the Wiki Package features: "The Package will include unlimited registered team members, One Click Customization, Project Announcements page, Objectives page, Task List, Known Issue List, Article Library, RSS Feeds, Team Directory, Activity Tracking, Create-A-Page, Instant Messenger, Calendar, Blog, Filesharing, Knowledge Base and IMail List."

WhatHelps?, Inc. CEO, Michelle Wilbers said, "The Wiki's ease of use is what has made it so popular," she added. "The trick, which we have mastered, has been adding new features without making the Wiki more difficult to use. People can literally sign into our Wiki and begin working immediately with other members of their Wiki group. No training is needed. If you can email, you can Wiki."

"Because there is no software to buy, install, or maintain and no server required, Wikis are becoming increasingly popular among small businesses and organizations. They have found they can provide their people with some of the best real-time collaboration software available, on an as-needed basis, without making a big financial commitment. And, because Wikis are so easy to use, they do not have to spend a lot of time and money on training."

Educational institutions are using Wikis for student collaboration and projects. The pharmaceutical industry uses Wikis to manage clinical trials and develop new technology. Engineering firms have found Wikis useful in tracking engineering projects, bids and technology development. And organizations of all types are finding that Wikis are cost-effective ways to manage projects and documentation.

About WhatHelps?

WhatHelps?, Inc., co-founded by CEO, Michelle Wilbers in 2000, is headquartered in Bellevue, Iowa. WhatHelps? provides its communication-oriented tools in packages of web site add-ons, or as individual web tools, on a subscription basis. For most small businesses and individuals, the cost of purchasing, installing and maintaining these types of tools is cost-prohibitive. By providing tools in a unique, shared hosting environment, WhatHelps? makes even the most expensive and complex tools affordable and easy to use. Should a particular tool not fully meet a customer's needs, WhatHelps? offers an Add-A-Feature service, which, for a reasonable fee, provides customers with the option of changing and/or adding features.

Tracey Kozelka

WhatHelps?, Inc.

306 N. 2nd Street

Bellevue, Iowa 52031 USA

(563) 872-4231 (weekdays, 9 a. m. to 5 p. m. CST)

Http://whathelps. com/helpform. htm (http://whathelps. com/helpform. htm)

###

Scirex appoints samer e. Kaba, md, as vp clinical research and medical management

2011-04-25T01:50:00.000-07:00

SCIREX Appoints Samer E. Kaba, MD, as VP Clinical Research and Medical Management

SCIREX Corporation today announced the appointment of Dr. Samer E. Kaba to the position of Vice President Clinical Research and Medical Management. Dr. Kaba will direct the operations of the Medical Management and Safety group, monitor the medical and safety aspects of projects managed by the company and provide medical and safety consulting services to Sponsors, clinical sites and project teams.

(PRWEB) May 5, 2005

Dr. Kaba joins SCIREX from PRA International, where most recently he was Senior Director, CNS, Global Product Development Services, responsible for formulating clinical development strategies and providing consultative and life cycle management advisory services for new therapies.

Dr. Kaba is a graduate of the Damascus University School of Medicine and did residency training in internal medicine and neurology at the State University of New York (SUNY), Buffalo. He completed fellowships in neuro-immunology/multiple sclerosis at SUNY, and in neuro-oncology at the University Of Texas M. D. Anderson Cancer Center in Houston, where he also served as a faculty member. Dr. Kaba currently holds an adjunct faculty position at the Department of Neurology at Emory University in Atlanta. He served as the Director of Research at the Shepherd MS Center in Atlanta and as Assistant Professor at the University of Arkansas in Little Rock, where he also managed a private neurology practice. Dr. Kaba is certified by the American Board of Psychiatry and Neurology and has multiple scientific publications on topics relating to CNS diseases and disorders. He holds professional memberships in the American Academy of Neurology, the Society for Neuro-Oncology, the American Society of Clinical Oncology, and the American Academy of Pharmaceutical Physicians.

ÂThis is a significant appointment for SCIREX,Â said John Whalen, M. D., General Manager, Clinical Development Services. ÂSince excellence in clinical trial design and patient safety are at the heart of the services we provide our clients, Dr. KabaÂs academic achievements, his experience as a clinician and his substantial industry experience make him superbly qualified to lead these critical areas of our operations.Â

About SCIREX

SCIREX Corporation is a leader in the delivery of Phase I-IV drug development services to the global pharmaceutical and biotechnology industries. SCIREXÂs clinical trial management capabilities include drug development planning, protocol design, submission services, regulatory affairs consulting, investigator and patient recruitment, data management, statistics, medical writing and offers an array of technology solutions including IVRS, EDC and SIMS(TM) (Study Information Management System). SCIREXÂs experience portfolio includes more than 1,000 clinical trials involving well over 100,000 patients, evaluating new treatments for pain and inflammation, neurological and psychiatric disorders, infectious diseases and gastrointestinal and cardiovascular indications. SCIREX is a wholly-owned subsidiary of Omnicom Group, Inc.

For more information contact Blythe Vito, SCIREX Corporate Marketing at (215) 907-1330 x1054, or visit www. scirex. com.

# # #

Argo translation’s solution for medical device translation receives iso 9001:2008 certification from tÜvrheinland&#174

2011-04-23T12:41:00.000-07:00

Argo Translation’s Solution for Medical Device Translation Receives ISO 9001:2008 Certification from TÜVRheinland®

Argo Translation, provider of efficient, accurate translation and localization services focused on quality and clarity for a wide range of companies across North America, announced today that its Regulatory Compliance Platform for delivering transparent quality assurance for medical translation and medical device localization has received ISO 9001:2008 certification, an internationally recognized standard issued to organizations with a quality management system.

Glenview, IL (Vocus) December 15, 2009

Argo’s medical translation solution, launched earlier this year as the Regulatory Compliance Platform (RCP), provides transparent quality-assurance to the localization supply chain for clients in regulated industries such as medical, medical devices, pharmaceuticals and financial.

The certification was authorized by TÜVRheinland®, a premier global provider of independent testing and certification services with 15 locations throughout North America. ISO 9001:2008 provides a set of requirements that must be in place to have a quality management system, regardless of the organization’s size, product or service line, or public or private status. Certification to the standard is voluntary, and organizations must complete a rigorous auditing process by a third-party registrar.

“Quality has always been a cornerstone of our service at Argo Translation,” said Peter Argondizzo, President. “Achieving this certification with a perfect score of zero infractions is excellent recognition for our project management team and their commitment to repeatable quality.”

About TÜVRheinland®
TÜVRheinland® delivers premier independent testing, assessment, and certification services to help companies gain access into global markets. Boasting an international network across six continents, the company’s in-country experts ease the path to compliance with cost-effective pricing and quick turnaround times. The $1.5 billion corporation is comprised of an international network of more than 12,500 employees in 62 countries and serves most industry sectors and markets worldwide. For more information, visit http://www. us. tuv. com.

About ARGO Translation
Having successfully executed projects requiring simultaneous translations in 46 different languages, ARGO Translation provides specialized and professional translation services for a multitude of domains ranging from legal and technical to marketing and financial and everything in between. Argo provides efficient, accurate translation and localization services focused on quality and clarity for a wide range of companies across North America. More information available at http://www. argotrans. com.

###

Drug-free rehabilitation proves successful

2011-04-23T10:07:00.000-07:00

Drug-Free Rehabilitation Proves Successful

Brain disease theory lacks merit for addiction treatment while drug-free approach of Narconon Arrowhead shows long-term success in rehabilitating former addicts.

(PRWEB) February 11, 2005

For several decades drug and alcohol addiction has been viewed as an incurable brain disease by the scientific, medical and psychiatric communities. However, in a statement released by the National Institute of Drug Abuse (NIDA), the director contradicted herself by claiming that Âdrug addiction is a brain disease,Â in one sentence and then saying that abnormalities have been discovered in Âthe brains of some, but not all, addicted individuals.Â

A new Treatment Improvement Protocol released by the Substance Abuse and Mental Health Services Administration (SAMHSA) claims that 50-75 percent of patients in substance abuse treatment programs have co-occurring mental illness. SAMHSA's 2003 National Survey on Drug Use and Health suggested that about 4.2 million adults aged 18 and older met their criteria for both substance abuse and mental illness, yet these claims are based on subjective diagnoses instead of factual data.

Concurrent with the theory of addiction being a brain disease the NIDA director also asked for more Âcontributions of the pharmaceutical industry in developing new medications.Â The problem with this, as evident by the recalls, law suits, black box warning labels and the seemingly endless list of side-effects, is that putting people on more drugs doesnÂt help them in the long run and certainly doesnÂt fit the definition of rehabilitation. A person cannot be considered clean and sober if they are on mind-altering drugs, whether they are legally prescribed or not.

According to Gary Smith, Executive Director of Narconon Arrowhead, ÂOur goal is the total eradication of substance abuse. It is possible, but we as individuals, agencies, communities and as a nation must agree that it can be done and support programs that show results. We canÂt keep pouring money into ineffective measures while the social fabric continues to decay because of drugs.Â

Narconon Arrowhead is the nationÂs leading drug-free rehabilitation and education program. With a success rate of approximately 70% of program graduates remaining drug-free, its application of L. Ron HubbardÂs drug rehabilitation methodology has proven to be successful for many years and has been validated by research studies as well as ongoing empirical evidence.

The more science and medicine focus on the chemical composition of human beings' brains and develop more drugs to treat symptoms such as anxiety, depression and other observable behavioral indicators that are normal for a drug addict to experience, the more we as a nation are denying these individuals the ability to overcome their addiction.

In the substance abuse field, there are simple and extremely effective rehabilitation strategies that don't use drugs to treat individuals or subjectively evaluate people. Thousands of former addicts around the world are now living healthy, productive and drug-free lives because of the tools provided to them by the NarcononÂ® Drug Rehabilitation and Education Program, most of whom had tried traditional medical approaches first only to find no results.

To get free information about substance abuse or to get help for a loved one in need, contact Narconon Arrowhead today at 1-800-468-6933 or log on to www. stopaddiction. com.

# # #

Free prescription drugs available

2011-04-22T16:52:00.000-07:00

Free Prescription Drugs Available

Pharmaceutical manufacturers have patient assistance programs that give away millions of dollars worth of free prescription medication annually. Free Booklet explains how and where to go for help. The A to Z list of prescription drug programs includes contact phone numbers.

Washington, DC (PRWEB) August 16, 2006

Is your medication too expensive for your budget? If so, information in a new, free booklet might help.

The Cost Containment Research Institute in Washington, DC has just published a 33-page booklet "Free and Low Cost Prescription Drugs 8th Edition." The revised booklet gives information on how and where to get free and low cost prescription drugs.

"Many major drug companies provide free or low cost medication, but rarely, if ever publicize the programs," says Gary Nave, director of The Institute. "We've published an A to Z listing of all the drugs that are available through patient assistance programs, for free or at very low cost directly from the manufacturer."

Not all people will qualify for the programs. There are 103 programs and 1,104 drugs listed. Qualifications vary by manufacturer. In the last ten years thousands of people have used these programs to receive free prescription medication.

Consumers can download the booklet for free from The Institute's Internet web site: www. institutedc. org

# # #

Introducing directorsofpharmacy. Com

2011-04-21T11:52:00.000-07:00

Introducing DirectorsofPharmacy. com

DirectorsofPharmacy. com is a new community website aimed at pharmacy leaders and their colleagues.

San Francisco, CA (PRWEB) May 25, 2010

DirectorsofPharmacy. com is a new community website aimed at pharmacy leaders and their colleagues. Currently, these busy professionals do not have adequate online services to find information and connect with peers. The recently launched website will cater directly to professional pharmacists and feature a wide range of content, community and useful tools. Built by pharmacists for pharmacists, this community covers a broad range of topics geared to empower busy directors.

Now, pharmacy leaders and their colleagues can easily find up-to-date news, interesting articles, useful forms and intuitive community networking that has been specifically tailored for their needs. The site provides information about various continuing education programs and business best practices in addition to event listings and other useful tools. Pharmacists can ask a question in the forums, comment on a new trend or upload something useful to the community database. Pharmacy leaders can finally find everything they need in a single, easy to use one-stop-shop.

For additional information, contact: Peter Leach

Contact: Peter Leach
DirectorsofPharmacy. com
415-367-4657
Fax 415-362-3611
Info(at)directorsofpharmacy(dot)com
Www. directorsofpharmacy. com

DirectorsofPharmacy. com is a new community website created by and for pharmacy leaders. Pharmacists now have an online home to network and share information.

DirectorsofPharmacy. com was formed in 2010 to serve pharmacy leaders online. The company is powered by Igloo Software and partnered with Pipeline Healthcare (www. pipelinehealthcare. com), a leading telepharmacy and remote-order-entry provider.

# # #

Announcing the spazz-g, by colours wheelchairs: no compromise necessary

2011-04-21T11:35:00.000-07:00

Announcing the Spazz-G, by Colours Wheelchairs: No Compromise Necessary

Colours 'N Motion announces a 'breakthrough' wheelchair: The Spazz G. Designed to be lightweight, stylish and affordable, the Spazz G is the next innovation by Colours.

Corona, CA (PRWEB) February 1, 2005

Ultra-Light, Ultra-Hip, Ultra-Adjustable, Ultra-Durable, Ultra-Affordable, Ultra-Stylish, Ultra-COLOURS. The thought of a stylish and affordable wheelchair has been considered by many to be beyond dreams. Now Colours has changed this. The new SPAZZ-G is not only a totally adjustable and stylish wheelchair, but with a suggested retail price of only $1,450.00 in the USA and approximately euro1450 in Europe (final price to be determined) it is priced to be fully covered by most world-wide health payment plans.

The SPAZZ-G features expandable seat width and depth, as well as adjustable positioning. The contoured frame is designed to be not only stylish, but also practical since it is easy to pull into the car and over the steering wheel. At 19 lbs (8.6 kg), including wheels, it is sleek, lightweight and easy to lift.

The SPAZZ-G has a main rigid axle tube that gives durability, rigidity and support. It has positive locking adjustable backrest, offering a full range of infinite backrest angle settings.

But best of all, it is not one of those mass produced, ordinary wheelchairs. The SPAZZ-G is different, because it's a Colours Wheelchair. Celebrate life in a Colours Wheelchair.

About Colours:

Colours is a leader in the rehabilitation industry for its design of innovative everyday, sport and pediatric wheelchairs. Colours' wheelchairs are lightweight, adjustable and customizable. At 14.5 pounds (6.6 kg) the custom-designed Zephyr (http://www. colourswheelchair. com/products/prod_zephyr. htm (http://www. colourswheelchair. com/products/prod_zephyr. htm)) is one of the lightest wheelchairs on the market. The Boing! (http://www. colourswheelchair. com/products/prod_boing. htm (http://www. colourswheelchair. com/products/prod_boing. htm)) is the first wheelchair with four-wheel independent suspension. For more information: www. ColoursWheelchair. com. Colours is now expanding in Europe. European distributors interested in distributing Colours Wheelchairs are encouraged to contact Med Services Europe, ColoursÂ European representative.

About Med Services Europe:

Med Services Europe B. V. is based in Amsterdam, The Netherlands and conducts Sales, Marketing and Business Development services for the Pharmaceutical, Diagnostic and Medical Equipment Industry. Med Services' specializes in building and managing distribution networks for medical manufacturers in Eastern and Western Europe. We are Colours' Representative in Europe. European Wheelchair distributors are invited to contact us.

Www. MedServicesEurope. com

Telephone: +31648566707

# # #

Us pressure sensing markets see two bright spots

2011-04-20T20:58:00.000-07:00

US Pressure Sensing Markets See Two Bright Spots

In addition to life sciences, automotive applications are expected to offer pressure component suppliers solid bookings opportunities. "One of the highest growth prospects, both in rate of growth and total dollar volume, is expected for automotive vehicle application of pressure transducers. Auto makers, and their subsystem suppliers, are incorporating pressure sensing in a wide range of new applications," says Jim Taylor, Director of VDC's Industrial Automation and Control Practice.

(PRWEB) February 21, 2003

Natick, Massachusetts - February 19, 2003 - Demand for pressure transmitters and transducers is strong in the US life sciences and automotive markets.

According to Venture Development Corporation (VDC), the life sciences market, including biotech and pharmaceutical segments, is expected to grow faster than any other market segment consuming pressure transmitters and transducers. According to Jim Taylor, Director of VDC's Industrial Automation and Control Practice, "More than $40 billion in spent annually on biotech and pharmaceutical industry research. That spending includes a wide range of test, instrumentation and process control equipment incorporating pressure transmitters."

Additional drivers of this demand include:

1. Biotech industry investment in research and development equipment and programs incorporating pressure sensing, monitoring and control requirements;

2. Biotech industry development of commercial systems and subsystems that include the use of pressure transmitters and transducers; and

3. Pharmaceutical industry investments, in R&D and process control equipment.

One example of these systems, Tire Pressure Monitoring System (TMPS), is gaining popularity as the U. S. government tries to mandate tire pressure standards. The 2000 Transportation Recall Enhancement, Accountability, and Documentation Act (TREAD) states that all new vehicles must meet a tire monitor standard by the fall of 2003. In a TMPS, drivers are notified of low tire pressure, and even maintaining tire pressure in some systems. Car makes such as Ford and General Motors are currently installing these systems in their flagship models.

ABOUT VDC

Founded in 1971, VDC is a technology market research and consulting firm that specializes in industrial and commercial electronics, computing, communications, software and power systems markets.

**************************************************

Report Availability

Www. vdc-corp. com/components/works/br02-38.html (http://www. vdc-corp. com/components/works/br02-38.html )

**************************************************

For further information about "The U. S. Pressure Transducer, Transmitter and Sensor Industry", contact:

Jim Taylor, Group Manager - jimt@vdc-corp. com

508-653-9000, ext. 121

Marc Regberg, Senior Vice President - msr@vdc-corp. com

508-653-9000, ext. 111

If you would like to subscribe to more VDC updates go to: www. vdc-corp. com/subscriptions (http://www. vdc-corp. com/subscriptions)

Launch of hematology oncology pharmacy association

2011-04-20T11:32:00.000-07:00

Launch of Hematology Oncology Pharmacy Association

A new organization representing Hematology Oncology Pharmacy practice has been launched.

Duluth, GA (PRWEB) September 15, 2004

A new professional organization has been formed with the intention of empowering hematology/oncology pharmacy practitioners to optimize the provision of cancer care. HOPA, the Hematology/Oncology Pharmacy Association, was officially launched on April 3, 2004 in St. Petersburg, Florida. The announcement coincided with the 8th Annual Making a Difference in Oncology conference.

The announcement was met with enthusiasm by the audience, the majority pharmacists with a particular interest in hematology/oncology practice. ÂThis organization needs to be not just for the people who are recognized across the United States as oncology pharmacists, but for the people who serve across the continuum of cancer care, all the way to the technician who prepares the chemotherapy every dayÂ said Terri Davidson, PharmD, acting secretary of HOPA.

The core membership of HOPA will include pharmacists with an interest in oncology and practicing in areas of clinical care, research, education, or administration. Associate memberships will be available to those who are not pharmacists but wish to support the mission of HOPA. Student/trainee memberships will be offered to encourage early involvement of those individuals planning a career in hematology/oncology pharmacy practice. According to HOPA Interim Executive Committee chair John Kuhn, the potential benefits of HOPA are substantial. Members will organize to develop and support educational activities, to provide research and information promoting the safe and cost-effective use of cancer-related treatments, to support and promote excellence in clinical practice, to act as patient and practice advocates to policy makers, and to increase public and professional awareness of the value of hematology/oncology pharmacy practice. Dr. Kuhn stated ÂIt is our HOPE that this Association will become the home for hematology/oncology pharmacists who are making a difference in the lives of patients with cancer every dayÂ.

The announcement was followed by the HOPA Inaugural address, given by Charles A. Coltman, M. D., Chairman of the Southwest Oncology Group and Professor of Oncology at University of Texas Health Science Center at San Antonio School of Medicine. Addressing the topic ÂThe Future of Cancer CareÂ, Dr. Coltman said, ÂThe individuals who benefit from collaboration between the hematologist/oncologist, oncology nurses, and hematology/oncology pharmacists are the cancer patientsÂ.

The HOPA Interim Executive Committee consists of John Kuhn of the University of Texas College of Pharmacy, San Antonio, Texas; Barry Goldspiel, NIH Clinical Center, Bethesda, Maryland (Vice-Chair); Susan Goodin, the Cancer Institute of New Jersey, New Brunswick, New Jersey (Treasurer); Terri Davidson, Syntaxx Communications, Duluth, Georgia (Secretary), and committee members Ross Davidson, Emory University, Georgia; Robert Ignoffo, University of California at San Francisco, San Francisco, California; and Phil Johnson, H. Lee Moffitt Cancer Center, Tampa, Florida.

HOPA plans to have its first annual educational meeting in San Diego in June 2005. Information about HOPA and how to join is available by calling 877-508-0836 or via e-mail to: info@hoparx. org. The HOPA website will soon be activated at www. hoparx. org.

Contacts (for pre-publication questions regarding this press release):

Philip E. Johnson, MS, RPh, FASHP

Director of Pharmacy, H Lee Moffitt Cancer Center

12902 Magnolia Drive

Tampa, FL 33612

813-979-3967, 813-979-3994 (fax)

Johnsonp@moffitt. usf. edu

Ann Birner, PharmD, BCOP

Pharmacy Department

Dartmouth-Hitchcock Medical Center

One Medical Center Drive

Lebanon, New Hampshire 03756

603-650-7362, 603-650-4454 (fax)

Ann. birner@hitchcock. org

Hematology/Oncology Pharmacy Association

305 West Country Drive

Duluth, Georgia 30097-5906

###

Electromagnetic flowmeter technology leader introduces new website and magnew two wire plus magnetic flowmeter that slashes installation costs

2011-04-18T22:10:00.000-07:00

Electromagnetic Flowmeter Technology Leader Introduces New Website and MagneW Two Wire Plus Magnetic Flowmeter That Slashes Installation Costs

Yamatake America – The Leader in Electromagnetic Flowmeter Technology Introduces A New Website Featuring the MagneW Two Wire Plus Magnetic Flowmeter that Slashes Installation Costs. Yamatake America, Inc. (YAI) is Dedicate to Providing the Industry with a Broad Range of Flow Measurement Capabilities and Instrumentation Resources that will Enhance Your Flowmeter and Transmitter Options.

Phoenix, Arizona (PRWEB) February 15, 2006

Yamatake America – The leader in electromagnetic flowmeter technology introduces a new website at http://www. yamatakeamerica. com/ (http://www. yamatakeamerica. com/) featuring the MagneW Two Wire Plus Electromagnetic Flowmeter that slashes installation costs. Yamatake America, Inc. (YAI) is dedicated to providing the industry with a broad range of flow measurements capabilities and instrumentation resources that will enhance your flowmeter and transmitter options, and the new website is designed to anticipate design needs and ease the way flowmeters are purchased in North America today.

Yamatake Electromagnetic Flowmeters, Pressure Transmitters, and Temperature Transmitters are available with 4-20mA output, HART® Protocol and Digital Enhanced (DE) Protocol. This is a result of a private label agreement that has now ended with Honeywell wherein Yamatake supplied magnetic flowmeters and other components to Honeywell to be sold as part of the Honeywell product line.

Several Yamatake America products come standard with both HART and DE protocols. Yamatake refers to this as a “Bi-Lingual” capability. Most of the Yamatake line, which is now sold on a direct basis throughout North America, is also available with FOUNDATION Fieldbus capability.

The new site includes an easy-to-use “Distributor Locator” where you are able to search by Product, by State, and by City to find the Yamatake Distributor closest to your plant and facility.

The new Yamatake America site also features a “Documentation” page that features specification sheets, brochures and Users Manuals online.

Documentation for each of the individual Yamatake Electromagnetic Flowmeters and magmeters is also available from http://www. yamatakeamerica. com/resources. asp (http://www. yamatakeamerica. com/resources. asp)

“Application Notes” which detail industry problems and Yamatake solutions for Biochemistry, Chemical, Petrochemical, Pharmaceutical, Municipal Utilities, Metal and Steel, Food & Beverage, and Pulp & Paper, are also available online.

Installation Drawings are available for all Yamatake flow meters and magmeters as well as for temperature transmitters and pressure transmitters.

Explore the new Yamatake America website today. Search the site by Product Name or by Model Number or browse the following pages to find the right category and locate the product you need.

Flowmeters: http://www. yamatakeamerica. com/flowmeters. asp (http://www. yamatakeamerica. com/flowmeters. asp)
Pressure Transmitters: http://www. yamatakeamerica. com/pressuretransmitters. asp (http://www. yamatakeamerica. com/pressuretransmitters. asp)
Temperature Transmitters: http://www. yamatakeamerica. com/temperaturetransmitters. asp (http://www. yamatakeamerica. com/temperaturetransmitters. asp)

Yamatake America, Inc. is dedicated to providing industry solutions for Biochemistry, Chemical, Petrochemical, Pharmaceutical, Municipal Utilities, Metal and Steel, Food & Beverage, and Pulp & Paper industries. The new Yamatake America website really is designed to anticipate your needs and ease the selection process to ensure that you get the flow meters, magmeters, temperature transmitters, and pressure transmitters that meet your needs.

About Yamatake Corporation and Yamatake America, Inc.

Yamatake America, Inc. is a wholly owned subsidiary of the Yamatake Corporation. Since our founding in 1906, Yamatake has built on its core of measurement and control technologies to maintain its position at the forefront of Japan's automation industry. Over our long history, during which we once operated under the name Yamatake-Honeywell, we have built a sterling reputation for providing optimum solutions in industrial automation, factory automation and building automation.

Industrial Automation: Process Control Systems, Field Instruments, and Control Valves for the industries, such as refining, petrochemical, chemical, pulp and paper, and public utilities

Control Products: Control Products for factories, such as semiconductor manufacturing, electric, electric components, industrial machinery, and automobiles

Building Automation: Systems and products for the building market, such as office buildings, factories, hotels and public facilities

Innovative Products: Innovative products developed with Yamatake's own advanced technologies.

Contact:

Bob Harvey

1-888-2-magnew (1-888.262-4639)

Or visit http://www. yamatakeamerica. com/ (http://www. yamatakeamerica. com/)

Arizona High Tech Talent Partnership

Http://www. azhttp. com/ (http://www. azhttp. com/)
Kathleen Austin

480-998-0246

###

Legalview reveals details of the fda mandated black box warning for fluoroquinolone antibiotics such as cipro and levaquin

2011-04-18T14:55:00.000-07:00

LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin

LegalView reported of a recent FDA warning for antibiotics under the fluoroquinolones drug family that will now require a black box warning, the strongest warning issued by the FDA. The FDA instituted the mandate due to the greater risk of tendonitis and tendon rupture among patients prescribed these drugs.

Denver (PRWEB) July 12, 2008

LegalView, the number one resource for everything legal on the Internet, reported details of a recent U. S. Food and Drug Administration (FDA) mandate regarding the fluoroquinolones antibiotics family of drugs. All of the fluoroquinolones will now carry black box warning labels to ensure physicians and patients understand that the drugs have been associated with an increased risk of tendonitis and tendon rupture.

Among the most common of the fluoroquinolone antibiotics are Levaquin, Cipro, Factive and Avelox - some of the most commonly prescribed anti-bacterial drugs. Levaquin, also known as levofloxacin, is an antibiotic that fights infections including bronchitis, pneumonia, Chlamydia, gonorrhea, skin infections, urinary tract infections, etc. It has been previously linked to Achilles tendonitis among patients who were prescribed the drug. A study released in The Journal of American Board of Family Medicine reported the Levaquin warning (http://levaquin. legalview. com) and associated risks with prescribing the drug, however, the drug was approved for the use of children as an antibiotic and potential treatment for airborne anthrax in 2008 only a few years after the report was published. According to the study, patients who had taken the drug at any time, even two years or prior, may be at an increased risk for tendonitis. And those who were elderly seemed to be at the highest risk. Individuals who have taken Levaquin are advised to contact an experienced pharmaceutical attorney to learn about the potential for developing a Levaquin lawsuit (http://levaquin. legalview. com).

Cipro, known as ciprofloaxacin, is manufactured and sold by Bayer A. G. and is used to treat bacterial infections, although it is not recommended for victims of the common cold or flu. A study published in the Clinical Rheumatology December 2003 issue, noted the relationship of the drug's consumption compared to patients with Achilles' tendon rupture and reported that there may be cause for a Cipro warning (http://cipro. legalview. com) that links the drug's use to the risk of tendonitis. In addition to this risk, other Cipro side effects (http://cipro. legalview. com) can include seizure, difficulty breathing, hallucinations, depression, blacking out, chest pain, suicidal thoughts and numbness.

Another one of the more commonly used drugs that is part of the fluoroquinolones group is Factive. Factive, gemifloxacin mesylate, is an oral prescription drug that has also been linked to the tendon rupture as the most serious risk, although some other Factive side effects (http://factive. legalview. com) can be considered just as serious, including phototoxicity, abnormal heartbeats and central nervous system conditions. The drug was released for market in April 2003 from Oscient Pharmaceuticals with the tendonitis Factive warning (http://factive. legalview. com) printed on an informational pamphlet issued by the company, although it was not at that time marketed with a black box warning even though the risks of Achilles' tendon rupture were known among the manufacturers. Factive, similar to Cipro and Levaquin, treats lung bacterial infections for patients 18 years and older.

Finally, adult patients who have been taking Avelox (moxifloxacin HCL) for treatment of either bacterial sinusitis, bronchitis or pneumonia infections should be aware that an Avelox warning (http://avelox. legalview. com) and increase of a black box labeling will also be issued per the FDA's mandate. Because Avelox is part of the fluoroquinolones antibiotic group, the Avelox side effects (http://avelox. legalview. com) also consists of an increased risk for tendonitis or tendon tear/rupture.

It is important for individuals who have taken or are currently taking any of these drugs (Levaquin, Cipro, Factive and Avelox) or any of the other fluoroquinolones antibiotics be aware of this increased warning and FDA mandate, as the potential for a prescription drug lawsuit may exist, especially if a patient that previously consumed any of these drugs has suffered from Achilles tendon rupture. It is advisable for a victim to contact an experienced pharmaceutical law firm to receive legal consultation for possible fluoroquinolone-related litigation. It is also important for patients to contact their physician immediately if muscle soreness or tenderness occurs while consuming any of these anti-bacterial prescription drugs, as this may be a sign of tendon rupture.

About LegalView:

LegalView. com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView. com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView.

###

Drugs in our drinking water? How to dispose of your medications safely

2011-04-18T11:15:00.000-07:00

Drugs In Our Drinking Water? How To Dispose of Your Medications Safely

Some useful guidelines from the Johns Hopkins White Paper 2008: Prescription Drugs on how to dispose of your unwanted medications safely to minimize the impact on humans and wildlife.

New York, NY (PRWEB) March 12, 2008

The Johns Hopkins White Paper 2008: Prescription Drugs recently published a summary of the Office of National Drug Control Policy literature on the subject of how to dispose of your medications safely.

According to a recent Associated Press investigation, prescription drugs have been found in drinking water across the U. S. They found a vast array of pharmaceuticals -- including antibiotics, anti-convulsants, mood stabilizers and sex hormones in the drinking water of 41 million Americans.

Though the level of concentration has been said to be very small, at this point it is unclear as to what the effects of continuous exposure to these drugs in these combinations could mean for humans and wildlife.

In light of these findings, the Johns Hopkins Prescription Drug White Paper summary should prove of some use in answering Americans' concerns about how to dispose of unwanted medications safely.

The original summary states:

How To Dispose of Your Medications
If you've ever wondered what to do with leftover or expired prescription medications, the federal government recently released some important advice. Here are the three options:

1. Throw in the trash.
To do this, remove pills from their original containers. If you are worried about illegal reuse, mix the pills with coffee grounds or kitty litter and place in an empty can or sealable bag.

2. Flush down the toilet.
Do this only if the drug label says so. Drugs that should be flushed down the toilet rather than thrown in the trash include narcotic pain medications, such as fentanyl (Actiq, Duragesic Transdermal System, Fentora), oxycodone (Oxycontin, Percocet), meperidine, and morphine (Avinza); the narcolepsy drug sodium oxybate (Xyrem); the hepatitis drug entecavir (Baraclude); the attention deficit-hyperactivity disorder drug methylphenidate (Daytrana Transdermal Patch); and the HIV drugs atazanavir (Reyataz) and stavudine (Zerit).

3. Utilize take-back programs.
If you are concerned about the environmental effects of flushing medications down the toilet or throwing them in the trash, take advantage of take-back programs, which allow you to bring unused drugs to a central location for proper disposal. Ask your local pharmacy or municipal waste collection system if they have such a program.
Source: THE OFFICE OF NATIONAL DRUG CONTROL POLICY, February 2007

But in view of the recent AP investigation findings, the Office of National Drug Control Policy might want to consider revising their recommendations with regard to Option 2.

In the meantime, Americans can all do their share for the environment by choosing Options 1 or 3.

We might also like to consider applying the same vigilance in disposing of any over the counter medications we might have on hand the next time we decide to clean out our bathroom cabinet.

For more Health Alerts on Prescription Drugs and how to take them safely, please visit:
Prescription Drugs Health Alerts (http://www. johnshopkinshealthalerts. com/alerts_index/prescription_drugs/653-1.html)

For a review of the latest research on prescription drugs, please visit The Johns Hopkins White Paper 2008: Prescription Drugs:
Prescription Drugs White Paper (http://www. johnshopkinshealthalerts. com/white_papers/prescription_drugs_wp/digital08_landing. html)

"How To Dispose of Your Medications" excerpted from The Johns Hopkins Prescription Drugs White Paper, page 41. C 2008

###

Gilead alberta receives ‘best practices award’ for improving pharmaceutical batch process with foxboro ph sensors

2011-04-15T03:59:00.000-07:00

Gilead Alberta Receives ‘Best Practices Award’ for Improving Pharmaceutical Batch Process With Foxboro pH Sensors

New York, NY (PRWEB) April 25, 2007

Invensys customer, Gilead Alberta, received a 2007 Plant Services Best Practices Award for improving pharmaceutical batch processing efficiency while substantially reducing costs using advanced-technology Foxboro pH sensors. Gilead Alberta is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics to advance the care of patients suffering from life-threatening diseases worldwide.

The Plant Services Best Practice Award recognizes management technique, work process, product, and service implementations that improve industrial plant performance, maintenance, reliability and asset management. Winners are selected by the more than 105,000 subscribers of Plant Services magazine, who judge entries based on short - and long-term return on investment, innovation, and breadth of application.

Gilead Alberta won the Best Practices award in the “Equipment” category for working with the Invensys Measurements & Instruments Division (www. foxboro. com/instrumentation (http://www. foxboro. com/instrumentation)) to develop an advanced pH sensor to assure consistent product quality and maximize batch yields in the company’s harsh process environment. The Foxboro 871PH Series sensor enabled Gilead to complete a pH adjustment in just three hours, rather than the 18 hours to 24 hours previously required.

“With the Foxboro 871PH sensor, yields have increased and cycle times have been shortened. When you add the increase in quality, the improved pH readings by one sensor can be worth hundreds of thousands of dollars per year,” says Robert Pastushak, senior technical/operational supervisor, Gilead Alberta.

According to Pastushak, the 871 PH sensor is also very durable. “The sensor we deployed more than two years ago looks like it did the day we bought it. Previously, as many as three probes, at approximately $600 per probe, would fail while processing just one batch.” says Pastushak.

Ash Grove Cement, another Invensys customer, was also selected as a runner up in the Plant Services Best Practices Award “Software/Systems” category, for expanding the scope of its computerized maintenance management system to reduced inventory and improve maintenance efficiency through the use of Invensys’ comprehensive Avantis EAM (enterprise asset management) solution.

About Invensys
Invensys is the world leader in industrial asset performance management, a strategy designed to help today’s industrial enterprises to effectively balance the availability and utilization of their production assets to match changing business requirements. In addition to its rapidly expanding Global Solutions and Performance Management services groups, Invensys’ automation businesses includes industry-leading brands such as Foxboro, Triconex, SimSci-Esscor, Wonderware, and Avantis, whose products are installed in more than 100,000 plants across the world. These range from small hybrid and batch plants to the world’s largest upstream projects, refineries, gas plants, petrochemicals plants, power plants, and pulp and paper mills. For more information on Invensys’ process automation businesses, please visit www. invensys. com/ps (http://www. invensys. com/ps).

The Invensys Group (www. invensys. com) is headquartered in London and is listed on the London Stock Exchange, with approximately 30,000 employees working in 60 countries.

Foxboro, Triconex, SimSci-Esscor, Wonderware, Avantis, and Invensys Validation Technologies are trademarks of Invensys plc, its subsidiaries, or affiliates. All other brands and product names may be trademarks of their respective owners

###

Are perceived savings of plan d worth the hassle

2011-04-13T12:30:00.000-07:00

Are Perceived Savings of Plan D Worth the Hassle

Are perceived savings of Plan D worth the hassle? For many seniors, the lure of substantial savings with Plan D now has them mired in mass confusion and wondering if it's all worth it

Vancouver, B. C. (PRWEB) February 7, 2006

Medicare Plan D is proving to be a chaotic mess for all concerned: the pharmacists, the doctors and most of all, the patients. More than 20 states have had to cover the cost of drugs for patients who are being refused their medications because they have not made it onto the system or they have fallen through the cracks.

“The country’s most frail and sickest are the ones who are really paying the price,” states Dr. Paul Zickler of DoctorSolve Healthcare Solutions (www. doctorsolve. com), an online pharmacy service. “They are waiting five to seven days, while the pharmacist attempts to wade through the bureaucratic mess to get them their prescriptions. I feel badly for patients who are caught in the inefficiencies of a plan that is destined to fail.”

Is it all worth it? At the end of 2005, one million seniors voluntarily signed up for Plan D, believing that it was the best, most affordable option. Numerous reports, such as the recent one from AARP (American Association of Retired Persons), worked very hard at convincing them that Medicare is cheaper than buying from Canada.

However, studies cited are narrow, and Medicare Plan D is a more complex picture than a slivered cross-section of patients can adequately represent. There are multitudes of plans, many with sub plans and reams of dizzying formularies to confuse the issue. “It is unlikely that patients with more than one medication will be able to find all their drugs on one formulary at the lowest price,” states Zickler. “Many factors will affect the cost outcome dramatically. Also, many studies don’t take into account that drug prices will go up, and that formularies can change at the insurance company’s discretion.”

For more than half of senior citizens, wrapping their head around Medicare is simply not worth the trouble. A recent survey by DSS Research indicated that over half of their respondents (53%) said they had not chosen a Part D plan and have no plans to do so. The study also showed that disinterested non-buyers would “prefer not to pay attention to information involving numbers.” In other words, they are more approachable with messages that do not show the numbers.

With the confusion over eligibility, delayed access to drugs and the sheer complexity of Medicare, it’s no wonder why many seniors choose the simplicity and reliability of Canadian pharmacy services. “However we fit into the lives of American seniors – whether we’re their only drug source or a fall-back option, they know that when they come to us for their drugs, they won’t be turned away,” states Zickler. “We always deliver with low prices and safe medications. We succeed where Medicare Plan D fails.”

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37), offers lower-cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best online pharmacies by PharmacyChecker. com. DoctorSolve has filled more than 200,000 U. S. prescriptions.

For more information, call 1-866-732-0305 or visit http://www. doctorsolve. com (http://www. doctorsolve. com)

Contact:

Dianne Bidewell

1-866-732-0305

###

New multiplex tissue biomarker service launched to advance companion diagnostics development in a regulated environment

2011-04-12T22:31:00.000-07:00

New Multiplex Tissue Biomarker Service Launched to Advance Companion Diagnostics Development in a Regulated Environment

Digital pathology services leader Flagship Biosciences announces the launch of a novel approach for quantitative measurement of multiple tissue biomarkers called FACTS (Feature Analysis on Consecutive Tissue Sections).

Flagstaff, AZ (PRWEB) October 21, 2010

Flagship Biosciences announced today the launch of a new tissue biomarker multiplexing analytical tool for tumors and other tissues. The patent pending technique is based on advanced image registration approaches in radiology fields and applied to consecutive histology sections. The novel technology approach will be presented at Pathology Visions 2010 in San Diego. Flagship is currently offering the multiplexing technology as part of their digital pathology services.

The technique, known as FACTS (Feature Analysis on Consecutive Tissue Sections), expands the number of IHC markers that can be measured cost-effectively and reproducibly in oncology clinical trials and translational medicine. Multiple biomarkers are measured in aligned tissue sections, preserving morphology while not changing well-established histology and immunohistochemistry practices. The multiplexing approach is designed for use in GLP or CLIA regulated environments, as it improves standardization of immunohistochemistry and offers a complete audit trail of the glass and digital slide.

“In oncology drug development, there is an urgent need for more standardization of pathologist reading of immunohistochemistry, especially with companion diagnostic development and in clinical trials. In the development of FACTS, we worked backwards from the needs in CLIA regulated IHC laboratories to what could be developed for improving pathologist workflows on multiple tissue biomarkers,” said David Young, President and Chief Pathologist of Flagship Biosciences. “We can now efficiently and reliably measure specifically designated tissue regions for protein expression on 4-8 different IHC biomarkers on consecutive tissue sections. By separating stains with color deconvolution and using image registration approaches from radiology, we can offer clients a more reproducible IHC measurement without compromising established histology technologies.”

“There is a strong and immediate need for increased standardization of anatomic pathology in oncology clinical trials, and digital pathology is an important step in this direction. FACTS is a second exciting step that brings digital pathology capabilities to a new level,” said David Eberhard, Director of Clinical Trials Pathology Services at LabCorp’s Center for Molecular Biology and Pathology and Adjunct Associate Professor at the University of North Carolina. “FACTS enables a multiplexed analysis of protein expression on a technology platform that can be validated in a similar fashion to the many IHC digital imaging clearances already on the market. This is extremely important for late-stage oncology trials.”

In addition to the use of FACTS in regulated oncology clinical trials, there are also time-saving applications for the technology in preclinical GLP toxicology and biomarker expression analysis in research environments. “Pharmaceutical discovery groups demand as many protein expression profiles as possible in tissues. FACTS is a major improvement over existing IHC approaches, and is a great match for human xenograft tumor profiling,” said Neal Goodwin, Program Director of Jackson Labs Cancer Services.

About Flagship Biosciences

Flagship Biosciences is a pathologist-owned company whose mission is to deliver digital pathology services in pharmaceutical and medical device development. Flagship’s services include tissue biomarker development on-demand, low-cost digital pathology slide scanning, secure hosting, pathologist-supervised IHC and histology placement, and custom image analysis and companion diagnostics services. All of their services are reviewed and supervised by board-certified pathologists.

# # #

Medical professionals on call 24/7

2011-04-11T10:27:00.000-07:00

Medical Professionals on Call 24/7

Epocrates survey reveals the "off-duty" commitment of healthcare professionals

San Mateo, CA (PRWEB) October 3, 2007

"Is there a doctor in the house?" may sound like a line from popular medical television shows like Grey's Anatomy (http://abc. go. com/primetime/greysanatomy/index) or Scrubs (http://www. nbc. com/Scrubs/), but a recent survey by Epocrates Inc. revealed that it occurs in the real world as well. A survey of more than 400 physicians and other healthcare professionals by the PDA medical software (http://www. epocrates. com/products/rx/) company uncovered some interesting experiences and attitudes about healthcare and advice outside of the exam room.

The survey found that:
•Is there a doctor in the house? -- Three out of four medical professionals consider their career a way of life, not just a job, and have responded to a request for spontaneous medical attention at a public place, such as at a shopping mall or restaurant.

•Hippocratic Oath or lawsuit? -- Fear of malpractice lawsuits have caused some clinicians to consider holding back from providing medical assistance outside of their hospital or practice. More than half of survey respondents agreed they hesitated to provide off-duty medical care because of potential legal repercussions.

•Leave it at the office -- Being a medical professional is no doubt rewarding and well respected, but it can also bring some unwanted questions, as captured in the popular book, 'Why do Men Have Nipples?' (http://www. amazon. com/Nipples-Hundreds-Questions-Doctor-Martini/dp/1400082315/ref=pd_bbs_sr_1/105-7585971-1182865?ie=UTF8&s=books&qid=1191267174&sr=8-1) When asked about avoiding unsolicited medical questions, 68 percent of respondents confessed that they have refrained from introducing themselves as a healthcare professional to enjoy their personal time.

"I have helped provide medical attention at auto accidents, on a plane and even provided stitches to friends on my dining room table. Being a doctor is an intrinsic part of who I am," said Michelle Condon, MD, Grand Rapids, Michigan.

Note: Visit Epocrates Insights (http://insights. epocrates. com/is-there-a-doctor-in-the-house) for comprehensive survey results and to read comments from practicing clinicians about their experiences and opinions about providing medical care to family, friends and strangers in need.

About Epocrates Inc.
San Mateo, Calif.-based Epocrates is transforming the practice of medicine by developing innovative mobile software and web-based solutions that support clinical decisions at the point of care. More than 500,000 healthcare professionals, including more than one in four U. S. physicians, actively use Epocrates' medical software to improve patient safety, avoid drug interactions and save time. The company's services also enable communication between its users and healthcare organizations such as pharmaceutical manufacturers, government agencies and market research firms. For more information about Epocrates, please visit www. Epocrates. com.

All trademarks are properties of their respective owners.

###

A safe, non-toxic solution found for the world wide head lice epidemic

2011-04-11T01:45:00.000-07:00

A safe, non-toxic solution found for the world wide head lice epidemic.

(PRWEB) June 23, 2000

CONTACT:

Ricki de Wolff

ArborVida Natural Products

Business: (858)535-8203

Home: (858)535-8030

Fax: (858)535-8164

Support@nonits. com

Nonits, the Non-Toxic Solution to Head Lice, Proven to be 100% Effective.

San Diego, Ca--June 15, 2000-- ArborVida Natural Products, the environmentally conscious organization, puts new, reformulated, non-toxic head lice removal product on the market. With the current head lice epidemic amongst children throughout the world, this comes as good news for all concerned. After extensive testing conducted by Lice Source Services with Professor Terri Meinking as consultant, Nonits was found to have 100% efficacy at killing head lice. The successful completion of these laboratory tests allows the general public access to the non-toxic, all natural head lice solution that serves as a safe and effective alternative to over-the-counter head lice solution products that contain potentially harmful chemicals and pesticides.

ArborVida Natural Products, one of the innovators in the design and production of health and environmentally conscious products was founded by Ricki de Wolff after researching the ingredients contained in over-the-counter head lice removal products: "When my youngest son got head lice, I decided to look into the products being sold for head lice removal. I was shocked to find out how dangerously toxic the majority of head lice solutions really are." De Wolff, using her background in pharmacology, came up with a non-toxic solution, and after using it on her son, offered it to friends who used it on their children. After testing by Lice Source Services, de Wolff has decided to produce Nonits as a safe alternative for other parents concerned with the dangerous side effects caused by the pesticides contained in over-the-counter products. Health conscious parents and nurses throughout the United States have recently embraced Nonits. Says de Wolff of Nonits, "I am very happy to be able to make a product available that is completely safe for use on children."

ArborVida Natural Products prides itself on the safety and high quality of its non-toxic products. Importantly, they are committed to on time delivery of all products. ArborVida Natural Products is constantly developing new safe and healthy products for their customers. For additional information on Nonits or other all-natural products offered by ArborVida Natural Products, call 1-800-707-9597.

# # #

Venture capital investment rises 37% this week to $413 million

2011-04-10T15:44:00.000-07:00

Venture Capital Investment Rises 37% This Week to $413 million

CapitalHunter. com has verified that 37 companies received $413 million over the period February 20-February 26, a 37% increase from the previous week.

SAN DIEGO, CA (PRWEB) March 3, 2006

Venture capital investment rose this week, as $413 million was placed in 37 separate companies, up over 37% from the previous period. Unlike in previous weeks, where early stage funding generally dominated the headlines, later stage funding stole the spotlight, as almost 60% of the aforementioned $413 million went to such ventures. Biotechnology and software, the two most popular sectors for venture investment, received the lion’s share of the week’s funding, as 24% and 20%, respectively, were placed into such companies. A significant amount of this week’s biotech funding was invested in Cadence Pharmaceuticals, a pharmaceutical company located in San Diego which develops and licenses therapeutics that can be utilized in hospital settings. Cadence received $60.8 million ($53.8 million in Series B growth capital and $7 million in debt financing) in growth financing from well-known venture capital firms Frazier Healthcare Ventures, Versant Ventures, Technology Partners, Domain Associates, ProQuest Investments, BB Biotech, CDIB BioScience Venture Management and a group of individual investors.

IPO Activity

The IPO market, which was hot a few weeks ago when over 30 companies listed within a two week stretch, has cooled considerably. This reporting period has only two IPOs to report, and one of them is a blank-check listing (for those of you unaware of what a blank-check listing is, a blank-check company is a company that has no business plan or is planning to merge or acquire either assets, such as land or real estate or another established company. Such offerings that qualify for any of the three major exchanges are usually of the merger & acquisition nature.) The two companies that listed this week are as follows:

Liquidity Services, which priced at $76.9 million on the NASDAQ, is an online auction marketplace for wholesale, surplus, and salvageable assets.

Grubb & Ellis Realty Advisors, which priced at $125 million on the AMEX, is a blank-check company organized to acquire real estate-related assets.

Top Venture Investments

The three largest investments of the period were:

Cadence Pharmaceuticals, a developer, acquirer and licensor of hospital-related therapeutic products, raised $53.8 million in Series B financing (as well as an additional $7 million in debt financing) from Frazier Healthcare Ventures, Versant Ventures, Technology Partners, Domain Associates, ProQuest Investments, BB Biotech Ventures and CDIB BioScience Ventures.

Netifice Communications, a provider of business-class connectivity solutions, raised $35 million in late stage financing from Boston Millennia Partners, Columpia Capital, Dolphin Equity Partners, Fidelity Ventures, H. I.G. Capital, Rho Ventures, Comcast Interactive Capital, Performance Equity Management, Trident Capital, and USVP.

EndoGastric Solutions, a developer of endoluminal reconstructive gastric instruments and procedures, raised $32 million in Series C financing from Chicago Growth Partners, MPM Growth Capital, Advanced Technology Partners, Foundation Medical Partners and Oakwood Medical Investors.

Venture Funding Breakdown

California was the largest recipient of venture capital funding this week. Eighteen California companies raised $231 million in new equity financing, which accounted for 55% of the total venture capital invested this reporting period. The largest private venture financing in California was placed into the aforementioned Cadence Pharmaceuticals.

The biotechnology sector raised the most venture capital this reporting period, with three companies raising $96.4 million in venture financing, which accounted for 24% of the venture capital this period. The largest private venture financing in the medical device sector this period was also placed into Cadence Pharmaceuticals.

Start-ups raising their Series C round of financing represented the largest share of the funding pie, as 29% of all money invested this period went into such companies. The largest late stage financing was placed into EndoGastric Solutions. EndoGastric Solutions raised $32 million in financing and is developer of endoluminal reconstructive gastric procedures as well as instruments used to perform the procedures.

About CapitalHunter. com

CapitalHunter. com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter. com searchable database to research newly and historic financings and to identify active investors.

Please visit www. capitalhunter. com and get immediate access. New subscribers can request a free investor analysis.

###

Tamiflu approved for use against swine flu, but timing is a critical factor in the drug's effectiveness, cautions doctorsolve

2011-04-10T06:16:00.000-07:00

Tamiflu Approved for Use Against Swine Flu, but Timing is a Critical Factor in the Drug's Effectiveness, Cautions DoctorSolve

If taken too late, Tamiflu does little to arrest H1N1 bug and stop spread of virus.

Vancouver, B. C. (PRWEB) May 6, 2009

The swine influenza (H1N1) that has hit Mexico has jumped borders into the US, Canada, Spain, Israel, Britain, Switzerland, Peru, Austria, New Zealand and Germany and is causing many to frantically search for medical protection.

The World Health Organization, which has raised the threat awareness level to five out of six, has cleared Tamiflu (oseltamivir), an antiviral drug, for use against H1N1. The Centers for Disease Control also recommends it. President Obama has asked congress for $1.5 billion to help battle the current and potential cases of the virus by stockpiling different medicines including Tamiflu.

Tamiflu is an anti-viral drug that has been in production for a decade. It is believed that Tamiflu helps to fight the flu once a person has been infected. However, when the drug is taken is a critical factor in its effectiveness.

"Tamiflu needs to be ingested within the first two days of showing symptoms or contracting the virus," says Doctor Zickler of DoctorSolve Healthcare Services, an online internet pharmacy (http://doctorsolve. com). A doctor's prescription is required in order to buy Tamiflu online (http://www. doctorsolve. com/searchSingleMed. asp? search=Tamiflu). By the time symptoms are evident and patients can see a doctor, it's often past the point when the bug can be arrested. "Most patients take it too late for it to do any good." If you need a referral to a physician's office for a Tamiflu prescription consultation, please call us at 1-866-732-0305 or visit http://www. doctorsolve. com." (http://www. doctorsolve. com.")

Meanwhile, Zickler says good old-fashioned hygiene can increase your chances of staying healthy. "Wash your hands frequently and thoroughly. Eat healthy and exercise. Above all, keep an open mind and a level head when it comes to the H1N1 flu. Fear comes from not knowing, and that can lead to undue stress, which in the long run is much more harmful to your health and well being."

For more information, call 1-866-732-0305 or visit http://www. doctorsolve. com (http://www. doctorsolve. com)

###

Sai systems awarded gsa idiq contract from gsa - ecoe

2011-04-10T00:53:00.000-07:00

SAI Systems Awarded GSA IDIQ Contract from GSA - ECOE

SAI Systems will assist the US General Services AdministrationÂs (GSA) Energy Center of Expertise (ECOE) in their nationwide program in monitoring progress towards energy reduction goals as they apply to federal buildings.

Shelton, CT (PRWEB) May 26, 2004 -

Â SAI Systems International, Inc. (SAI Systems) announced that it has been awarded an indefinite-delivery, indefinite-quantity (IDIQ) contract for database development and maintenance services by the US General Services AdministrationÂs (GSA) Energy Center of Expertise (ECOE). The duration of the contract is for a base period of one year and three-year options period. The contract number is GS-11P-04-YAD-0019.

Under the GSA contract terms, SAI Systems will assist the ECOE in their nationwide program in monitoring progress towards energy reduction goals as they apply to federal buildings, as well as implementing energy conservation projects through traditional and innovative methods. The ECOE utilizes the Energy Usage Analysis System (EUAS), a custom application, to track energy usage in Federal facilities throughout the nation. The scope of the resulting task orders will involve maintaining and developing various energy related databases, incorporating new functional requirements and enhancements related to end-user needs. SAI Systems will provide architecture and design services (including restructuring for higher availability and performance), monitoring of database instances specified by ECOE, production and storage of statistics for future database capacity planning and sizing, and database management services. The software to be developed under this contract will be used across all GSA buildings nationwide to cut energy consumption as mandated by Congress.

Dr. Ramesh Wadhwani, President and CEO of SAI Systems said, ÂWe are delighted on being chosen by ECOE for their energy database warehouse development, support and on-going maintenance service requirements. This contract was won amongst stiff competition over 84 competing vendors nationwide. We are proud to be a small company providing high quality services. SAI Systems knowledge management system, which is designed to incorporate all past learning in the area of project execution, shall add to the effective execution of this contract.Â

Manoj Wadhwani, Vice President - Technology said, ÂThe thrust of the work SAI Systems will perform on this contract is focused on quality database development and maintenance services to help the ECOE in monitoring progress towards energy reduction goals while achieving cost reduction with improved system reliability.Â

SAI Systems has been providing value added and cost effective services to the Government sector for several years. SAI Systems is ISO 9001:2000, SEI CMM Level 3, GSA Approved, Small Business 8(a) certified, Minority and Women Owned business enterprise. SAI Systems was established in 1986 with the mission to improve clientsÂ business and productivity through the development and implementation of cost-effective, custom technology solutions. SAI has strong global technology consulting services experience and domain competencies from having worked with many US Government agencies and leading companies in the Telecommunication, Banking and Financial Services, Healthcare, Transportation, and Pharmaceutical industries.

About GSA

GSA is a centralized federal procurement and property management agency created by Congress to improve government efficiency and help federal agencies better serve the public. It acquires, on behalf of federal agencies, office space, equipment, telecommunications, information technology, supplies, and services. GSA, comprised of 14,000 associates, provides services and solutions for the office operations of more than one million federal workers located in 8,300 government-owned and leased buildings in 1,600 U. S. communities. For additional information, please visit the GSA website at http://www. gsa. gov (http://www. gsa. gov)

About SAI Systems International, Inc.

SAI Systems is a rapidly growing technology service provider based in Shelton, CT. Established in 1986, SAI Systems has grown over the years to be among the fastest growing companies in the state of Connecticut and has an enviable client base from diverse industry segments. SAI Systems is a process driven organization with a customer centric and market facing focus. With a large team of qualified, experienced and highly motivated technology professionals and domain specialists, SAI Systems offers cost-effective, timely and quality software solutions and consulting services to companies of all sizes. For additional information, please visit the SAI Systems website at http://www. saisystems. com (http://www. saisystems. com)

Netunity software releases the wsrp. Net framework 3.0

2011-04-09T15:53:00.000-07:00

NetUnity Software Releases the WSRP. NET Framework 3.0

NetUnity Software today announced the latest release of its product for developing Web Services for Remote Portlets(WSRP) compliant portal-based business solutions using the Microsoft. NET Framework.

Virginia Beach, Virginia (PRWEB) May 3, 2010

NetUnity Software today announced the latest release of its product for developing Web Services for Remote Portlets(WSRP) compliant portal-based business solutions using the Microsoft. NET Framework.

This latest release supports the WSRP 2.0 specification including support for events, public parameters and in-band resource requests. A single producer developed using the WSRP. NET Framework will automatically support both WSRP 1.0 and WSRP 2.0 consumers.

Version 3.0 of the WSRP. NET Framework greatly improves the use of ASP. NET pages for portlet development. These improvements significantly lessen the need for a developer to learn any new programming interfaces when developing WSRP portlets. WSRP producers and portlets can be developed using either Visual Studio 2005 or Visual Studio 2008.

The WSRP. NET Framework is a comprehensive portlet development framework and runtime that allows businesses to build and deploy portal-based business solutions based on the published OASIS web service standard that promotes plug-and-play interoperability among portals and portal components - Web Services for Remote Portlets (WSRP). IT organizations, application vendors and content providers can now implement WSRP portal solutions using. NET and the popular Visual Studio™ development environment to target WSRP compliant portals. The NetUnity WSRP. NET Framework is available for evaluation to qualified businesses or for immediate purchase.

About NetUnity Software
NetUnity Software provides WSRP-based products and services that enable businesses to develop and deploy open standard portal solutions for the Microsoft. NET platform. NetUnity is an active member of the OASIS WSRP Committee responsible for the development of the WSRP Specification and has formal partnerships with the major portal vendors supporting WSRP.

NetUnity Software products are used by global organizations in financial, healthcare, energy, pharmaceutical, education, transportation, professional services and employer services industries. NetUnity is committed to helping customers and partners deliver high-quality, easily maintainable, WSRP applications and integration solutions.

For more information:
Http://www. netunitysoftware. com (http://www. netunitysoftware. com)
866-843-0987

###

Nusil technology debuts ultra-soft elastomer with gel-like properties

2011-04-07T12:55:00.000-07:00

NuSil Technology Debuts Ultra-Soft Elastomer with Gel-like Properties

Low-durometer MED-4286 ideal for applications requiring a soft, flexible, moldable elastomer.

Carpinteria, Calif. (Vocus) September 1, 2009

NuSil Technology LLC (http://www. nusil. com (http://www. nusil. com)]), a leading formulator and manufacturer of silicone compounds for the healthcare and pharmaceutical industries, announces the release of MED-4286 (http://www. nusil. com/library/products/MED-4286P. pdf), an ultra-soft elastomer with a feel similar to a firm gel but with greater physical properties, providing a product ideal for potting, encapsulating or molding devices.

MED-4286 is a pliable silicone elastomer designed for applications requiring low “000” durometer, as well as low modulus and high elongation. Featuring a low, pourable viscosity and 12-hour work time, MED-4286 is easily moldable, providing versatility for various applications. This material is designated as Unrestricted and can be considered for use in long-term implants (implanted 29 days or longer).

“MED-4286 is a notable material for applications that require a soft, yet moldable material that can keep its form,” said Brian Nash, vice president of Marketing and Sales.

With a one-to-one mix ratio, MED-4286 is conveniently packaged in a side-by-side kit for easy use. For implant applications of less than 29 days or applications that come in contact with body fluid and/or skin, NuSil offers a Restricted version of MED-4286, which can be considered for use in such applications.

For more information on NuSil’s silicones for healthcare applications, call 805-684-8780 or visit http://www. nusil. com/products/healthcare (http://www. nusil. com/products/healthcare).

###

Irody and medminder launch new software and medical technology to automatically manage medications and track patient adherence

2011-04-06T01:01:00.000-07:00

Irody and MedMinder Launch New Software and Medical Technology to Automatically Manage Medications and Track Patient Adherence

Epilepsy Patients First to Benefit from Combined ActivPrescription™ and Maya™ Electronic Pillbox Technologies through Epilepsy. com.

Lexington, MA and Newton, MA (PRWEB) October 20, 2010

Irody, the leader in software for patient reported symptoms and outcomes, and MedMinder Systems, the leader in medication adherence solutions, today announced they have integrated their respective products to create a generalized and comprehensive solution for patients and their physicians to improve chronic disease management.

For the first time, patients will be able to take advantage of an integrated electronic solution to automatically track and record medical information, including their most current symptoms, medication side effects and whether they are having issues with compliance. In addition, patients will be able to share this information on a real-time basis with their physicians and caregivers.

“Because medications and compliance play such a pivotal role in the management of chronic conditions, knowing the pattern of how patients are taking their medication is important for maximizing the benefits and reducing the risks of the therapy,” said Eran Shalvesky, CEO of MedMinder.

“Patients’ behavior can be directly linked to therapy outcomes in many cases,” said Eyal Bartfeld, D. M.D, Ph. D., CEO of Irody. “Currently, physicians need to ask patients for this information and rely on good memory. Having the capability for patients to log relevant information right when and where it happened makes the record more detailed and accurate. With this new solution, we automatically collect the data about medication taking, and further enrich and enhance the accuracy of the data made available to both patients and clinicians.”

Through epilepsy. com, the first application of this automated and patient-friendly solution will be launched for patients with epilepsy. This application will make it possible to take information generated by MedMinder’s Maya™ electronic pillbox and store it directly in Irody’s ActivPrescription™ software platform. Thousands of patients with epilepsy who have already adopted My Epilepsy Diary on epilepsy. com, the world’s largest website for epilepsy resources, information and community, will be able to access the Maya electronic pillbox through their diaries. The information from the Maya electronic pillbox will be added to patient reported symptoms and outcomes already available in the diary. Patients and physicians can get the information securely using the web, as well as on smart phones, when granted permission by the patient

Robert S. Fisher, M. D., Ph. D., Editor-in-Chief of epilepsy. com and Director of the Stanford Epilepsy Center and consultant to Irody commented, “This linking of an automated electronic pillbox with an on-line diary of seizures and side effects will provide real-world accurate information on seizures and missing medications. Adherence (compliance) is a major reason for treatment failure in epilepsy, and this solution is a new approach to the problem. It also could find use in clinical trials of new medications.”

“The combination of these two technologies advances how we can manage epilepsy to the best of our ability today and potentially to gain important patient information for improving the treatment of epilepsy in the future. Further, this new automated solution makes it possible and practical to track the patient’s experience, which is especially critical for people with epilepsy,” said Warren Lammert, Chairman of the Epilepsy Therapy Project. “We are delighted to take epilepsy. com’s “My Seizure Diary” to the next level and provide the epilepsy patient community with a state-of-the-art way to help manage their treatment.”

About Irody, Inc.
Irody is the leader in online medication management. Its cloud-based ActivPrescription™ platform provides patients suffering from chronic diseases with a convenient method of managing their own health. With ActivPrescription, patients, doctors, HMOs, researchers, disease associations and pharmaceutical manufacturers gain access into how medications are consumed and impacted by other medications, environment and patient actions. For more information, visit http://www. irody. com.

About MedMinder Systems, Inc:
MedMinder Systems, a Newton, Mass.-based company, was founded in 2007 with the purpose of providing services that simplify medication management and improve medication adherence. The company’s flagship product “Maya” is an affordable, easy-to-use solution that helps users take medications on time and provides reports to family and providers. For more information, visit http://www. medminder. com.

About epilepsy. com:
Epilepsy. com is an online resource that was developed by the Epilepsy Therapy Project to provide in-depth information and community for people living with epilepsy. The mission of epilepsy. com is to inform, empower and connect patients, families and caregivers facing newly-diagnosed epilepsy and those struggling with epilepsy that has resisted the usual treatments. Founders and editorial board members of epilepsy. com include leading clinicians and researchers in the field of epilepsy from leading medical institutions. For more information, visit http://www. epilepsy. com.

###

Inside beauty taps industry leaders for advisory board - nutraceutical & personal care innovators to lead conference program development

2011-04-04T09:17:00.000-07:00

Inside Beauty Taps Industry Leaders for Advisory Board - Nutraceutical & Personal Care Innovators to Lead Conference Program Development

Inside Beauty, a new trade show and educational conference for the beauty, health, and wellness industries, announces that a virtual whoÂs who in the nutraceutical and personal care markets have joined its inaugural Advisory Board. Inside Beauty, (www. inside-beauty. com) is scheduled to take place, September 27-29, 2005 at the Jacob K. Javits Convention Center in New York, alongside the 13th Annual HBA Health & Beauty America.

Princeton, NJ (PRWEB) April 25, 2005

ÂTheir collective expertise into the latest scientific research and developments of this growing market sector, provides a strong knowledge base for Inside Beauty to serve the beauty, health & wellness market. Our goal is to present a well rounded Education Program which will cover the challenges, opportunities and new market developments,Â said Laura Connolly, Project Manager for Inside Beauty. ÂPutting in place a top notch Advisory Board, reflecting different disciplines of the market, allows us to serve all participants of this highly integrative industry.Â

The Inside Beauty 2005 Advisory Board includes:

ÂAnthony L. Almada, B. Sc., M. Sc., President and Founder of IMAGINutrition, and natural products pioneer since 1975. IMAGINutrition is an innovation and science marketing think tank focusing upon nutritional technologies, IP, clinical research validation, and science-driven media campaigns. The company is currently engaged in over 12 clinical studies in various universities and research centers around the world, is prosecuting several patents and is functioning as a technology transfer entity for process, composition and utility patents in the human and animal dietary supplement, cosmeceutical, and functional beverage and food sectors. In 1989 Mr. Almada introduced vanadyl sulfate and in 1991 the first thermogenic product to the market. In 1992 he co-founded Experimental and Applied Sciences (EAS), now the largest sports nutrition company on a global scale.

ÂTom Clough, Managing Director of Health Strategy Consulting, (HSC), founded the company in 1999. Mr. Clough is a recognized industry expert and leader and provides strategic advice to companies wishing to grow in the health industries. His companyÂs service range from strategy development to complete implementation, deals with partnering and licensing strategies, competitive intelligence, market trend and forecast reporting, and customized market research. To-date, HSC has performed over 300 projects with clients across the globe. Prior to founding HSC, Mr. Clough spent five years as a Managing Consultant with Gemini Consulting and led projects with various clients in the chemicals, energy, pharmaceuticals, computers, and telecommunications industries.

ÂLynda M. Doyle, Director of Business Development for DSM Nutritional Products, Inc., has 16 years of experience in the dietary supplement, food and pharmaceutical industries. She joined DSM when it was Roche Vitamins Inc. in June 1996 as Coloration Project Manager for the Food Business, concentrating on carotenoids as food colorants. In 1998, Ms. Doyle joined the Dietary Supplement and Health Group as Sr. Marketing Manager and became Director of Marketing for New Ingredients and Business Development in 2001. Prior to joining DSM, she managed sales territories for BASF's Human Health and Nutrition Group and for EM Industries' Fine Chemicals Division. Ms. Doyle currently serves as Sr. Vice President for the Drug, Chemical and Associated Technologies Association (DCAT).

ÂDarrin C. Duber-Smith, President of Green Marketing, has served in both full-time and advisory capacities for a large number of organizations in a variety of different industries, including consumer goods manufacturers, suppliers, retailers, service providers, publishers, and event producers. With specialized expertise in the natural products/wellness/environmental sustainability marketplace, he is uniquely positioned to offer expertise to both large, more mature organizations as well as smaller, less formalized companies experiencing high growth rates. Mr. Duber-SmithÂs partial client list includes: Jason Natural Cosmetics, FM Branding/Maplewood Bake Co, Elementis, J. M. Huber, Bath & Body Works, Nine Sigma, Natural Marketing Institute, Chipeta Sun Resort & Spa, Draco Natural Products, Nature's Apothecary, Shoyeido Corp., ZAND Herbal Formulas, and Borg-Warner.

ÂLoren D. Israelsen is President of LDI Group, Inc., a consulting firm that specializes in dietary supplements, functional foods and phytomedicine issues. While acting as Vice President of Strategic Development, of NatureÂs Way Products, he engineered agreements with Efamol Ltd., Madaus AG, and Dr. Willmar Schwabe, GmbH, to bring phytomedicines to the United States. He has been heavily involved in the ongoing political and regulatory issues facing the supplement industry. Mr. Israelsen has also served as industry liaison to the Food and Drug AdministrationÂs Expert Advisory Committee to Ephedra and as advisor to the National Institutes of HealthÂs Office of Dietary Supplements. Since 1992, he has served as Executive Director of the Utah Natural Products Alliance, which was instrumental in the development and passage of the Dietary Supplement Health and Education Act of 1994.

ÂGÃ©rard Pilley is a Pharmacist of the University of Paris and has been a professional in the pharmaceutical industry for 30 years. After a few years of experience with Laboratories LABAZ (now SANOFI), he embarked on a successful career of managing, creating and acquiring laboratories in France and abroad. He has been a member of several government commissions working on drugs and health products and has been an elected member of the National Council of Pharmacy for more than 10 years. He holds several patents for drugs currently on the market and has been a speaker at the Foundation for Innovation in Medicine (who coined the word Nutraceutical) since 1986. He is a member of the Editorial Advisory Board of several professional magazines. GÃ©rard Pilley was awarded the honor of ÂChevalier de lÂOrdre National du MÃ©riteÂ by the French Ministry of Health and was promoted as ÂOfficerÂ in 1998.

In addition to the two-day conference, Inside Beauty will also offer a Keynote Address by Cheryl Forberg, an anti-aging expert and nutritionist as well as best-selling author of ÂStop the Clock! Cooking: Defy Aging & Eat the Foods You Love," on Tuesday, September 27th at 12 Noon. The three-day exhibition floor at Inside Beauty, will bring together the established as well as emerging companies that are at the forefront of this new trend in beauty and personal care. Manufacturers and marketers of beauty and personal care products along with R&D formulators, drugstore and food market retailers, and medical and wellness spa owners will be able to source new minerals, proteins, oils, herbs, botanicals, functional foods and dietary supplements, distributors, packaging, private labels and finished goods that promote health, beauty and well-being.

Inside Beauty, is produced by HBA Health & Beauty America in partnership with Nutraceuticals World magazine, and is focused exclusively on the growing convergence of beauty, health and wellness in the cosmetics and personal care industries. Located alongside the 13th Annual HBA Health & Beauty America, the largest cosmetic and personal care product development event in North America, Inside Beauty will benefit from HBAÂs worldwide marketing and promotion campaign and is expected to draw attendees and exhibitors from Europe, Asia, North America, and South America. For more information on Inside Beauty visit www. inside-beauty. com or contact Laura Connolly, Project Manager, at lconnolly@cmpprinceton. com or call 1-609-452-2800, ext. 104.

CMP Princeton, Inc.

CMP Princeton, Inc., the producer of Inside Beauty and HBA Health & Beauty America, is a wholly owned subsidiary of United Business Media, London, UK, the leading international publishing, trade show organizer and B2B media company. For more information on HBA go to www. hbaexpo. com or call 1-609-452-2800.

Nutraceuticals World

Nutraceuticals World is the premiere industry trade magazine serving the dietary supplement, functional food and nutritional beverage industries. The magazine, which was launched in 1998, has achieved widespread industry recognition and acceptance and covers marketing and technology trends, regulatory developments, breaking research and new product news throughout the global nutraceuticals industry. It is published 10 times a year including a corporate profiles issue. Nutraceuticals World can be reached at 70 Hilltop Road, Suite 3000 Ramsey, NJ 07446; 201-825-2552; Fax: 201-825-0553; E-mail: nutraceuticals@rodpub. com; Website: www. nutraceuticalsworld. com.

# # #

Visiongain report places pfizer at pivotal moment

2011-04-01T21:31:00.000-07:00

Visiongain Report Places Pfizer at Pivotal Moment

Pfizer, the world’s first druggernaut, has sales of over $52 billion and profits of $14 billion and showed 17 percent growth from 2003 to 2004, far above the industry average. However, according to the latest visiongain report specifically focussed on the drug company, the next five years may not be as positive.

(PRWEB) November 4, 2005

Pfizer owns the patents to some of the world’s top drugs, including ten blockbusters (drugs with over $1 billion annual sales revenue), but the company is about to lose the patent protection to a number of key products, and consequently suffer significant income loss in a very short space of time. Patent protection is key to the product life span of drugs for the pharmaceutical industry, and is usually granted for a period of 20 years.

Lipitor, the world’s best-selling drug, will have patent protection until at least 2009, but is producing such high revenues that the generic companies are itching to gain some of the market share. Pfizer has already lost one patent court battle for Lipitor, admittedly in the relatively insignificant Austrian market. Even the market strength of Viagra is wilting as competitors take its market share.

“Although recent Q3 results from Pfizer were not as positive as many in the industry were expecting, they were not a surprise,” says Tristan Heath pharmaceutical market analyst at visiongain. “Whilst Pfizer have dominated the pharmaceutical industry in recent years, the latest downturn in sales and future profit warnings from Pfizer were predicted by visiongain in our latest report – Pfizer, Current Challenges and Future Difficulties, 2005-2010.”

Pfizer has not given up, and this year plans to spend a staggering $8 billion on research and development. However its search for the next blockbuster is not an easy one and visiongain doubts whether Pfizer will rely on their research alone for continued success. The $60 billion Pharmacia merger propelled Pfizer to the top but was a mixed blessing. Pfizer gained the rights to the painkilling blockbusters, Bextra and Celebrex, but these have suffered under the Vioxx scandal. Visiongain believes that Pfizer will look for other mergers to satisfy the demand for further growth.

As health authorities, particularly in the US and EU, try to reduce their expenditure on drugs still further, this visiongain report explores the key issues for Pfizer and how it plans to remain the most influential drug company in the world today.

Notes for editors: To receive your complimentary overview of - Pfizer, Current Challenges and Future Difficulties, 2005-2010 - Please, telephone Sara on +44 (0) 20 8767 6711 or visit www. visiongain. com. Please include your full name, title of publication, contact telephone number, email, and details of where you saw this release. Upon receipt of this information, an overview will be emailed to you.

Background:

Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and E-Zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the Defense sector.

For information on visiongain, please visit www. visiongain. com

###

Bycast announces storagegrid® 8

2011-04-01T09:30:00.000-07:00

Bycast Announces StorageGRID® 8

Latest version addresses needs of digital archiving market with game-changing capabilities

Vancouver, BC, Canada (PRWEB) November 17, 2008

Bycast Inc., the leading provider of storage virtualization software for large-scale digital archives, today announced the general availability of StorageGRID 8. This latest release sets a new standard for large-scale long-term digital archives by delivering an open platform that virtualizes information retention and access over a spectrum of storage devices ranging from high-performance disk to archival media, distributed over multiple sites.

In addition to providing a flexible, general purpose archive platform, StorageGRID 8 delivers the performance, scalability and reliability required by the most data-intensive applications.

Key New Features in StorageGRID 8 include:
Distributed File System Gateway: StorageGRID 8 features the new Distributed File System Gateway (DFSG), a high performance clustered file system front-end to complement StorageGRID's distributed multi-tier object store. By delivering the high performance and throughput of the DFSG clustered file system, together with the reliability and scalability of the StorageGRID distributed archive, StorageGRID 8 allows customers to easily scale their environments in support of a variety of applications. With this advancement, StorageGRID 8 provides a unified storage solution that integrates storage assets ranging from ultra-high performance disk to deep archive devices in a single system that is accessed by applications through a standard file system interface. Multi-Tenancy: StorageGRID 8 includes innovative multi-tenancy functionality specifically aimed at enabling service providers, as well as internal IT departments running their operations as a service, to address the rapidly emerging storage service provider market using the StorageGRID platform. Discrete security partitions ensure that multiple customers or departments leveraging the same storage service have their own independent secure archives. Enhanced Audit and Reporting: StorageGRID 8's enhanced audit and reporting capabilities provide improved usage tracking, enabling storage service providers and departments to implement per-transaction, per-byte, or per-asset chargeback models. VMware ESX Support: Customers can now run a number of StorageGRID components inside VMware, providing them with more implementation options to further reduce their data center server footprint and operational expenses.

Together with the launch of StorageGRID 8, Bycast is also announcing the availability of StorageGRID 8 Express Bundles for small and medium sized businesses. StorageGRID 8 Express Bundles are simplified configurations of StorageGRID which offer smaller enterprises the same robust platform used to protect some of the largest life-critical digital archives in the world, and are available for storage hardware systems from leading manufacturers.

"Our research indicates organizations are going to archive over 80,000 petabytes of file content over the next three years to meet regulatory, legal and business reference requirements," commented Terri McClure, an analyst with Enterprise Strategy Group. "We have seen an explosion in file data creation and retention as a result of the healthcare, pharmaceutical, media and entertainment and energy industries use of scale-out, file-based applications in the past few years, and we expect more markets to follow suit. This makes the introduction of StorageGRID 8 extremely timely as customers need a more efficient, cost-effective way to manage and retain their file-based information."

"With the ongoing transformation to digital, customers need to retain large and growing volumes of data for long periods of time," said Moe Kermani, Bycast's CEO and President. "StorageGRID is an established platform for large-scale digital archives and this release continues to raise the bar on scalability and performance. New capabilities enable customers to utilize StorageGRID across a broader set of data intensive applications, including the delivery of digital archiving as a service."

About Bycast
Bycast is the leading provider of storage virtualization software for large-scale digital archives. For organizations whose business depends on access to vital data, Bycast protects and preserves digital assets over their lifetime. Bycast software simplifies the management of massive fixed-content storage systems and enables organizations to optimize their storage infrastructure and ensure the integrity and availability of their valuable data assets. StorageGRID also enables the formation of archives that can scale to petabytes of data across hundreds of sites. StorageGRID is sold globally through OEM relationships with two of the world's major storage vendors. Bycast Inc. is a privately held company headquartered in Vancouver, BC. To learn more about the company and its solutions, visit www. bycast. com.

Media Contact
Annette Saliken
Director, Marketing Communications
Bycast Inc.
Tel.: (604) 692-3083
Email: asaliken @ bycast. com

###

Big pharma news - pharmaceutical and biotech sector news service

2011-04-01T00:13:00.000-07:00

Big Pharma News - Pharmaceutical and Biotech Sector News Service

A new automated news delivery service for the pharmaceutical and biotech community.

England (PRWEB) February 13, 2004 -

Big Pharma News (http://www. bigpharmanews. com (http://www. bigpharmanews. com)) provides news information for the pharmaceutical and biotech community - all from one central web site.

Keeping up with all the various news in this sector has become increasingly difficult. Big Pharma News has been designed with one goal in mind, to deliver all the pharmaceutical related content to one place.

There are numerous features available on Big Pharma News, including:

Over fifty news feeds, constantly updated - each feed is credited to its owner. Two ways to search for items; a standard key word search or a search from a pre-defined list of big pharma companies. Alert a friend of an interesting item, via email. Access 350 global leading research firms and consultancies for related reports. Option to customize your own report search.

The web site is an obvious advantage to people who require up-to-minute breaking news in pharmaceuticals, biotech and healthcare. Big Pharma News is working on content delivery to mobile devices such as phones and Personal Digital Assistants (PDA) to ensure that people who require pharmaceutical related news can pick it up wherever they are.

The service is also a bonus to the feed providers, increasing web site traffic direct to them from the links off their feeds. Big Pharma News is constantly looking out for feeds to add that will be of benefit to the pharmaceutical and biotech community.

Built on Java technology, this site implements third party utililities including the Technews aggregator engine, PortalWizard and RSSLibJ.

CONTACT INFORMATION:

Big Pharma News

Http://www. bigpharmanews. com (http://www. bigpharmanews. com)

###

Ink jet prints codes up to 64 mm high

2011-03-29T10:59:00.000-07:00

INK JET PRINTS CODES UP TO 64 mm HIGH

The Crayon X-tra large character ink jet printer from Imaje can use water or alcohol based inks allowing coding of both porous and non-porous substrate with one or two lines of type.

(PRWEB) March 17, 2002

Flexibility, reliability and ease of use are the main features of the Crayon X-tra large character ink jet case coder from Imaje. A choice of one or two 7 nozzle or one 16 nozzle print heads provides for one or two line coding with type from 10mm to 64mm high at up to 90 m/min.

The keyboard/display unit with two line, scroll-down LCD display can communicate with and control several printers, keeping hardware investment to a minimum, and a RS232 interface allows network connection to a central control computer. The large memory allows storage, up to 350 product codes of fifteen characters each, simplifies set-up at product changeover and minimises the risk of human input error.

Designed specifically for industrial coding applications, the modular Crayon X-tra is self-contained, robust and has a very high MTBF (mean time between failure). The only supplies required are compressed air with a fixed regulator to 0.5 bar and a 50/60 Hz electrical supply of between 90 and 250 volts at 0.5 A, making integration into an existing production line a quick and simple operation.

The large text memory and 2000 character print buffer combined with the selectable 5, 7, 14 and 16 dot character generators with adjustable pitch and single or double font printing, real time clock, Julian calendar and two counters allow a high level of coding customisation. The operator keyboard/display interface has access protection to minimise operator error by displaying only the required menu and is available in eleven European languages.

The unique head design is easy to clean without the use of special tools to keep maintenance and training costs to a minimum. The Crayon X-tra can use either water or alcohol based inks for coding onto porous or non-porous materials. Black and coloured ink is supplied in easy to change, 4.5 and 30 litre dispensers to match medium and high production rates. Printing can be to the side, top or bottom of the case for easy integration into the packing line.

Imaje UK Limited is a subsidiary of Imaje SA (part of the Dover Technologies Group), one of the world leaders in industrial coding and marking. The company specialises in the development and distribution of continuous ink coding and print & apply systems to the food and drink, pharmaceutical, mailing, aerospace component and cable industries. Imaje SA operates in more than 120 countries and its products and services are available through a network of 30 subsidiaries and more than 50 distributors.

ENDS

Karl d’cunha to speak at 10th annual valuation of hard-to-value securities and portfolio conference

2011-03-25T19:52:00.000-07:00

Karl D’Cunha to Speak at 10th Annual Valuation of Hard-to-Value Securities and Portfolio Conference

Houlihan Smith & Company, Inc. announced today that Karl D’Cunha will be featured as a keynote speaker on March 23 at the 10th annual Valuation of Hard-to-Value Securities and Portfolios conference titled “Mitigating Operational Risk Associated with the Valuation Process.”

Chicago, IL (Vocus) March 18, 2010

Karl D’Cunha (http://www. houlihansmith. com/index. php/about-us/professionals/16-karl-dkunha) is a Senior Managing Director at The Houlihan Firm and oversees the firm’s financial advisory practice. He is the head of the firm’s Hedge Fund Advisory Services Group (http://www. houlihansmith. com/index. php/services/asset-manager-services) and a team leader of the firm’s Technical Standards Committee. Mr. D’Cunha has over 13 years experience in the alternative investments industry, including working with some of the largest hedge funds globally on valuation, restructuring and M&A issues. Mr. D’Cunha has been actively involved in alternative and asset management industry related services since 1997 and has prepared, supervised, and consulted upon assignments to US and International private equity, venture capital and hedge funds, investment advisors, mutual funds, and other entities.

About the Houlihan firm:
Founded in 1996, The Houlihan Firm (http://www. houlihansmith. com/index. php/home) is a global investment banking firm that provides financial advisory and financing services to public and private businesses as well as asset managers. The Houlihan firm is recognized as a leading provider of financial opinions, financing, merger and acquisitions advisory, and other corporate advisory services. In addition, the firm is the forefront service provider to the hedge fund industry and works with 25 of Alpha Magazine’s Top 100 Hedge Funds. The firm’s tailored services include Portfolio Valuation (FAS 157 compliant); Distressed Asset Placement; Restructuring; and M&A Advisory to both alternative and traditional asset managers. The firm’s experienced professionals work across the globe from offices in Chicago, New York, Los Angeles, London, Toronto, and Accra (http://www. houlihansmith. com/index. php/contact-us).

About FRA:
Financial Research Associates and its divisions, Pharmaceutical Education Associates, Legal Education Associates, FRA webinars and Healthcare Education Associates, provide access to timely and focused business information and networking opportunities through top-level, executive summits, conferences and seminars. Offering highly targeted events, FRA positions itself as a preferred resource for executives and managers seeking cutting-edge information on the next wave of business opportunities in: Finance, Pharmaceuticals, and Legal Education.

Click Here To Register (http://www. frallc. com/register. aspx? ccode=b743)

# # #

Breast cancer thought leaders differentiate development compounds in new medpredict report

2011-03-25T04:10:00.000-07:00

Breast Cancer Thought Leaders Differentiate Development Compounds in New MedPredict Report

MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report in its oncology series entitled “Thought Leader Insight & Analysis: Breast Cancer,” designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area.

Scottsdale, AZ (PRWEB) March 12, 2010

MedPredict interviewed renowned North American and European breast cancer thought leaders to identify the most promising candidates in clinical development, as well as explore unmet needs.

“This report summarizes the perspectives of six world-class experts in the treatment of breast cancer,” according to MedPredict President Dr. Jeffrey Berk. “They provide their opinions on standards of care today and their expectations for experimental therapeutics. The Panel deals with a number of issues of importance to companies trying to differentiate their new drugs within a very crowded space, including strategies and clinical trial designs that will help to leapfrog more advanced competitors. They reveal the key indications worth pursuing, and the classes of drugs that can produce meaningful survival advantages for women with these breast cancers.”

Mechanisms/targets discussed in this report include: Angiogenesis inhibitors (VEGF / PDGF /FGF / VDA) , Antiresorptives, Antimitotics, Bcl2, glycoprotein NMB (GPNMB), HER2, HER2/EGFR, HER3, IGF1, MEK, PARP, PI3K / mTOR / AKT, WT1.

Companies/Partnerships included in this report: Abbott (ABT-737, ABT-888), Abraxis (Abraxane), Amgen (Prolia, AMG-479), AstraZeneca (olaparib, AZD-6244, AZD-8055), Bayer Schering Pharma (Bonefos), Bayer Schering/Onyx (Nexavar), BiPar/Sanofi-Aventis (BSI-201), Bristol-Myers Squibb (Ixempra), Celldex (CDX-011), Cell Therapeutics (Xyotax), Eisai (Eribulin), Exelixis/Sanofi-Aventis (XL-765, XL-147), Genentech (Avastin, Herceptin, Omnitarg, Genentech/ImmunoGen (trastuzumab-DM1), GlaxoSmithKline (Tykerb, 1120212, 690693), Merck (dalotuzumab, MK-4827, MK-2206), Merck/Ariad (ridaforolimus, deforolimus, MK-8806, AP-23573), Novartis (Zometa, BEZ-235, BGT-226, everolimus), Pfizer (Sutent, neratinib, figitumumab, AGO14699), Roche (Xeloda), and Sanofi-Aventis/Merrimack (MM-121).

The full report can be purchased by contacting MedPredict.

About MedPredict
MedPredict (www. medpredict. com) maintains a proprietary database of over 1,000 global physician thought leaders. Based on primary interviews with these thought leaders, MedPredict publishes periodic therapeutic area reports to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and presentations, as well as clinical, regulatory and marketing activity.

For more information contact:
Elizabeth Mathews
MedPredict
513.271.1924
Liz(at)medpredict(dot)com

###

The atticus group, llc launches new consulting service providing strategic marketing expertise to companies with novel medical technologies

2011-03-25T00:18:00.000-07:00

The Atticus Group, LLC Launches New Consulting Service Providing Strategic Marketing Expertise to Companies with Novel Medical Technologies

The Atticus Group's mission is to partner with medical technology companies to develop strategic marketing plans and tactical marketing initiatives which drive revenue growth and help them to achieve their business objectives.

Portsmouth, NH (PRWEB) September 22, 2009

The Atticus Group, LLC, a privately held company, announced today the establishment of its marketing consulting service for medical technology companies. Through this service the Company will provide both strategic planning and tactical marketing support to companies who are developing and commercializing novel medical technologies.

"Many companies with innovative new medical technologies are currently faced with the difficulty of managing both people and financial resources as they begin product commercialization efforts," stated Larry Yost, Managing Partner of the Atticus Group. "We offer an economical alternative for these Companies by providing the expertise needed to assess the market dynamics for their technologies and the creation of comprehensive marketing strategies designed to drive revenue growth."

Services (http://www. theatticusgroup. net/services) the Atticus Group offers include the assessment of the clinical value, market potential and competitive advantage for new medical technologies, the development of in-depth strategic marketing plans, as well as the development and implementation of clinical strategies which support product commercialization efforts. The Company also has the capability to create and develop marketing collateral which support tactical sales activities.

With experience across a wide range of medical and surgical markets, The Atticus Group is currently providing strategic marketing consultative services to both U. S. and foreign-based technology companies who are commercializing novel medical technologies in the U. S. and select global markets.

About The Atticus Group, LLC:
The Atticus Group's mission is to partner with medical technology companies to develop strategic marketing plans and tactical marketing initiatives which drive revenue growth helping them to achieve business objectives. The Atticus Group's primary focus is towards companies which have novel medical technologies being commercialized in the U. S. and select global markets. The Company also conducts technology due-diligence assessments for venture capital groups. The Atticus Group was founded by Larry Yost (http://www. theatticusgroup. net/background) who has over 25 years of domestic and international medical device and pharmaceutical company experience.

For more information on The Atticus Group, visit our website at http://www. theatticusgroup. net (http://www. theatticusgroup. net).

Contact information:
Larry Yost
Managing Partner
The Atticus Group, LLC
P. O. Box 455
Portsmouth, NH 03802-0455
(603) 969-5421
Www. theatticusgroup. net

###

Backus receives top martindale hubbell rating

2011-03-23T10:09:00.000-07:00

Backus Receives Top Martindale Hubbell Rating

Leland “Gene” Backus, receives AV® Preeminent™ 5.0 out of 5 Martindale-Hubbell Peer Review Rating.

Las Vegas, NV (PRWEB) March 1, 2010

BACKUS • CARRANZA (http://www. BackusLaw. com), a Las Vegas-based law firm with a reputation for handling complex litigation, recently announced that President and Senior Shareholder Leland Eugene “Gene” Backus had received an AV® Preeminent™ 5.0 out of 5 Martindale-Hubbell Peer Review Rating.

The ratings reflect the anonymous opinions of members of the Bar and the judiciary and attest to a lawyer's legal ability and professional ethics. To be rated, lawyers must meet the "very high" General Ethical Standards Rating and must also be rated on their legal ability. The rating includes one of three certification marks: AV® Preeminent™ (requiring 4.5-5.0 points), BV® Distinguished™ (3.0-4.4 points) or Rated (1.0-2.9 points). Legal ability ratings are rated on a scale of 1 to 5 (with 1 being the lowest and 5 being the highest), based on legal knowledge, analytical capabilities, judgment, communication ability and legal experience.

“I was very pleased to receive Martindale’s top peer rating,” says Backus. “During my career, I’ve enjoyed serving as chief trial counsel or regional counsel on some of the largest complex cases in the country, including the MGM Fire Litigation, Agent Orange, asbestos, Dupont Hotel Fire Litigation, the Pepcon Plant Explosion, Bone Screw Litigation, tobacco, diet drug and other medical/pharmaceutical complex and class action litigation. I like to specialize in highly complex and involved cases where my experience and capability as a litigator can be put into play. But, to have been named AV Preeminent, as well as to have received a 5.0 certification mark by my peers, is truly icing on the cake.”

About BACKUS • CARRANZA:
BACKUS • CARRANZA –a law firm holding an unparalleled reputation for handling complex cases – prides itself on getting results for corporate clients involved in construction, professional liability, insurance litigation, health care litigation and transactional matters. The firm represents hotels, general contractors, construction managers, subcontractors, design professionals, lawyers, physicians, hospitals, medical device manufacturers, product manufacturers, pharmaceutical companies and insurance companies. For more information, call (702) 872-5555 or visit http://www. BackusLaw. com (http://www. BackusLaw. com).

###

Sdi and cegedim strategic data announce oncology partnership -- agreement to jointly launch new oncology promotion audit service

2011-03-22T14:57:00.000-07:00

SDI and Cegedim Strategic Data Announce Oncology Partnership -- Agreement to Jointly Launch New Oncology Promotion Audit Service

SDI and Cegedim Strategic Data (CSD) will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011.

Plymouth Meeting, PA (Vocus) December 1, 2010

SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.

With a robust panel of medical and radiation oncologists and hematologists/oncologists, the monthly service will provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, details, messages, and promotional spending. The service will permit analysis by tumor type, staging, and modalities.

“The Oncology Selling Audit continues to extend SDI’s Promotional Audit Suite,” notes Andrew Kress, CEO of SDI. “SDI continues to be a leading company that tracks and reports on virtually all forms of biopharmaceutical promotion including personal, non-personal, and consumer channels. This service additionally complements SDI’s ability to provide real-time insights on the oncology disease and therapeutic marketplace through our other core data assets.”

SDI’s Promotional Audit Suite includes services that measure detailing, sampling, events, journal advertising, ePromotion, sales force sizes, and direct-to-consumer advertising.

CSD has Promotion Databases in 39 countries including the USA which also cover the above metrics.

“We are pleased to be partnering with SDI to bring this key service to the marketplace. This launch reaffirms the commitment to innovation that both organizations bring to healthcare measurement,” says Bruno Lempernesse, Chief Operating Officer Sales and Marketing of Cegedim Strategic Data. “This partnership will benefit from CSD’s global experience in Promotion Audits and allow for more in-depth analysis of sales and marketing strategies for all cancer treatments.”

More information about the Oncology Selling Audit can be obtained by contacting Kelly Sborlini at 484-567-6010 or ksborlini (at) sdihealth (dot) com.

About SDI:
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, retail pharmacy, and medical device companies, enabling them to better understand the healthcare market. SDI also serves the government and the financial services, media, and consumer packaged goods industries. Founded in 1982, SDI counts the world’s top 50 pharmaceutical and biotech firms as its clients. To learn more, please visit: http://www. sdihealth. com.

About Cegedim Strategic Data (CSD):
CSD is a leading Market Research company dedicated to the healthcare industry and operating worldwide. With over 36 years experience in the Pharmaceutical industry, CSD offers a comprehensive range of market research services and solutions to its customers, which include more than 50 global and 500 local Pharmaceutical companies. CSD integrates primary and secondary analyses with its medical expertise to meet its customer’s research needs. To learn more, please visit: http://www. cegedimstrategicdata. com.

About Cegedim:
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,600 people in more than 80 countries and generated revenue of €874 million in 2009. Cegedim SA is listed in Paris.

To learn more, please visit: http://www. cegedim. com.

###

Cataract surgery information and education website appoints additional editorial advisors <a href="http://www. Aboutcataractsurgery. Com" onclick="linkclick(this. Href)">www. Aboutcataractsurgery. Com</a>

2011-03-21T02:03:00.000-07:00

Cataract Surgery Information and Education Website Appoints Additional Editorial Advisors www. aboutcataractsurgery. com

Medical Management Services Group, L. L.C., managers of the Cataract Surgery & Lens Implant patient information and Cataract Surgeon Directory www. aboutcataractsurgery. com have appointed two new additional Editorial Advisors for 2009.

North Andover, Massachusetts (PRWEB) June 19, 2009

"Our current advisors are instrumental in the selection of articles that we present to patients wishing to learn about Cataracts, Cataract Surgery and Lens Implants (IOL's). We now welcome Eric Donnenfeld, M. D. (http://www. aboutcataractsurgery. com) of Ophthalmic Consultants of Long Island and Jeffrey Horn, M. D. (http://www. aboutcataractsurgery. com) of Vision For Life in Nashville to share in the workload of continuing to develop ideas and themes for new articles of importance to Cataract patients", said Katherine Carlisle, the Managing Partner of www. aboutcataractsurgery. com as well as the LASIK information and LASIK Surgeon Directory website www. seewithlasik. com.

Drs. Donnenfeld and Horn are widely respected Cornea, Refractive and Cataract Surgeons who are active in patient care, clinical research, publications and physician education in the areas of Cataract Surgery and Lens Implants. They both share a special interest in helping patients minimize or even possibly eliminate the need for eyeglasses, bifocals or reading glasses after Cataract Surgery through the implantation of advanced technology IOLs, including those that can correct astigmatism as well as those that correct near vision and presbyopia after Cataract Surgery.

"We are excited to have Dr's. Donnenfeld and Horn join our group of Editorial Advisors and are looking forward to their ongoing contributions to patient education on www. aboutcataractsurgery. com", said Ms. Carlisle.

In order to provide eye care consumers with the most unbiased information, unlike many websites offering information about Cataracts, Cataract Surgery, Cataract Surgeons or Lens Implants, www. aboutcataractsurgery. com does not accept funding, support or advertising from pharmaceutical, medical device, laser or lens implant companies.

CONTACT: Katie Carlisle, Medical Management Services Group, L. L.C.
978.470.8217

SOURCE: Medical Management Services Group, L. L.C.

# # #

Weekly venture capital activity week sep. 12, 2005 through sep. 18, 2005

2011-03-15T20:17:00.000-07:00

Weekly Venture Capital Activity Week Sep. 12, 2005 Through Sep. 18, 2005

Companies based in California operating in the software industry and that have raised their Series B financing round led the pack in the amount of venture financing raised this week. There were once again no initial public offerings this week.

San Diego, CA (PRWEB) September 23, 2005

www. CapitalHunter. com was able to verify that $342 million of venture capital was invested in 38 U. S.-based companies during this weekÂs reporting period. The average deal size was approximately 9.00 million. The amount of venture capital invested this period decreased by 21% compared to last periods $431 million.

Geographically, eleven California companies raised $93.32 million in new equity financing which was 29% of the total venture capital invested this reporting period. The largest private venture financing in California this period was invested into Freeborders. Freeborders raised $20 million and is a San Francisco based provider of technology solutions and outsourcing from China.

The software sector raised 34% of the venture capital this period. Sixteen software companies raised $112.8 million in venture financing. The largest private venture financing in the software sector this period went into Verid Software. Verid is a Ft. Lauderdale based provider of real-time identity verification and authentication solutions for companies in the financial services, telecommunications, retail, online-services and payment-processing sectors.

Companies raising theirSeries B financing round led this weekÂs venture capital activity. These financings represented 39% of the total venture capital deployed this period. The largest Series B private venture financing was placed into GlobeImmune. GlobeImmune is an Aurora, Colorado based pharmaceutical company developing immunotherapies for cancer and infectious diseases.

The three largest venture deals this period are as follows:

1 GlobeImmune Biotechnology $34.3 million

2 FreeBorders IT Services $20 million

3 Stoke Telecommunications $19.8 million

The following twelve and other unnamed investors funded the above mentioned top three venture capital investments for $74.1 million:

1 Adams Street Partners

2 Biogen Idec

3 GC&H Investments

4 Genentech

5 HealthCare Ventures

6 Kleiner Perkins Caufield & Byers

7 Lilly Ventures

8 Medica Holdings

9 Morgenthaler Ventures

10 Partners Healthcare

11 Sequel Venture Partners

12 Sequoia Capital

A total of 67 equity financings of private and public companies occurred during this reporting period. Each of the 67 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPEÂs, and IPOÂs.

About www. CapitalHunter. com

Www. CapitalHunter. com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the www. CapitalHunter. com searchable database to research newly and historic financings and to identify active investors.

You can still submit your business plan to CapitalHunter. com, for a free review by our experienced staff of analysts and see if you qualify for investment capital. Also, if you want to advertise with our newsletter (circulation 20,000) call us at 619-236-9998 and we can make an arrangement suitable for you.

Please visit www. capitalhunter. com and get immediate access. New subscribers can request a free investor analysis.

###

Rapid bio tests corp. Announces new president

2011-03-15T01:26:00.000-07:00

Rapid Bio Tests Corp. Announces New President

Rapid Bio Tests Corporation (OTCBB: RBIO), the (ÂCorporationÂ) is pleased to announce the appointment of Thomas F. Zimmerman Ph. D. as Director and President of the Corporation. Geoffrey V. F. Seaman Ph. D., who is resigning as President of the Corporation has been appointed Chairman of the Board of Directors in addition to his duties as CEO and Director. Dr. Zimmerman will report directly to Dr. Seaman.

(PRWEB) September 6, 2003

Springfield, Oregon (PRWEB)ÂSeptember 3, 2003ÂRapid Bio Tests Corporation (OTCBB: RBIO), the (ÂCorporationÂ) is pleased to announce the appointment of Thomas F. Zimmerman Ph. D. as Director and President of the Corporation. Geoffrey V. F. Seaman Ph. D., who is resigning as President of the Corporation has been appointed Chairman of the Board of Directors in addition to his duties as CEO and Director. Dr. Zimmerman will report directly to Dr. Seaman.

The Board of Directors of the Corporation is now comprised of Geoffrey V. F. Seaman Ph. D., Chairman of the Board, CEO and Director, Paul Hemmes Ph. D, CFO and Director, Thomas F. Zimmerman Ph. D., President and Director and Dr. David Regan, Vice President Medical Affairs and Director.

Dr. Seaman earned his Doctorate in Biophysics from Cambridge University in 1959.Dr. Seaman has over 30 years experience in the development and production of a variety of diagnostic test platforms. He is the author of more than 200 scientific publications and patents. He has been one of the principal organizers for the ÂLatex CourseÂ, a course given annually for the last twelve years, teaching the diagnostic community, diagnostic test development. The course since inception has had more than 1000 students from over 300 corporations attend and graduate. In addition, Dr. Seaman regularly provides review and consulting services to a variety of government agencies such as N. I.H. and various diagnostic and pharmaceutical companies.

Dr. Hemmes received his Doctorate in Physical Chemistry from the Polytechnic Institute of Brooklyn in 1976. He has been employed by various diagnostic companies in his career, both in the development of rapid diagnostic tests and in taking them from the development stage to the manufacturing stage. Dr. Hemmes has published over 60 articles and has eight patents. He specializes in diagnostics detection methodology.

Dr. Zimmerman received his Doctorate in Psychology from the University of Oregon in 1966. He has extensive executive experience, in corporate presentation, and has developed and executed a variety of marketing and business plans. He has authored numerous papers and made scientific presentations on a range of topics related to medical education, healthcare, and the role of technology. Dr. Zimmerman has extensive international experience in Europe, Russia, Mexico and South America; he served for several years as Medical Education Consultant to the World Medical Association.

Dr. Regan received his medical degree from the University of Southern California in 1969. He is a practicing hematologist and oncologist. Dr Regan has a strong entrepreneurial background with expertise in setting up clinical trials and quality assurance programs.

About Rapid Bio Tests Corporation

Rapid Bio Tests Corporation(www. rapidbiotests. com) is a diagnostics company, which has developed rapid diagnostic testing technology platforms, that will be used for the development and manufacturing of an array of rapid diagnostic tests. These tests will not require instrumentation or electricity and will be simple to use in the field or office and will only require a few minutes to produce a result. The initial tests that the Corporation is proposing to develop include; West Nile Virus, Hepatitis B, HIV 1 and 2, Tuberculosis, Bubonic Plague and the four strains of Malaria.

Rapid Bio-Tests Corporation

Contact: Dr. Geoffrey Seaman, Phone: 541-686-5989

Fax: 503-296-5990 info@rapidbiotests. com

Statworks, inc. Supports industry trials with openclinica enterprise

2011-03-14T14:04:00.000-07:00

StatWorks, Inc. Supports Industry Trials with OpenClinica Enterprise

StatWorks, Inc. announces it has selected OpenClinica Enterprise to facilitate Electronic Data Capture (EDC) for industry-sponsored clinical trials.

Research Triangle Park, NC (PRWEB) February 15, 2008

StatWorks, Inc., a contract research organization (CRO) specializing in statistical and data management services, announces it has selected OpenClinica Enterprise to facilitate Electronic Data Capture (EDC) for industry-sponsored clinical trials. StatWorks is one of the latest in a growing roster of CROs to rely on OpenClinica to power their clinical studies.

"OpenClinica Enterprise allows our company to benefit from a flexible, high quality EDC solution without assuming the risks inherent in proprietary technology and ongoing license fees," said Mark Paul, StatWorks' Chief Executive Officer. "We view OpenClinica as a long term strategic component to our company's continued growth."

Contract Research Organizations appreciate OpenClinica's flexible ability to support diverse clinical studies. The OpenClinica software makes it easy to quickly deploy studies, re-use study components like case report forms (CRFs), and operate multiple studies from a single system. The software can be set-up once and used in numerous studies without having to worry about large incremental costs.

OpenClinica Enterprise allows CROs and other clinical research organizations to obtain a spectrum of services (such as training, study set-up, and validation support) to enhance their use of the OpenClinica software. With OpenClinica Enterprise, an organization can maintain its independence from a software vendor while obtaining full support for a modern, robust clinical research (http://www. openclinica. org) technology platform. OpenClinica Enterprise products and services are delivered by Akaza Research of Cambridge, Massachusetts.

StatWorks, Inc
StatWorks, Inc., founded in 1997, is a growing clinical research firm that specializes in providing high quality statistical analysis, statistical programming, data management, and technical services to biopharmaceutical and medical device companies. The company's expertise spans all phases of clinical development from phase I to phase IV, as well as supporting regulatory filings and manuscript preparation. For more information, see http://www. statworks. net (http://www. statworks. net).

About OpenClinica®
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for download at http://www. OpenClinica. org (http://www. OpenClinica. org).

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www. akazaresearch. com (http://www. akazaresearch. com).

###

World health organization warning millions at risk from avian flu pandemic -- 'us unprepared for deadly avian flu,' abc news 9/29/05

2011-03-14T13:58:00.000-07:00

World Health Organization Warning Millions at Risk from Avian Flu Pandemic -- 'US Unprepared for Deadly Avian Flu,' ABC News 9/29/05

The World Health Organizaton is warning about a Global Health Pandemic from Avian Flu. The medication needed to fight the virus is known but in short supply in US as only 2.5 million doses are available when 200 million may be required. Consequently, Americans may have to buy medications on line from Canadian prescription companies like www. LePharmacy. com just as they did during the Flu vaccine shortage of 2004.

(PRWEB) October 4, 2005

Scientists from the World Health Organization are again sounding the alarm on the influenza A (H5N1) virus, Z strain, commonly known as "Bird Flu". The virus, which first appeared in Hong Kong in 1997, could mutate genetically, making it easier for humans to catch and transmit the disease among themselves.

Avian Influenza is an infectious disease of birds caused by Type A strains of the flu virus. The WHO says that 57 people have died in Indonesia, Vietnam, Thailand and Cambodia mainly from contact with infected birds. The real danger is the increasing number of human cases and the highly infectious nature of the virus. The mortality rate for infection is 75 per cent. Only Ebola and Rabies come close at about 50 %.

Signs the disease has spread recently to birds in Russia and Kazakhstan are adding to concerns, the WHO says. When asked whether he thought a widespread outbreak in humans was imminent, Jong - Wook Lee, Director General of the WHO said: "We don't know when it will come. But it would be hugely irresponsible if the WHO and member states did not take preventive measures now." Accordingly, the WHO has made plans to have three million treatments of a medication called Tamiflu stockpiled in case of a pandemic in humans.

Tamiflu (Also known as Oseltamivir) is an antiviral drug primarily invented for the purpose of treating influenza. Tamiflu can also prevent the onset of flu even if you have been exposed to people who have it. Tamiflu is the only drug that is effective in stopping the Avian/Bird Flu from spreading once exposed.

A draft report of the US Federal Government's Avian Flu emergency plan predicts that as many as 200 million Americans could be infected. Roche Pharmaceutical, the manufacturer of Tamiflu, has set up a first come, first served waiting list and the US is nowhere near the top of the list. According to Laurie Garrett, senior fellow for global health at The Council on Foreign Relations, the current US stockpile for Tamiflu treatments is only around 2.5 million. When asked why the United States did not order Tamiflu earlier, US Health and Human Services Secretary Michael Leavitt said, "I can't answer that. I don't know the answer."

To many Americans, this sounds distressingly familiar to the 2004 flu shot shortage that saw US citizens flocking north to Canada and enlisting the help of Canadian prescription drug agencies like www. LePharmacy. com. " The prospect of having to protect oneself and one's family against Avian Bird Flu is gaining momentum" said Ross McKinlay, Director of Sales at www. LePharmacy. com a leading online Canadian pharmacy intermediary. He also added " beware of those companies that offer Tamiflu without a prescription. I know that much of this non-prescription Tamiflu is being sourced through Turkey and other similar countries that do not have the same strict health standards as the US and Canada. Neither the quality nor the manufacturer can be guaranteed. LePharmacy. com provides Tamiflu from Roche Pharmaceuticals only. We don't compromise the patient's health for the sake of profit."

Www. Le Pharmacy. com, based in Edmonton, Alberta, is a leading online Canadian mail-order agent for a Canadian Pharmacy. Our Internet site offers discounted affordable Canadian drugs without delays. Everyday we help thousands of Americans obtain high quality prescription drugs with our easy-to-use drug ordering system. To get further information and possible savings on drugs from Canada, please call us toll free at 1-888-453-6275, 24 hours a day, 7 days a week. To order online or register to receive our weekly newsletter, please click on www. LePharmacy. com.

# # #

Promotetop announces new industry-specific website marketing packages

2011-03-13T03:13:00.000-07:00

PromoteTOP Announces New Industry-Specific Website Marketing Packages

PromoteTOP Web Marketing, a leading Internet marketing firm, announced today it has launched new website marketing plans specifically designed to serve companies in select vertical industries and market sectors. These innovative plans are the result of market demand and customer requests for solutions that would meet the special online marketing needs that uniquely characterize each industry.

Debary, FL (PRWEB) November 19, 2005

The first industry-specific marketing package was developed by PromoteTOP to serve Travel, Tourism and Hospitality websites. The success of this first package lead to the introduction of additional packages now serving websites and companies in the following sectors: Financial Services, Real Estate, Legal, Consulting, Health, Medical and Pharmaceutical, Gaming, E-Commerce and Online Shopping.

"We are delighted with our new service range. We now have an unparalleled ability to offer a complete, professional, website marketing service that is tailored to fit the industry-specific needs of companies in select industries." said Dave Gilis, CEO of PromoteTOP.

The first package designed for the travel industry has became particularly popular with hotels, motels and other hospitality websites. When promoting each accommodation or hotel, there are many variables to be taken into consideration. For example, users can select numerous terms when searching for a hotel: motel, inns, resort, accommodation, rooms, lodging, B&B, bed and breakfast, suite, etc. When people are planning travel online their search parameters also include the local and geographic parameters they select, and they may also combine additional specific requirements in their search query such as ‘conventions’, ‘family rates’ or ‘spa’.

A standard SEO company can’t understand these industry-specific characteristics and that’s where PromoteTOP comes in. The company offers packages of search engine marketing services specifically targeted to respond to search terms and search sites used by the traveling public. Our website marketing services solves many of the visibility problems currently facing this industry.

Many owners of accommodation properties have been too busy running their businesses to actively pursue search engine marketing. This has allowed discounters to successfully become intermediaries between the hotels and their customers. PromoteTOP helps hotel operators to position their web sites properly in search results, allowing them to take control over the sales channels, thus diminishing the impact of the third part vendors.

Founded in 2000, PromoteTOP Web Marketing is a leading provider of website marketing services, including guaranteed search engine placement. The company offers industry-specific marketing plans that cater to websites in the travel, tourism, hospitality, real estate, financial services, legal, medical, gaming, health & pharmaceutical industries. The PromoteTOP Website provides a valuable collection of free Internet marketing tools, articles and resources. PromoteTOP is located in Haifa Israel with representation in Boston, MA, and can be found on the web at http://www. promotetop. com (http://www. promotetop. com).

###

kiralik-arabalar

Ellen de brabander, phd, named head of global r&d, merial ltd

Point of care dispensing improves doctor-patient relationships

The sweetest little shop in winston salem has just celebrated its first birthday

Uv-visible-nir microscope for broadband inspection

Apriori beauty launches celloxylin md

The ugly truth about commercial cosmetics

Buy soma and carisoprodol online in the privacy of your own home at us-meds. Com

Mediregs, inc. Acquires the compliance products of ihs health group, expands library of resources for the medical compliance and reimbursement industriesmediregs, inc. Acquires the compliance products of ihs health group, inc

Protection for the modular data center

New year's resolution: tackle ugly, yellow toenails and wear sandals this summer

American corporate identity honors mcmillian design

Pharmavoxx selected by med ad news as one of three most innovative pharmaceutical marketing ventures for its superior competitor intelligence database

It is becoming more cost effective to move pharmaceuticals production overseas. How is this going to affect your business&#194; viability now and in the future?

Gridlogics launches chemical patent analysis edition of patent insight pro – chempat™ edition

Johnson & johnson wins economist intelligence unit awards programme

Marine biotech revenues projected to reach $3.78 billion by 2012, according to new report by global industry analysts, inc

Latin america gets first taste of what's hot: beverage products in aluminum bottles

Mitchell joins amohs™, inc. Board of directors

Biodreaming: express through art what biotechnology means to you

Carterbaldwin executive search places former schering plough exec joe ciaffoni at atlanta's sciele pharma

Growth hormones direct teams up with fight magazine

Applied clinical trials european summit launches networking forum for 2007

Less medicine, better compliance: a revolution in the treatment of illness?

The lanier law firm opens new york office

Teleosis institute's "green pharmacy program" reduces pollution in the san francisco bay

&Amp;#20013;&#22283;&#29983;&#29986;&#30340;&#21697;&#36074;&#25215;&#35582

Cme outfitters announces new rheumatology cme snack series

Physicians total care helps connecticut facility get started with physician medication dispensing

A company overview of shire pharmaceuticals group plc including information about 46 deals made and 53 partnering companies

Legalview recounts the results of a recent mesothelioma study that reported high survival rates among patients taking new treatment

Colorado confirmed as top bioscience state by national rankings

Piribo: new publication announcement, medicines, ethics and practice a guide for pharmacists

Index ventures closes €350m fund and appoints three new partners

Launch of cancertreatmentmedicine. Com: characteristics of the main drugs used for the treatment of cancer

Pharmaceutical/biotech stability storage facility opens

Vapor4life explains what is in the &quot;juice&quot; known as propylene glycol

Selling warehouse direct indonesian furniture online

No walls needed! Freestanding rotocube rotating bulletin towers put information on the shop floor in the work cell

Age productions lends a hand to jane pauley

Thinspring will be exhibiting at the dia global electronic labeling seminar on sept. 26-27, 2006

Tippingsprung fields second brand-naming survey -- survey, in collaboration with brandweek magazine, identifies best and worst brand names in 10 popular categories

Impact unlimited adds bill smith as senior creative director and launches new west coast office moves bolster top-tier creative capabilities, strengthen west coast presence

6995diabetes. Com targets the uninsured with discount diabetes testing kit

First four teams of world renowned scientists answer starting gun for competition to win the muthuselah mouse prize

Artcraft health education has been recognized in the healthcare marketing report for interactive patient education solutions

Beware of fake cures & other medical frauds on the web

Citybook. Com launches a unique, family-safe online yellow pages directory

Center for terrorism law announces legal conference on state open government law and practice in a post-9/11 world at national press club, nov. 15-16

San francisco pharmacy earns industry’s top quality & safety endorsement

Blair underwood's "man up" ad campaign promotes ahf's free hiv testing services

Bidclerk reports construction projects up for bid in the chicago, il area

College of microscopy changes its name to hooke college of applied sciences

Webhelps announces launch of new wiki package

Scirex appoints samer e. Kaba, md, as vp clinical research and medical management

Argo translation’s solution for medical device translation receives iso 9001:2008 certification from t&#220;vrheinland&#174

Drug-free rehabilitation proves successful

Free prescription drugs available

Introducing directorsofpharmacy. Com

Announcing the spazz-g, by colours wheelchairs: no compromise necessary

Us pressure sensing markets see two bright spots

Launch of hematology oncology pharmacy association

Electromagnetic flowmeter technology leader introduces new website and magnew two wire plus magnetic flowmeter that slashes installation costs

Legalview reveals details of the fda mandated black box warning for fluoroquinolone antibiotics such as cipro and levaquin

Drugs in our drinking water? How to dispose of your medications safely

Gilead alberta receives ‘best practices award’ for improving pharmaceutical batch process with foxboro ph sensors

Are perceived savings of plan d worth the hassle

New multiplex tissue biomarker service launched to advance companion diagnostics development in a regulated environment

Medical professionals on call 24/7

A safe, non-toxic solution found for the world wide head lice epidemic

Venture capital investment rises 37% this week to $413 million

Tamiflu approved for use against swine flu, but timing is a critical factor in the drug's effectiveness, cautions doctorsolve

Sai systems awarded gsa idiq contract from gsa - ecoe

Netunity software releases the wsrp. Net framework 3.0

Nusil technology debuts ultra-soft elastomer with gel-like properties

Irody and medminder launch new software and medical technology to automatically manage medications and track patient adherence

Inside beauty taps industry leaders for advisory board - nutraceutical & personal care innovators to lead conference program development

Visiongain report places pfizer at pivotal moment

Bycast announces storagegrid&#174; 8

Big pharma news - pharmaceutical and biotech sector news service

It is becoming more cost effective to move pharmaceuticals production overseas. How is this going to affect your businessÂ viability now and in the future?

&Amp;#20013;國生產的品質承&#35582

Vapor4life explains what is in the "juice" known as propylene glycol

Argo translation’s solution for medical device translation receives iso 9001:2008 certification from tÜvrheinland&#174

Bycast announces storagegrid® 8